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Introduction
In our daily lives we constantly try to make the best choices. For example, you and 
a friend go out for dinner and can choose between two restaurants; the curry 
restaurant where you both have enjoyed good and tasteful food before or the pizza 
place that has pizza’s that are too thick to your taste. Based on your prior 
experiences you decide to go to the curry restaurant and anticipate on having 
good and tasteful food again. However, unbeknownst to you, the restaurants hired 
new cooks, and this time the curries were not as tasteful as you anticipated, 
lacking the depth of flavours that you so much adored.  Disappointed, you and 
your friend walk along the pizza place and through the window you see beautiful 
thin pizza’s, still sizzling from the oven. The pizza restaurant also hired a new 
cook that now makes much better pizza’s than before! 
Making the right choices and adapting to changes in the environment requires 
knowing which behaviour is currently rewarded or punished. This adaptive 
behaviour is complex and can be divided into multiple sub-processes. In the 
example above we can dissociate three processes that are needed to have a 
successful dinner evening. First, you need to acquire the knowledge that one 
restaurant serves good food and that the other restaurant serves bad food. Secondly, 
you need to flexibly update your knowledge about the restaurants when the quality 
of the food improves or becomes worse (i.e. prediction updating). Lastly, based on 
your current knowledge about which restaurant serves good food and which one 
serves bad food (i.e. the expected outcome), you will need to decide to which 
restaurant you will go this time (i.e. action selection). 
The research in this thesis focuses on the second process; how people keep track of 
which restaurant serves good food and which restaurant serves bad food in a 
constantly changing world. A crucial aspect in this process of adaptive learning is 
the use of outcome events to update the expected value of the outcome. The first 
step in this updating process is the calculation of a prediction error, that is, the 
difference between the expected and experienced outcome. A prediction error can 
be negative, e.g. when the food is worse than expected, or positive, e.g. when the 
food is better than expected. These prediction errors are then used to update the 
value of the expected outcome, such that when the prediction error is positive the 
expected value increases and when the prediction error is negative the expected 
value decreases. 
Dopamine has been shown to signal these prediction errors and is therefore 
thought to play an important role in prediction updating and associative learning. 
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In the literature, various tasks have been used to measure dopamine’s effects on 
adaptive behaviour and prediction updating. Box 1 describes three different tasks 
that have been used in studies referred to in this introduction (a probabilistic 
reversal learning paradigm, a probabilistic selection task and a deterministic 
reversal learning paradigm). In this thesis I have used the deterministic reversal 
learning task to investigate the modulatory role of dopamine in the process of 
prediction updating based on unexpected rewards and unexpected punishments. 
Unlike most other tasks that are used to study reward and punishment learning, 
this paradigm allows the direct comparison of reward and punishment prediction 
updating, while controlling for instrumental action-selection processes (see Box 1). 
This allowed me to investigate how dopamine shifts the balance between learning 
from reward and learning from punishment. 
Inter- and intra-individual variability in dopaminergic drug response
One way to study dopamine’s effects on human behaviour is by assessing the 
effects of dopaminergic drugs, either in healthy individuals or in patient groups 
that are treated with dopaminergic medication. However, previous studies that 
investigated adaptive behaviour in response to rewards and punishments revealed 
different and paradoxical effects. While some studies showed dopaminergic drug 
effects on punishment, but not reward learning (Cools et al., 2007; Dodds et al., 2008; 
Clatworthy et al., 2009; Voon et al., 2010b), other studies revealed dopaminergic drug 
effects on reward, but not punishment learning (Pessiglione et al., 2006; Voon et 
al., 2010a; Jocham et al., 2011). Indeed, the relationship between brain dopamine 
and task performance is complex and current evidence indicates that there is a 
large variability in drug response, both within individuals as well as between 
individuals. Thus, when using different cognitive tasks, it has been demonstrated 
that dopaminergic drugs can improve and impair task performance within the 
same subjects depending on the nature of the task (Cools et al., 2001; Mehta et al., 
2001; Cools et al., 2006; Frank and Claus, 2006; Clatworthy et al., 2009; Cools 
and D’Esposito, 2011). Accordingly, one reason for the inconsistent findings in 
previous work could relate to the fact that these studies used different tasks that 
each measure different aspects of adaptive behaviour (Box 1). In addition, it has 
also been shown that dopaminergic drug effects differ between individuals 
depending on clinical status (Mehta et al., 2004a; Voon et al., 2010a; Voon et al., 
2010b), baseline levels of working memory capacity (Kimberg et al., 1997; Mehta et 
al., 2000; Mehta et al., 2001; Frank and O’Reilly, 2006) and baseline levels of 
dopamine in underlying brain structures (Cools et al., 2001; Cools et al., 2009). 
Accordingly, another reason for inconsistent findings in previous work could 
relate to characteristics of the individuals tested. 
1Introduction
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Box 1  Measuring flexible updating of outcome predictions
The probabilistic reversal learning paradigm: The most frequently used task to investigate 
flexible prediction updating is the probabilistic reversal learning paradigm (Swainson 
et al., 2000; Cools et al., 2002) (Figure 1). In this task subjects are instructed to repeatedly 
choose between two visual stimuli presented on a screen. In the initial acquisition stage, 
subjects learn by trial and error that choosing one stimulus leads most often to reward 
(e.g. with a ratio of 80:20 for reward and punishment outcomes) while choosing the other 
stimulus leads most often to punishment. As such, subject usually learn to maximize 
reward outcomes by consistently choosing the visual pattern associated with 80% reward 
outcomes, despite the occasional ‘probabilistic’ punishment outcomes. When subjects 
have acquired this initial response pattern, contingencies are reversed without a warn-
ing, such that choosing the previously rewarding patterns will lead to 80% punishment 
outcomes while choosing the previously punished pattern will lead to 80% reward out-
comes. To optimize reward outcomes in this reversal stage, subjects will have to adapt 
their behaviour to choosing the previously punished stimulus. Because subjects learn to 
ignore probabilistic punishment outcomes they will initially perseverate in choosing the 
previously rewarded stimulus and only reverse to choosing the newly rewarded pattern, 
when they notice that the punishment outcomes occur more often than expected. Thus, 
to be able to notice the reversals, subjects will need to keep track of changes in outcome 
occurrences, by comparing actual outcome occurrences with those expected based on 
the initial acquisition stage.
Figure 1  The probabilistic  
reversal-learning task. 
An example of several trials in the 
probabilistic reversal-learning task is 
shown (running from bottom to top). 
On each trial, subjects are presented 
with two abstract visual patterns. 
 Using trial- and-error feedback, subjects 
discover which of the two patterns is 
correct (here indicated by a small 
 arrow on top of the pattern). After 
subjects have chosen one of the two 
patterns, feedback (a green smiley 
face or red sad face) is presented. 
Reprinted with permission from 
(Cools et al., 2002). 
Chapter 1
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Box 1  Continued
Non-pharmacological imaging studies revealed that this task implicates the ventral  striatal 
and ventrolateral prefrontal regions during final reversal errors, thus right before 
 individuals switched their choices to the newly rewarded pattern (Cools et al., 2002; 
Remijnse et al., 2005). In addition, pharmacological work revealed that dopaminergic 
medication modulates only striatal and not prefrontal activity during final reversal 
 errors (Cools et al., 2007; Dodds et al., 2008), suggesting that striatal dopamine may play 
an important role in this form of reversal learning. This was further supported by the 
observation that drug-induced changes on reversal performance were associated with 
drug-induced changes in D2 receptor availability in the striatum, as measured with 
 positron emission tomography (PET)(Clatworthy et al., 2009). 
Although the probabilistic reversal learning paradigm nicely captures the selection 
and decision processes as seen in real life, it also has its limitations. For example, the 
 probabilistic reversal learning task is instrumental, meaning that the outcomes always 
depend on subjects’ responses or actions. As a consequence, reversals are always signalled 
by accumulating negative performance feedback. Accordingly, this task only provides 
information about reversal learning from punishments (or negative performance feed-
back) and does not allow comparing reversal learning from punishments with reversal 
learning from rewards.
The probabilistic selection task: To better evaluate whether subjects learn more from rewarding 
outcomes than from punishing outcomes or vice versa, Frank et al., (2004) developed 
the probabilistic selection task (Figure2). The first phase of this task is similar to the 
acquisition stage of the probabilistic reversal learning task, but now subjects learn to 
choose the most rewarding stimulus for three different probabilistic stimulus pairs 
(AB, CD, EF). The probability for reward and punishment outcomes is 80:20 in the AB pair, 
70:30 in the CD pair and 60:40 in the EF pair. After subjects have learned to choose A, C 
and E over B, D and F, novel combinations of stimulus pairs are created including either 
stimulus A (AC, AE, AD, AF) or stimulus B (BD, BF, BC, BE). In the second selection stage 
subjects are asked to select the best stimulus, while no feedback is given. Behavioural 
measures from this second stage reveals whether subjects are better at choosing the most 
rewarding stimulus (A) over less rewarding stimuli (C or E) or to avoid the most punishing 
stimulus (B) over less punishing stimuli (D and F). Differential behaviour between the 
A and B pairs are thought to reflect differential learning from rewarding outcomes and 
punishing outcomes, respectively. Neuroimaging work revealed that better reward learning 
after sulpiride administration was accompanied by larger prediction error related activity 
in the striatum (Jocham et al., 2011) supporting the role of striatal dopamine in this task.
1Introduction
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Box 1  Continued
Figure 2  Example of stimulus pairs in the probabilistic selection task. 
Each trial, one of three pairs is presented and the subject selects one of the two stimuli. 
The frequency of positive feedback in the first stage of the task (train) is shown. In the 
second stage of the task (test) new combinations are formed in which stimuli A and B are 
paired with the other stimuli.  Reward and punishment learning is assessed by choose-A 
accuracy and avoid-B accuracy, respectively. 
Reprinted with permission from (Frank et al., 2007a).
Although the probabilistic selection task provides a good way to disentangle reward and 
punishment learning, it only provides information about the acquisition of stimulus-out-
come associations and not about the flexible updating of outcome predictions in a chang-
ing environment. 
The deterministic reversal learning paradigm: To disentangle reward and punishment based 
updating of stimulus-outcome associations Cools et al. (2006) developed a new determin-
istic reversal learning paradigm (Figure 3). In this paradigm, subjects are presented 
with two stimuli, a face and a scene. The subjects are told that one stimulus is always 
followed by a reward and the other stimulus is always followed by a punishment. In 
contrast to the instrumental paradigms described above, subjects do not choose between 
two stimuli, but instead are instructed to predict the outcome of a pre-selected stimulus, 
as in the better known weather prediction task (Moody et al., 2004). After the prediction, 
the actual outcome is presented. Thus, subjects are not provided with performance feed-
back but simply have to match their prediction with the actual outcome. When subjects 
learn to correctly predict the outcomes, contingencies reverse, such that the stimulus 
that was previously followed by reward is now followed by punishment and the stimulus 
that was previously followed by punishment is now followed by reward.
Chapter 1
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Box 1  Continued
+
ITI:  1500-6000 ms
Stimulus: until response
max 1500 ms
Outcome: 500 ms
- €100
Delay: 1000 ms
Selected stim: F  F S F S S F S F S S F 
Correct prediction: rw rw pn rw pn rw pn rw pn rw pn rw
Outcome: R R P R R R P R P P P R
Trial type: ER ER EP ER UR rev EP ER EP UP rev ER
Figure 3  The deterministic reversal learning paradigm. 
a) Two stimuli, a face (F) and a scene (S), were presented simultaneously. One of the two 
stimuli was highlighted with a black border and the participant’s task was to predict, with 
a right or left button press, whether this stimulus was followed by a reward (rw, a happy 
smiley with a + €100 sign) or a punishment (pn, a sad smiley with a -€100 sign). The actual 
outcome was presented after the participant’s prediction (100% deterministic). b) An example 
of a trial sequence. The participant learned to predict reward and punishment for the 
face and scene respectively; expected reward (ER) or expected punishment (EP). After 4-6 
consecutive correct predictions, the stimulus-outcome associations were reversed which was 
signalled by either unexpected reward (UR) or unexpected punishment (UP). Performance was 
measured on reversal trials (rev) immediately after the unexpected outcomes Reprinted 
from chapter 2.
With this new reversal learning paradigm it is possible to investigate prediction updating 
in two conditions; one condition in which reversals are signalled by unexpected rewards 
(reward condition) and one condition in which reversals are signalled by unexpected 
punishment (punishment condition). The critical behavioural measure in this task is the 
accuracy on the trial directly following these unexpected outcomes, i.e. the reversal 
trials, which measure how well subjects update their stimulus-outcome associations in 
response to unexpected rewards or unexpected punishments. An important advantage 
of this paradigm is that it enables comparisons between reward and punishment based 
reversal learning, while controlling for response maintenance versus switching.  Thus, 
a
b
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In this thesis I have further explored these factors and underlying neural mechanisms 
of individual variability in dopaminergic drug response in both healthy young 
adults as well as in patients with attention deficit hyperactivity disorder (ADHD). 
Exploring factors that determine variability in dopaminergic drug response is 
important for several reasons. First, many patients, such as those suffering from ADHD 
or schizophrenia, are treated with dopaminergic drugs. However, drug treatments are 
not always effective and often accompanied by unwanted side effects. It is currently 
unclear why some patients benefit from such pharmacological treatments, while 
others do not. Investigating the individual variability in drug response may 
therefore increase our understanding of both drug-induced improvements and 
impairments in these patient groups. This knowledge may ultimately advance the 
individual tailoring of clinical drug treatments. Second, a trend has been identified 
of increased use of dopaminergic psycho-stimulants in healthy students, with the 
purpose to enhance academic performances (Greely et al., 2008; Smith and Farah, 
2011). However, given current discrepancies on the effects of these drugs between 
clinical and healthy populations, it is unclear whether these drugs help or hamper 
behaviour. Accordingly, studying the variability of drug effects within and between 
individuals is not only relevant for psychiatry and clinical drug treatments, but is 
also relevant to better understand the effects of these agents in healthy subjects.    
The inverted-U hypothesis
One theory suggests that the within- and between-subjects variability described 
above reflects an inverted U-shaped relationship between brain dopamine and 
cognitive functioning (Swainson et al., 2000; Cools et al., 2001), with both too little 
as well as excessive dopamine levels impairing cognitive functioning (Arnsten, 
1997; Zahrt et al., 1997; Arnsten and Goldman-Rakic, 1998). This hypothesis is 
Box 1  Continued
any differences between reward and punishment reversal trials can be attributed to the 
valence of the preceding unexpected outcomes (i.e. valence-dependent reversal learning) 
while similar effects on reward and punishment trials may relate to common processes, 
such as the need to switch responses (i.e. valence-independent reversal learning). Note, 
however, that this paradigm does not dissociate between punishment, negative outcomes 
and reward omissions. Using this dissociation Robinson et al., (2010a) revealed signal 
changes in different striatal subregions for valence-dependent and valence-independent 
reversal learning, with the posterior dorsal striatum responding only to unexpected 
reward, and the anterior ventral striatum responding to both unexpected punishment 
as well as unexpected reward.
Chapter 1
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empirically supported by experimental animal work with monkeys demonstrating 
that low doses of D1 receptor agonists improve working memory maintenance, 
while high doses of D1 receptor agonists impair working memory maintenance 
(Zahrt et al., 1997; Kroener et al., 2009). However, most human dopaminergic 
drugs, as used in the studies described above, act primarily on D2  rather than on 
D1 receptors. Accordingly, it was suggested that a similar inverted U-relationship 
might exists for D2 receptor functioning (Cools and D’Esposito, 2011). In line with 
this suggestion, Cools et al. (2009) demonstrated that the effects of the D2 receptor 
agonist bromocriptine depend on baseline dopamine levels as measured with 
positron emission tomography (PET). While bromocriptine improved reward 
versus punishment learning in subjects with low striatal dopamine levels, it 
impaired reward versus punishment learning in subjects with high striatal 
dopamine levels. Similarly, in another study it was demonstrated that 
bromocriptine improved cognitive flexibility only in subjects with genetically 
determined low dopamine levels (van Holstein et al., 2011). To further investigate 
the neurochemical mechanisms underlying these individual differences in 
dopaminergic drug response (Cools and D’Esposito, 2011), I have tested the effects 
of the D2 receptor agonist bromocriptine, the D2 receptor antagonist sulpiride and 
the dopamine transporter blocker methylphenidate on flexible prediction 
updating. These drugs each affect dopamine functioning in a slightly different 
manner (see Box 2).  This allowed us to draw more specific conclusions about the 
neurochemical mechanisms underlying individual differences in dopaminergic 
drug effects. 
A model of reward and punishment learning
Neurobiologically informed computational models of valence-based learning 
provide a mechanistic account of the paradoxical effects of dopaminergic drugs 
on reward and punishment learning described above (Cohen and Frank, 2008). 
These models use simplified neuronal units and neural dynamics to help 
understand how specific circuits and their modulation by dopamine can support 
cognitive functions such as action selection and reinforcement learning. One 
group of nuclei, the basal ganglia, played a central role in the development of an 
influential model of reinforcement learning (Frank, 2005). This model proposes 
that dopaminergic signals for positive and negative prediction errors modulate, 
respectively, the learning from rewards by altering activity in the direct pathway 
of the basal ganglia and the learning from punishment by altering activity in the 
indirect pathway of the basal ganglia. The basal ganglia can be described at several 
levels, including the global organisation of cortico-basal-ganglia-thalamo-cortical 
circuits, the modulatory role of dopamine, the differential actions of D1 and D2 
receptor subtypes and the differential effects of pre- and postsynaptic receptors. 
1Introduction
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Box 2  Pharmacological agents
Bromocriptine (Parlodel®): 
Bromocriptine is a dopamine-receptor agonist and has a direct stimulating effect on D2 
receptors. Clinically, it is used for the treatment of Parkinson’s disease to reduce motor 
symptoms (Pharmacotherapeutisch Kompas). Bromocriptine can act on both pre-synaptic 
and post-synaptic D2 receptors (Jackson et al., 1988). While stimulation of post-synaptic 
receptors mimics the effects of endogenous dopamine, D2 autoreceptor stimulation 
decreases synaptic dopamine release and synthesis and thereby, indirectly reduces 
post-synaptic receptor stimulation (Stahl, 2013). Pre-synaptic D2 autoreceptors are found 
to be more sensitive than postsynaptic receptors and thus are stimulated at lower doses 
(Skirboll et al., 1979). In line with that, bromocriptine has shown to produce biphasic 
motor effects, with low doses producing motor depression through stimulation of D2 
autoreceptors, and high doses producing motor excitation, through stimulation of 
post-synaptic D2 receptors (Pizzolato et al., 1985; Brannan et al., 1993). Various studies 
used bromocriptine to investigate dopaminergic modulation of cognitive functioning 
and reward and punishment learning in humans (Mehta et al., 2001; Gibbs and 
D’Esposito, 2005a; Cools et al., 2006; Cools et al., 2009).  Other dopamine agonists that 
have been used in studies on reward and punishment learning are pramipexol (Cools et al., 
2006; Bodi et al., 2009) and cabergoline (Frank and O’Reilly, 2006). 
Sulpiride (Dogmatil®): 
Sulpiride is an atypical anti-psychotic and selectively blocks the D2 receptor (Pharmaco-
therapeutisch Kompas). It is used to treat acute psychosis, mania and schizophrenia 
(Stahl, 2013). Similar to bromocriptine, sulpiride has a biphasic profile (Jenner and 
Marsden, 1982). Low doses mainly affect pre-synaptic D2 receptors, increasing synaptic 
dopamine synthesis and release. High doses of sulpiride block the effects of endogenous 
dopamine on the post-synaptic D2 receptor. Various studies used sulpiride to investigate 
dopaminergic modulation of cognitive functioning and reward and punishment 
learning in humans (Mehta et al., 2003; Mehta et al., 2004b; Mehta et al., 2005).  Other 
dopamine antagonists that have been used in studies on reward and punishment 
learning are haloperidol (Frank and O’Reilly, 2006; Pessiglione et al., 2006) and amisulpiride 
(Jocham et al., 2011). 
Methylphenidate (Ritalin® and Concerta ®): 
Methylphenidate (MPH) acts by blocking the dopamine transporter (DAT) and the 
norepinephrine transporter (NET) resulting in increases of extracellular catecholamine 
levels (Volkow et al., 2002). Psychostimulants such as methylphenidate (MPH) are the 
first-line medication treatment of attention deficit hyperactivity disorder (ADHD) 
 (Pharmacotherapeutisch Kompas). There are multiple preparations of MPH that differ 
in their temporal dynamics. Sustained osmotic-controlled release MPH (Concerta®) elicits 
smooth-rising plasma concentrations through the day, while multiple administrations of 
immediate-release MPH (Ritalin®) elicit peaks and troughs in plasma concentrations 
(Swanson et al., 2003; Spencer et al., 2006). Various studies have used oral methylphenidate 
to study dopaminergic modulation of cognitive functioning and reward and punishment 
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Box 2  Continued
learning in humans (Mehta et al., 2000; Mehta et al., 2004a; Eagle et al., 2007; Dodds et al., 
2008; Clatworthy et al., 2009; Finke et al., 2010).
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Box 2  Continued
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Figure 4   Schematic overview of the neurochemical effects of methylphenidate, 
bromocriptine and sulpiride. 
A) Electrical impulses in the pre-synaptic neuron evoke the release of the neurotransmit-
ter dopamine into the synaptic cleft. Here it can bind to post-synaptic D1 and D2 
receptors. Binding to post-synaptic D1 receptors facilitates signal transduction in the 
direct pathway of the basal ganglia, while binding to post-synaptic D2 receptors inhibits 
signal transduction in the indirect pathway of the basal ganglia (Surmeier et al., 2007). 
Extracellular dopamine levels are controlled by the activation of pre-synaptic dopamine 
transporters (DAT), which remove excessive dopamine from the synaptic cleft, and 
dopamine binding to pre-synaptic D2 autoreceptors, which inhibit dopamine synthesis 
and release (Stahl, 2013). Under normal conditions, there is an optimal balance between 
the activity in the D1 receptor mediated direct pathway and the D2 receptor mediated 
indirect pathway. B) Methylphenidate blocks the DAT, resulting in reduced clearance of 
dopamine from the synaptic cleft and thus a net increase of extracellular dopamine and 
post-synaptic receptor stimulation(Volkow et al., 2002). As a result, methylphenidate 
shifts the balance towards the direct pathway. On a longer term methylphenidate is 
suggested to indirectly reduce dopamine synthesis and release through D2 autoreceptor 
stimulation (Grace, 1991; Robbins, 2002; Seeman and Madras, 2002). C) Bromocriptine is 
a D2 receptor agonist. At lower doses it binds primarily to pre-synaptic D2 autoreceptors 
where it inhibits dopamine synthesis and release (Brannan et al., 1993), resulting in a net 
decrease of extracellular dopamine and post-synaptic receptor stimulation. As a result 
pre-synaptic effects of bromocriptine shift the balance towards the indirect pathway. 
D) At higher doses, bromocriptine also binds to post-synaptic D2 receptors (Brannan et 
al., 1993), where it inhibits activity in the indirect pathway. E) Sulpiride is a D2 receptor 
antagonist. At lower doses it primarily blocks the pre-synaptic D2 autoreceptors where it 
prevents the inhibition of dopamine synthesis and release (Stahl, 2013), resulting in a net 
increase of extracellular dopamine and post-synaptic receptor stimulation. As a result 
pre-synaptic effects of sulpiride shift the balance towards the direct pathway. F) At higher 
doses, sulpiride blocks post-synaptic D2 receptors, where it prevents the inhibition of 
activity in the indirect pathway.
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I will now first give an overview of the anatomical organisation of the basal ganglia 
and then further describe the model in more detail.
The basal ganglia
The basal ganglia consist of several interconnected subcortical nuclei that have 
highly organized reciprocal connections with virtually the entire cerebral cortex, 
hippocampus and amygdala. Thus, the basal ganglia receive major excitatory 
inputs from the cerebral cortex and send its outputs, via the thalamus, back to the 
cortex, forming extensive cortico-basal ganglia-thalamo-cortical circuits. Figure 1 
shows a schematic overview of the connections within this cortico-basal ganglia- 
thalamo-cortical circuit. The basal ganglia consist of 3 principle nuclei; the 
striatum, the globus pallidus and the subthalamic nucleus.  The striatum is the 
major recipient of all cortical inputs and consist of 3 major subdivisions, the 
caudate nucleus, the putamen and the nucleus accumbens. From here two parallel 
pathways, the direct and indirect pathway, arise that project to the internal 
segment of the pallidum. The direct pathway projects directly to the internal 
segment of the pallidum via GABA-ergic inhibitory projections, whereas the 
indirect pathway passes first through the external segment of the pallidum and 
then to the subthalamic nucleus via GABA-ergic inhibitory projections.  From the 
subthalamic nucleus they project to the internal segment of the pallidum via 
glutamatergic excitatory projections. The internal segment of the pallidum 
tonically inhibits the thalamus through GABA-ergic projections, thereby 
decreasing excitatory cortical outputs. The organisation of the GABA-ergic and 
glutamatergic pathways in the direct and indirect pathways allows for dynamic 
modulation of this thalamic inhibition. Thus, when considering the summed 
polarities of connections in the direct and indirect pathways, these pathways have 
opposing effects on thalamic output neurons. Activity in the direct pathway 
disinhibits thalamic output neurons, thereby increasing thalamo-cortical 
excitation (i.e. the ‘GO’ pathway), while activity in the indirect pathway inhibits 
thalamic output neurons, thereby preventing thalamic-cortical excitation (i.e. the 
‘NOGO’ pathway). As such, the basal ganglia can ‘gate’ various cortical representations. 
Animal tracing work has shown that the cortico-basal ganglia-thalamo-cortical 
circuits are organized in multiple segregated functional circuits whereby different 
parts of the striatum are reciprocally connected with different parts of the cortex 
following a ventromedial to dorsolateral gradient (Alexander et al., 1986) (Figure 2). 
The dorsolateral regions of the striatum are interconnected with the primary 
motor cortex and are thought to gate action selection. Dorsomedial regions of the 
striatum are interconnected with dorsolateral prefrontal regions and are thought 
to gate information flow related to more cognitive processes, such as working 
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memory updating and attention shifting. Ventromedial regions of the striatum 
are interconnected with orbitofrontal and limbic regions including the amygdala 
and hippocampus and are thought to gate information regarding motivation and 
value representations (Alexander et al., 1990; Haber and Knutson, 2010).
The basal ganglia are highly innervated by dopamine. The substantia nigra pars 
compacta (SNpc) and ventral tegmental area (VTA) in the midbrain are the major 
sources of brain dopamine and extensively project to the basal ganglia. Here, 
dopamine plays an important role in modulating activity and plasticity in the 
Figure 1   Schematic overview of the direct and indirect pathways in the basal ganglia.
Glutamatergic (red) inputs from the cortex project to the striatum. In the striatum, two 
subclasses of cells project either directly or indirectly, via the external segment of the globus 
pallidus and subthalamic nucleus, to the internal segment of the globus pallidus, which in 
turn inhibits thalamic output projections to the cortex. The direct, ‘GO’ pathway is mediated 
by D1 receptors and has the net effect of disinhibiting the thalamus, thereby facilitating 
action representations in the cortex. The indirect ‘NOGO’ pathway is mediated by D2 
receptors and has the net effect of further inhibiting thalamic output neurons, thereby 
suppressing action representations in the cortex. Dopamine (green) from midbrain nuclei 
(the substantia nigra pars compacta and ventral tegmental area) modulates the balance 
between direct and indirect pathway activity by differentially affecting D1 and D2 receptor 
subtypes.
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direct and indirect pathway. More specifically, the two pathways are affected 
differentially by dopamine due to the selective expression of D1 and D2 receptor 
subtypes in the direct and indirect pathways, respectively. The activation of D1 
and D2 receptors has distinct and opposing downstream effects. Stimulation of D1 
receptors results in increased production of cyclic adenosine monophosphate 
(cAMP) and the cAMP-dependent protein kinase (PKA). Conversely, activation of D2 
receptors inhibits the production of cAMP and PKA, directly opposing the 
downstream effect of D1 receptor stimulation. Thus, while stimulation of D1 
receptors increases the responsiveness of striatal neurons to sustained cortical 
glutamatergic inputs (i.e. facilitating transmission), stimulation of post-synaptic 
D2 receptors reduces the excitability of striatal neurons to glutamatergic cortical 
Figure 2   Schematic overview of the three main cortico-basal ganglia-thalamo-cortical 
circuits.
Different parts of the striatum are reciprocally connected with different parts of the 
cortex following a ventromedial to dorsolateral gradient (Alexander et al., 1986). Coloured 
projections reflect separate loops associated with the updating of action selections (orange), 
cognitive representations and working memory (blue) and value representations (green). 
Dopamine (DA) innervates all striatal circuits and facilitates adaptive learning in each loop.
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inputs (i.e reduces transmission) (Surmeier et al., 2007). This organisation allows 
dopamine to dynamically modulate the balance between direct and indirect 
pathway activity. Elevated dopamine levels have the net effect of increasing 
activity in the direct GO pathway while inhibiting activity in the indirect NOGO 
pathway. Conversely, low levels of dopamine have the net effect of decreasing 
activity in the direct GO pathway and increasing activity in the indirect NOGO 
pathway.  
A computational model of reinforcement learning
In the context of their computational model, Frank et al, (2005) proposed that 
these effects of dopamine on direct and indirect pathway activity are particularly 
relevant for reinforcement learning and the updating of value representations. As 
described above, adequate prediction updating requires the use of prediction error 
signals. Thus, one way to correctly update predictions in a constantly changing 
world is by comparing current predictions about future events with the observed 
events, and by updating the prediction as a function of this error in prediction. 
Electrophysiological work has demonstrated that midbrain dopamine neurons 
signal this prediction error (Montague et al., 1996; Schultz, 1997). More specifically, 
these studies revealed that the firing rate of midbrain dopamine neurons increases 
(i.e. phasic bursts) during unexpected rewards and drops or pauses when expected 
rewards are omitted (or during punishments). These dynamics are also thought to 
extend to the regulation of synaptic plasticity involved in learning processes. More 
specifically, experimental animal work has demonstrated that activation of D1 
receptors evoke long-term potentiation (LTP), while activation of D2 receptors 
evoke  and long term depression (LTD) (Surmeier et al., 2007; Shen et al., 2008). 
Supported by electrophysiological evidence (Montague et al., 1996; Schultz, 1997), 
Frank et al. (2005) simulated dopamine bursts after positive prediction errors 
(unexpected rewards) and dopamine pauses after negative prediction errors 
(unexpected punishments or reward omissions) using their neurocomputational 
model of the basal ganglia. In this model, simulation of dopamine bursts resulted 
in potentiation of basal ganglia output neurons, by increasing activity in the 
direct pathway via D1 receptor stimulation, and reducing activity in the indirect 
pathway via D2 receptor stimulation and representations associated with the 
occurrence of reward were facilitated through long-term-potentiation. Conversely, 
simulation of dopamine dips resulted in inhibition of basal ganglia output 
neurons, by reducing activity in the direct pathway and increasing activity in the 
indirect pathway and the representations associated with the occurrence of 
punishment were inhibited through long-term-depression. Together, this 
computational model suggested a mechanism by which dopamine bursts during 
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rewards promote reward learning via the D1 receptor mediated direct ‘GO’ 
pathway, whereas dopamine dips during punishments promote punishment 
learning via the D2 receptor mediated indirect ‘NOGO’ pathway. 
Testing the model in Parkinson’s disease
To test the model, Frank used the probabilistic selection task (Box 1) and tested 
his task in patients with Parkinson’s disease (PD) while they were both ON and OFF 
their normal dopaminergic medication. PD is characterized by depletion of striatal 
dopamine. Because of the relative selective dopamine depletion in the striatum, 
PD provides a good model to study the effects of dopaminergic medication on 
striatal functioning. To simulate the low dopamine state in PD patients Frank 
reduced tonic dopamine levels in the model, i.e. overall extracellular dopamine 
levels, which affects the efficacy of the phasic dopamine changes described above. 
The effects of L-dopa and dopamine receptor agonists were simulated as an increase in 
tonic dopamine. The model predicted that when patients are OFF their medication the 
limited amount of dopamine availability would impair reward learning due to the 
reduced potency of phasic bursts to activate D1 receptor mediated GO-units during 
reward occurrences. Conversely, when patients are ON medication, the high 
availability of dopamine would impair punishment learning due to the attenuated 
efficacy of dopamine dips to prevent disinhibition of the NOGO-units during 
punishment occurrences. This model correctly predicted paradoxical effects of 
dopaminergic medication in PD patients (Frank et al., 2004; Frank, 2005; Frank et 
al., 2007a) on the probabilistic selection task. Thus, when PD patients withdrew 
from their regular medications (i.e. had low striatal dopamine levels), they were 
better than healthy controls at avoiding the most punishing stimulus than at 
choosing the most rewarding stimulus. Conversely, when PD patients were ON 
their dopaminergic medications this pattern reversed, such that PD patients were 
improved at choosing the most rewarding stimulus while they were impaired at 
choosing the most punishing stimulus (Frank et al., 2004; Frank et al., 2007a). 
The probabilistic selection task measures the learning from reward and punishment 
in a stable and unchanging world. However, given these observed opposite effects 
of dopaminergic drugs on reward and punishment learning on this task, the 
question rose whether opposite, valence-dependent effects would also be seen for 
flexible prediction updating. Accordingly, Cools et al.(2006) developed the 
deterministic reversal learning task (Box 1) that allowed comparing reversal 
learning based on unexpected rewards versus unexpected punishments (or reward 
omissions). The task was assessed in Parkinson patients that were ON and OFF 
their medication. Results revealed that dopaminergic drug effects on this form of 
prediction updating were indeed valence-dependent. Consistent with Franks results 
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(Frank et al., 2004; Frank and O’Reilly, 2006; Frank et al., 2007a), PD patients showed 
impaired reward relative to punishment learning when OFF their dopaminergic 
medication and improved reward relative to punishment learning when ON 
there dopaminergic medication. Taken together, the computational model of 
reinforcement learning proved to be a good model for flexible prediction updating 
in medicated and non-medicated Parkinson patients.  
Baseline-dependency of dopaminergic drug effects
The observed dopaminergic drug effects in PD patients suggest a key role for 
striatal dopamine in regulating the balance between reward and punishment 
learning. However, effects of dopaminergic drugs on reward and punishment 
learning are known to depend on clinical status (Mehta et al., 2004a; Voon et al., 
2010a; Voon et al., 2010b). A critical question therefore is whether effects of 
dopaminergic drugs on the balance between reward and punishment learning 
extends to healthy controls. Indeed, in contrast to PD patients, in healthy adults it 
was seen that the D2 receptor agonist cabergoline impaired reward relative to 
punishment learning, while the D2 receptor antagonist haloperidol improved 
reward relative to punishment learning (Frank and O’Reilly, 2006). In line with 
the inverted U-hypothesis, these contrasting results suggest that dopaminergic 
drug effects depend on baseline dopamine levels, improving reward versus 
punishment learning in PD patients that have low baseline dopamine levels, while 
impairing it in healthy adults, which presumably have optimal baseline dopamine 
levels. This hypothesis was tested in a neurochemical PET study (Cools et al., 2009) 
which used the tracer 6-[18F]fluoro-L-m-tyrosine (FMT) to index pre-synaptic 
dopamine synthesis capacity in striatal terminals of midbrain dopamine neurons. 
There was large individual variability in baseline dopamine levels, with some 
subjects having low baseline dopamine levels and others having high baseline 
dopamine levels. This study revealed that these individual differences in baseline 
dopamine levels were indeed associated with individual differences in reward 
versus punishment learning. Consistent with the model, low baseline dopamine 
synthesis was associated with better punishment versus reward learning and high 
baseline dopamine synthesis was associated with better reward versus punishment 
learning. Moreover, the D2 receptor agonist bromocriptine improved reward 
relative to punishment learning in subjects with low baseline dopamine synthesis, 
while it impaired reward versus punishment learning in subjects with high 
baseline dopamine synthesis capacity. This finding supports the suggestion that, 
similar to the relation between cognitive performance and D1 receptor functioning 
in the prefrontal cortex (Zahrt et al., 1997; Arnsten and Goldman-Rakic, 1998), an 
inverted U-shape relationship might exist for flexible prediction updating and D2 
receptor functioning in the striatum. 
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Various other studies have demonstrated that the effects of D2 receptor agents on 
cognitive flexibility depend on baseline working memory capacity (Kimberg et al., 
1997; Mehta et al., 2000; Mehta et al., 2001; Frank and O’Reilly, 2006). Accordingly, 
it is often suggested that these working memory dependent effects reflect effects 
that depend on striatal baseline dopamine levels. Indeed, striatal dopamine 
synthesis as measured with PET has been shown to be positively associated with 
baseline working memory capacity (Cools et al., 2008b; Landau et al., 2009) 
suggesting that working memory capacity could serve as a proxy for baseline 
dopamine synthesis. In chapter 2 I further investigate this baseline dependency 
hypothesis of D2 receptor agents (Cools and D’Esposito, 2011) and test whether 
individual differences in dopaminergic drug effects on striatal BOLD could be 
reliably explained by an individual baseline measure of working memory capacity. 
Effects of the D2 receptor agents bromocriptine and sulpiride 
Establishing the role of striatal dopamine in reward and punishment learning
Frank’s model implicates a specific role for striatal dopamine in dynamically 
shifting the balance between reward and punishment learning. This implication 
has been supported by neuroimaging studies that revealed that various drugs 
modulate striatal BOLD response during probabilistic selection and reversal 
learning tasks (Pessiglione et al., 2006; Cools et al., 2007; Dodds et al., 2008; Voon 
et al., 2010a; Jocham et al., 2011). However, as these studies used different tasks 
these imaging studies do not provide definitive evidence for the role of striatal 
dopamine in the modulation of reward and punishment learning. In chapter 2 I 
have used the deterministic reversal learning task to directly compare drug effects 
on striatal BOLD during reward-based reversals and punishment-based reversals. 
In a non-pharmacological neuroimaging study Robinson et al. (2010a) investigated 
neural activity during reversal learning using this paradigm in healthy adults. 
More specifically, the authors compared striatal activity during valence-independent 
reversal learning (reward and punishment reversals) and valence-dependent 
reversal learning (the difference between reward and punishment reversals). 
While both unexpected reward and unexpected punishment activated a wide 
network including the ventromedial striatum, anterior cingulate and prefrontal 
cortex, this study also revealed differential activity for unexpected reward and 
punishment in other parts of the striatum including the putamen and caudate 
nucleus suggesting that different striatal subregions are involved in valence- 
dependent and valence-independent reversal learning. However, the interpretation 
of these BOLD changes and how they relate to dopamine signalling are still 
ambiguous. Valence-independent BOLD changes might reflect processing that is 
the same for both the unexpected reward and unexpected punishment condition, 
such as saliency of the unexpected outcome or behavioural response switching 
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versus maintenance (Redgrave et al., 1999a; Zink et al., 2003a; Jensen et al., 2007). 
Alternatively, valence-independent BOLD changes may represent co-representa-
tions of distinct positive and negative prediction errors (Seymour et al., 2005; 
Menon et al., 2007; Seymour et al., 2007a; Delgado et al., 2009). In chapter 2 I have 
used this task to further investigate whether opposite effects of dopaminergic drugs 
on reward and punishment reversal learning are accompanied by modulation of 
valence-independent and/or valence-dependent activity in the striatum during 
unexpected rewards and unexpected punishments.
A second issue is that previous pharmacological imaging studies have used 
different drugs, with some drugs acting on both D1 and D2 receptors and others 
acting on the dopamine transporter. Moreover, most drugs are neurochemically 
nonspecific acting not only in the dopamine system, but also on e.g. the 
noradrenalin system. It therefore remains unclear whether the drug-induced 
modulations observed in these imaging studies are dopamine- or even recep-
tor-specific. According to current standards in animal pharmacology (Feldman et 
al., 1997), claims about neurochemical specificity of drug effects can be made only 
when the action of a receptor agonist is blocked by co-administration of a receptor 
antagonist (or vice versa) (See box 3). In chapter 2 and 3 I tested the neurochemical 
specificity of striatal modulation during reversal learning. In four sessions I 
administered placebo, the dopamine D1/D2 receptor agonist bromocriptine, the 
dopamine D2 receptor antagonist sulpiride and combined administration of both 
drugs. If drug-induced changes are exerted via D2 receptors, which are targeted by 
both the agonist and the antagonist, then co-administration of both drugs should 
abolish effects seen for one of the drugs.
Exploring new factors that explain individual variability in dopaminergic 
drug response
In chapter 2 I focussed my analysis on dopaminergic modulations of the striatum. 
However, as early as in the seventies, it was demonstrated that monkeys with 
lesions in orbitofrontal cortex (OFC) and amygdala show impairments in reversal 
learning (Iversen and Mishkin, 1970; Jones and Mishkin, 1972). Accordingly, it is 
also well accepted that reversal learning depends on the OFC and amygdala. 
Importantly, the interactions between the prefrontal regions, amygdala and 
striatum are thought to be modulated by dopamine. Thus, both midbrain 
dopamine projections and glutamatergic projections from the cortex or limbic 
regions converge onto medium spiny neurons in the striatum and amygdala, such 
that dopamine can facilitate glutamatergic inputs (Pennartz et al., 1994; 
Rosenkranz and Grace, 2002; Sesack and Grace, 2010). These observations have led 
to the suggestion that dopamine regulates the degree to which the striatum, 
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amygdala and prefrontal cortex interact to integrate information about reward 
value, motivation and expectation and to ultimately facilitate adaptive and flexible 
behaviour (Pennartz et al., 2011). Based on this anatomical organisation it could be 
argued that dopaminergic drug effects on striatal activity during reversal learning 
might depend on the anatomical infrastructure of white matter pathways in a 
fronto-limbic-striatal network. The anatomical connection strength of white 
matter pathways can be measured non-invasively in humans with diffusion tensor 
imaging (DTI; see BOX 3). Accordingly, DTI provides the opportunity to investigate 
whether dopaminergic drug effects on striatal BOLD depend on anatomical 
connection strength of white matter pathways connecting the OFC, amygdala and 
striatum. This method was recently used to test a similar hypothesis regarding 
dorsal fronto-striatal interactions. This study revealed that dopaminergic drug 
effects on striatal BOLD signal during an attentional shifting task varied as a 
function of anatomical connection strength of a dorsal fronto-striatal-thalamic 
pathway (van Schouwenburg et al., 2013). In chapter 3 I have extended the results 
from chapter 2 with DTI measures to investigate whether individual difference in 
dopaminergic drug effects on striatal BOLD during reversal learning could be 
predicted from anatomical connection strength of the orbitofrontal-limbic-stria-
tal network. The results of this study not only address the question about whether 
dopamine’s effects depend on anatomical connection strength, but may also 
provide insight into possible new individual trait factors that might contribute to 
the known individual variability in drug response (Cools and D’Esposito, 2011). 
Effects of methylphenidate 
Cognitive enhancement in the healthy population 
In addition to assessing the effects of direct dopamine receptor agents that are 
used mainly in psychiatric and neurological patients (e.g. Parkinson’s disease, 
schizophrenia), I have also studied the effects of the more indirect dopamine and 
noradrenalin reuptake inhibiter methylphenidate. Methylphenidate (or Ritalin) is 
one of the most prescribed psychostimulants for attention deficit hyperactivity 
disorder (ADHD), but is also gaining popularity in the healthy (student) population, 
because it is thought to enhance cognitive and academic performance. Methyl-
phenidate acts by blocking the dopamine (DAT) and norepinephrine (NET) transporter, 
which removes excessive dopamine and norepinephrine from the synaptic cleft, 
resulting in an increase of extracellular chatecholamine levels (Volkow et al., 2002). 
Thus, while bromocriptine and sulpiride act directly on D2 receptors, methyl-
phenidate affects dopamine receptor stimulation indirectly by increasing tonic 
dopamine levels. As with D2 receptor agents, effects of methylphenidate have also 
been shown to depend on baseline performance levels (Mehta et al., 2000; Mehta et 
al., 2004a; Eagle et al., 2007; Finke et al., 2010) and task demands (Clatworthy et al., 
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2009). For example, Mehta et al. (2004) showed that methylphenidate improved 
performance on a spatial working memory task only in ADHD subjects that had 
low baseline working memory capacity. Together with evidence from PET studies, 
it has been suggested that these baseline-dependent effects of methylphenidate 
reflect effects that depend on baseline dopamine synthesis capacity (Volkow et al., 
2002). 
Because of the beneficial effects of methylphenidate in individuals with ADHD, 
methylphenidate is increasingly used by healthy students with the purpose to 
enhance cognitive functioning and academic performance (Greely et al., 2008; 
Smith and Farah, 2011). Given the suggested baseline-dependency, this raises 
questions about its effects in the healthy population. In chapter 5 I have 
investigated the baseline-dependency of methylphenidate effects in healthy adults 
and tested whether the effects of methylphenidate on reward and punishment 
learning varied as a function of baseline working memory capacity. In addition, by 
investigating the effects of both D2 receptor agents and methylphenidate on the 
same reversal learning task, results from this study may also increase our 
understanding of the possible neurochemical mechanisms underlying individual 
variability in response to D2 receptor agents. Thus, while dopamine transporters 
are located only on the pre-synaptic cleft, D2 receptors are located on both the  pre- 
and post-synaptic cleft resulting in bimodal effects of D2 receptor agents (BOX 2). 
Accordingly, it is interesting to see whether blockade of pre-synaptic dopamine 
transporters would parallel effects seen for dopamine D2 receptor agonists, 
improving reward versus punishment learning in low dopamine subjects, or 
whether it would parallel that seen for dopamine D2 receptor blockade.   
Long term treatment effects in ADHD
Chapters 2-5 investigate the baseline-dependency of acute effects of a single dose 
of a dopaminergic drug in a population of healthy young adults. However, in the 
clinical population, patients use medication on a daily basis for several years and 
the effects of such long term treatment regimens are still unclear. ADHD is 
characterized by symptoms of inattention, impulsivity and hyperactivity (DSM-IV, 
APA) and associated with both deficits in executive functioning (e.g. (Barkley, 1997) 
as well as with deficits in motivational and reward processing (Sonuga-Barke, 
2003; Luman et al., 2005; Castellanos et al., 2006). According to current theorizing 
in the domain of addiction, hyperactive and impulsive behaviour might result 
from a combination of aberrant reward processing, associated with increased 
subcortical phasic dopamine signalling and reduced inhibitory control, associated 
with prefrontal tonic dopamine levels (Jentsch and Taylor, 1999). By analogy, 
ADHD has been associated with increased reward sensitivity and reduced 
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inhibitory control (Sonuga-Barke, 2005; Castellanos et al., 2006). Accordingly, 
methylphenidate is suggested to exert its therapeutic effects by directly increasing 
prefrontal tonic dopamine, but on the longer term, by paradoxically dampening 
down phasic dopamine signals in subcortical regions through auto-receptor 
stimulation (Grace, 1991; Seeman and Madras, 1998; Robbins, 2002; Bilder et al., 
2004). In line with these suggestions, research with experimental animals has 
shown that repeated exposure to methylphenidate in adolescent rats results in 
decreased responsiveness to natural rewards (Marco et al., 2011) and reduced 
preference for environments associated with cocaine seeking behaviour (Andersen 
et al., 2002).
 
Studies investigating reward processing in ADHD have often demonstrated 
deficient reward processing in subjects with ADHD compared with healthy 
controls (Frank et al., 2007b; Scheres et al., 2007; Ströhle et al., 2008; Hoogman et 
al., 2011). However, these studies were mostly conducted in groups of patients who 
had been taking medication for a long time. Therefore, it remains unclear whether 
these findings reflect aspects that are inherent to the disorder, or instead reflect 
effects of the long-term use of medication such as the suggested down-regulation 
of subcortical phasic dopamine signalling. In chapter 5 I investigated the effects of 
medication withdrawal in a group of ADHD subjects who used methylphenidate 
for at least 9 months on reward and punishment learning and assessed whether 
withdrawal of methylphenidate was associated with reduced reward relative to 
punishment learning. In addition, based on evidence that dopaminergic drug- 
induced changes in phasic dopamine signalling depend on the temporal drug 
kinetics (Post, 1980; Samaha et al., 2008), we compared withdrawal effects of 
subjects that used sustained release methylphenidate and immediate release 
methylphenidate (See Box 1). Differential effects between immediate and sustained 
release methylphenidate further support the suggestion that reduced reward 
processing is due to long term treatment effects on phasic dopamine signalling. 
Moreover, results from this post-hoc analysis provided preliminary evidence for a 
new hypothesis on the role of temporal dynamics in long term methylphenidate 
effects on reward and punishment learning. 
Reward and punishment learning during adolescence
The major part of my thesis is focussed on reward and punishment learning in 
adults. However, the brain undergoes major changes in the period between 
childhood and adulthood, including remodelling of fronto-limbic-striatal circuits 
and dopamine functioning (Wahlstrom et al., 2010). Given the importance of these 
systems in valence-based learning, the question raises whether such developmental 
changes in fronto-striatal circuits and dopamine functioning are accompanied by 
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changes in reward and punishment learning. Indeed, supported by observational 
studies and self-reports that reported a peak in reward sensitivity and risk-seeking 
during adolescence (Steinberg, 2010) it was suggested that differential 
developmental trajectories of prefrontal and sub-cortical regions may result in 
increased reward (relative to punishment) sensitivity and reduced executive 
control (Casey et al., 2010; Somerville and Casey, 2010; Crone and Dahl, 2012). 
However, laboratory tasks do not fully support this hypothesis and show 
discrepancy with regard to the developmental profiles seen for reward and 
punishment learning. Consistent with the self-report data some studies do report 
non-linear inverted-U shaped changes in reward processing by showing increased 
reward sensitivity in adolescents compared with children and adults (Cauffman et 
al., 2010; Somerville and Casey, 2010). Conversely, other studies reveal linear 
changes, with better performance in adults than in adolescents (Galvan et al., 
2006; van Duijvenvoorde et al., 2008; van den Bos et al., 2009; Cauffman et al., 
2010; Van Leijenhorst et al., 2010b; Van Leijenhorst et al., 2010a; Koolschijn et al., 
2011; van den Bos et al., 2012). Importantly, similar to studies investigating drug 
effects in adults, these developmental studies also used various tasks that differ in 
terms of behavioural demands. Thus, most tasks used in these studies were unable 
to directly compare reward and punishment learning, leaving it unclear whether 
non-linear changes were specific to reward processing (Box 1). The deterministic 
reversal learning tasks does allow the comparison of reward and punishment 
based reversal learning. Accordingly, in chapter 6 I used this task to test the 
ingrained hypothesis of increased reward (relative to punishment) sensitivity 
during adolescence. Specifically, I investigate age-related effects on valence-depen-
dent reversal learning (i.e. reward versus punishment learning) and valence-inde-
pendent reversal learning (i.e. reward and punishment learning) across 4 age 
groups between 10 and 25 years old. An additional advantage of using this task is 
that the neurobiological mechanisms underlying task performance are well-char-
acterized and known to involve ventral fronto-limbic striatal circuits (Robinson et 
al., 2010a; van der Schaaf et al., 2012; van der Schaaf et al., 2013) (See also Chapter 
2 and 3). This allowed me to relate age-related effects on the task with known neu-
robiological and dopaminergic changes during development. 
Outline of the thesis
The research presented in this thesis focused on the modulatory role of dopamine 
on reward and punishment learning. Previous research has demonstrated large 
variability in dopaminergic drug effects with drug effects depending both on the 
nature of the task as well as on baseline levels of cognitive functioning or dopamine 
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levels. In this thesis I have attempted to further elucidate factors that determine 
individual variability in drug responses by investigating different populations 
and different drugs on one reversal learning task. This task measured flexible 
updating of stimulus-outcome predictions in response to unexpected rewards and 
unexpected punishments. Unlike most other tasks that are used to study reward 
and punishment learning, this task allowed the direct comparison of reward and 
punishment learning, while controlling for instrumental action-selection 
processes. In addition, stratifying drug effects by baseline working memory 
capacity, a measure that has been shown to be positively associated with baseline 
dopamine synthesis capacity (Cools et al., 2008b; Landau et al., 2009), enabled me 
to take into account putative individual differences in baseline dopamine levels. 
Taken together, in this thesis I investigate variability in drug response within 
individuals as a function of task demands, i.e. depending on the valence of the 
outcome, and between individuals as a function of baseline working memory 
capacity. Investigating individual variability in dopaminergic drug effects is 
clinically relevant as it can help us understand both the beneficial as well as 
detrimental effects of dopamine agents in psychiatric disorders such as ADHD and 
schizophrenia. Understanding the underlying mechanisms and elucidating 
possible factors that predict dopaminergic drug response may improve individual 
tailoring of treatment regimens in psychiatry. In addition, given the increased use 
of psychostimulants by the healthy population, these insights are also relevant for 
our understanding of dopaminergic drug effects in healthy populations.
Chapter 2 and 3 investigate the effects of the D2 receptor agents bromocriptine 
and sulpiride. Previous work has demonstrated that these drugs have opposite 
effects on reward and punishment learning. According to computational 
modelling these opposite effects reflect a shift in the balance between striatal GO 
and NOGO pathways (Frank, 2005; Frank, 2011). In Chapter 2 I used functional 
MRI and pharmacological co-administration (See box 3) to test this hypothesis and 
address two unresolved issues in the literature. First, I investigate whether a shift 
in the balance between reward and punishment learning is accompanied by 
dopaminergic modulation of striatal BOLD responses during reward and 
punishment learning. Second, I test the neurochemical specificity of striatal BOLD 
modulations, i.e. whether these effects are mediated through D2 receptor 
mechanisms, by testing whether the effects of a D2 receptor agonist are abolished 
by a D2 receptor antagonist (or vice versa). 
Chapter 2 focuses on dopamine functioning in the striatum. However, reversal 
learning is also known to depend on interactions between the striatal, prefrontal 
and limbic regions. Chapter 3 extends the results from chapter 2 with DTI 
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measurements (See Box 3) to investigate whether dopaminergic drug effects on 
striatal BOLD during reversal learning depend on anatomical connection strength 
between the striatum, orbitofrontal cortex and amygdala. The finding that 
anatomical connection strength can predict dopaminergic drug effects on brain 
function could advance  the understanding of treatment effects in psychiatry, as 
many psychiatric disorders have been associated with white matter abnormalities 
(Mandl et al., 2012).   
Chapter 4 and 5 investigate the effects of the indirect dopamine reuptake inhibiter 
methylphenidate. This drug is the main treatment option for ADHD, but an 
increasing group of healthy individuals are using methylphenidate to enhance 
academic performance as well. Given the suggested baseline-dependency of 
dopaminergic drug effects, this raises questions about the effects of these drugs in 
the healthy population. Chapter 4 investigates whether the effects of methylphe-
nidate in healthy adults vary within individuals as a function of task demands, i.e. 
depending on the valence of the outcome, and between individuals as a function 
of baseline working memory capacity. The results of this study increase our 
understanding of inter-and intra-individual differences in dopaminergic drug 
responses and elucidate factors that contribute to the large variability of drug 
effects currently reported in the literature. 
While chapter 3-4 explored acute dopaminergic drug effects in healthy individuals, 
chapter 5 explores the effect of methylphenidate withdrawal in subjects with 
ADHD who have been using methylphenidate for a longer period of time. I tested 
whether subjects with ADHD exhibit reduced reward relative to punishment 
learning when OFF their medication relative to ON medication and relative to 
healthy controls. In a post-hoc analysis I further investigate possible differential 
long-term effects of immediate release and sustained release methylphenidate in 
individuals. Such differential effects would support the hypothesis that reduced 
reward learning is related to long-term medication use, but would also provide 
preliminary evidence for a new hypothesis on the possible role of temporal 
dynamics in long-term drug effects (Samaha et al., 2008).    
Chapter 6 investigates developmental changes in reward and punishment learning 
during adolescence. The dopamine system and interactions between frontal 
cortical and subcortical regions change dramatically during this period. One 
theory proposes that the differential development of cortical and subcortical 
regions is accompanied by increased reward sensitivity in adolescents relative to 
children and adults. Chapter 6 tests this hypothesis by investigating the 
developmental trajectory of reward versus punishment learning as measured with 
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the deterministic reversal learning task in a cross sectional study with 4 age 
groups between 10 and 25 years old and interprets the behaviour patterns revealed 
by this study in relation to known developmental changes in the brain. 
Finally in chapter 7 I will present an overview of the results and interpretation of 
the findings presented in this thesis.
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Box 3  Methods
Functional Magnetic Resonance Imaging
Functional magnetic resonance imaging (fMRI) is a non-invasive imaging technique that 
measures neural activity in the human brain. fMRI is used to investigate the involvement 
and function of brain regions during the performance of specific cognitive tasks. When 
a region is activated during a given task, this region will show an enhanced glucose and 
oxygen uptake rate, which in turn will lead to increased oxygenated blood flow to this 
region. By using the differential magnetic properties of oxygenated and de-oxygenated 
hemoglobin in the blood, fMRI can measure blood oxygenation that has shown to be a 
reliable proxy of neural activity and post-synaptic excitatory activity (Logothetis, 2002; 
Huettel et al., 2004). The measured difference between oxygenated and de-oxygenated 
hemoglobin in blood is called the blood-oxygen-level-dependent (BOLD) signal. fMRI has 
a relatively high spatial resolution with a precision of 1 to 3 mm allowing for precise 
localisation of BOLD signal changes, including those in subcortical structures such as 
the basal ganglia. The temporal resolution of fMRI is relatively low, because blood flow is 
in itself a slow response, peaking about 5 seconds after neural firing. However, when 
taking in to account the temporal characteristics of the BOLD response and when 
optimizing the timing of stimulus presentations within the experiment it is possible to 
measure rapid ‘event-related’ BOLD responses. As such, I was able to measure rapid BOLD 
changes during the presentations of outcomes in my experiment. Because there is no 
standard baseline of BOLD signal, activity is usually studied in terms of the relative 
difference in BOLD signal between different conditions. In my studies I have contrasted 
BOLD signal during unexpected rewards and punishments with BOLD signal during 
expected rewards and punishments. Because the only difference between these 
conditions was the subject’s prediction or expectation prior to the outcome presentation 
(i.e. other aspects such as visual stimulation were equal), I was able to extract a signal 
representing the prediction error.     
Diffusion Tensor Imaging
Diffusion Tensor Imaging (DTI) is a non-invasive method used to measure structural 
connectivity between various grey matter regions in the human brain. Grey matter 
regions contain the neural cell bodies that are activated during cognitive tasks and are 
interconnected through white matter tracts that contain myelinated axons. DTI 
measures the diffusion of water in tissue, which depends on the tight packing of cellular 
axons and myelin sheets that encapsulate the axon fibres. In white matter fibre tracks 
water can move relatively freely along the fibre direction, while it is restricted to move 
perpendicular to the fibre direction. By contrast, in cerebral spinal fluid water can 
diffuse freely into all directions as there little tissue that restricts water diffusion. Two 
measures are generally obtained with DTI measurements; fractional anisotropy (FA) and 
mean diffusivity (MD). FA is a measure of the directionality of water diffusion and has 
been associated with dense coherent bundling and myelination of axons. MD reflects the 
general presence of barriers to free diffusion and has been associated with overall cell 
density. Collectively, FA and MD provide information on the micro-structural integrity 
and communicational efficacy of white matter fibre bundles that connect various brain 
Chapter 1
36
Box 3  Continued
regions (Beaulieu, 2002; Thomason and Thompson, 2011).  In chapter 4 I have used DTI to 
investigate whether dopaminergic modulation of striatal BOLD activity depends on 
individual differences in the micro-structural integrity of white matter fibre bundles 
between the striatum, prefrontal cortex and amygdala. 
Pharmacological fMRI
Pharmacological fMRI is a method to investigate the neurochemical modulation of BOLD 
signal, by comparing task-related BOLD measurements assessed after the intake of 
certain psychopharmacological agents with those assessed after the intake of placebo. 
Studying the neurochemical modulation of BOLD increases our insight into the role of 
these chemicals in cognitive functioning and associated neural mechanisms. Several 
studies have suggested the possibility that BOLD measurements are related to dopamine 
burst firing during unexpected rewards (Knutson and Gibbs, 2007; Schott et al., 2008; 
Düzel et al., 2009). For example, one study that combined fMRI with positron emission 
tomography (PET) revealed a relationship between local reward-related BOLD activity 
and dopamine release during the same task (Schott et al., 2008). In addition, previous 
pharmacological fMRI work has repeatedly demonstrated that reward prediction 
error-related BOLD responses in the striatum were modulated by dopaminergic agents 
(Pessiglione et al., 2006; Cools et al., 2007; Dodds et al., 2008; Jocham et al., 2011). In 
chapter 2 I investigated the neurochemical specificity of dopaminergic drugs on 
prediction error-related BOLD signal in the striatum by using a co-administration design 
(Feldman et al., 1997). In this study I administered, in four sessions, bromocriptine, 
sulpiride, placebo and a combination of bromocriptine and sulpiride. Sulpiride is a 
selective dopamine D2 receptor antagonist and bromocriptine is a D2 receptor agonist. 
By testing whether drug effects of one drug were abolished with co-administration of the 
other drug, I was able to investigate whether drug effects were exerted via D2 receptor 
mechanisms.
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Abstract
Drugs that alter dopamine transmission have opposite effects on reward and 
punishment learning. These opposite effects have been suggested to depend on 
dopamine in the striatum. Here, we establish for the first time the neurochemical 
specificity of such drug effects, during reward and punishment learning in 
humans, by adopting a co-administration design. Participants (N=22) were scanned 
on four occasions using fMRI, following intake of placebo, bromocriptine 
(dopamine receptor agonist), sulpiride (dopamine receptor antagonist) or a 
combination of both drugs. A reversal learning task was employed, in which both 
unexpected rewards and punishments signalled reversals. Drug effects were 
stratified with baseline working memory to take into account individual variations 
in drug response. Sulpiride induced parallel span-dependent changes on striatal 
BOLD signal during unexpected rewards and punishments. These drug effects 
were found to be partially dopamine-dependent, as they were blocked by co- 
administration with bromocriptine. In contrast, sulpiride elicited opposite effects 
on behavioural measures of reward and punishment learning. Moreover, sulpiride- 
induced increases in striatal BOLD signal during both outcomes were associated 
with behavioural improvement in reward versus punishment learning. These 
results provide strong support for current theories suggesting that drug effects on 
reward as well as punishment learning are mediated via striatal dopamine. 
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Introduction 
Brain dopamine has long been implicated in learning. One of the most robust 
observations in this domain is that dopaminergic drugs have opposite effects on 
learning from reward and punishment (Frank et al., 2004; Cools et al., 2006; Frank 
et al., 2007a; Moustafa et al., 2008; Bodi et al., 2009; Cools et al., 2009; Palminteri 
et al., 2009). According to recent theory, these opposite effects reflect dopamine- 
induced shifts in the balance between the GO- and NOGO-pathways of the basal 
ganglia(Frank, 2005). Specifically, it is suggested that increases in dopamine shift 
the balance towards the GO-pathway (improving reward relative to punishment 
learning) and decreases in dopamine shift the balance towards the NOGO-pathway 
(impairing reward relative to punishment learning). This model is supported by 
evidence from positron emission tomography (PET)(Cools et al., 2009), experimental 
animal work(Frank and Fossella, 2011) and genetic studies(Frank et al., 2007c; 
Frank and Hutchison, 2009) and is predictive of medication withdrawal effects in 
psychiatric disorders including Parkinson’s disease(Frank et al., 2004; Cools et al., 
2006; Frank et al., 2007a; Moustafa et al., 2008; Bodi et al., 2009; Palminteri et al., 
2009; Voon et al., 2010a), attention deficit hyperactivity disorder(Frank et al., 
2007b) and Tourette’s syndrome(Palminteri et al., 2009).   
Here we address two key remaining questions regarding these opposite drug 
effects on reward and punishment learning. First, we establish the neurochemical 
specificity of these drug effects in humans. Previous studies have used drugs that 
are neurochemically non-specific, acting also, e.g., on the noradrenaline system. 
According to current standards in animal pharmacology(Feldman et al., 1997), 
claims about the neurochemical specificity of drug effects can be made only based 
on the blocking of receptor agonist action by co-administration with a receptor 
antagonist (or vice versa). Such a co-administration approach has been rarely 
adopted in human research. Here, we administered, in four sessions, sulpiride, 
bromocriptine, placebo, and a combination of sulpiride and bromocriptine. Sulpiride 
is a selective D2-receptor antagonist and bromocriptine is a D1 and D2 receptor 
agonist with high affinity for the D2 receptor. If drug-induced changes are 
 dopamine-dependent (i.e. exerted via dopamine (D2-) receptors, targeted by both 
drugs), they should be blocked by co-administration with the other drug. 
Second, despite the consistency of dopamine’s effects on behaviour, there is 
controversy with regard to dopamine’s effects on human striatal responses during 
reward and punishment learning, as measured with pharmacological fMRI. Some 
studies have revealed drug effects on the striatum during punishment but not 
reward (Cools et al., 2007; Dodds et al., 2008; Voon et al., 2010b). By contrast, other 
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studies have revealed dopaminergic drug effects on the striatum during reward 
but not punishment (Pessiglione et al., 2006; Voon et al., 2010a; Jocham et al., 2011; 
Ott et al., 2011). This discrepancy might lie in the use of different tasks. The former 
studies employed instrumental reversal paradigms, in which performance 
depended more critically on punishment-learning. Conversely the latter studies 
did not measure the reversal of contingencies. We used an adapted reversal 
paradigm, in which reversals were signalled by either unexpected rewards or 
unexpected punishments. Previous fMRI work with this paradigm has shown that 
both unexpected rewards and punishments elicit a prediction error signal in the 
striatum (Robinson et al., 2010a). Importantly, the demands for punishment- and 
reward reversals were matched (Cools et al., 2006; Cools et al., 2009), thus allowing 
us to investigate dopaminergic drug effects on human striatal responses during 
both punishment and reward learning. We considered two possibilities: First, 
we considered the possibility that the opposite effects of dopaminergic drugs 
on reward and punishment learning would be accompanied by similarly opposite 
effects on striatal BOLD during reward and punishment events. To this end we 
assessed drug effects on valence-dependent BOLD signal. Second, we also considered 
the possibility that the opposite effects on reward and punishment learning would 
be accompanied by parallel changes in striatal BOLD during both unexpected 
outcomes, so that improved reward relative to punishment learning would be 
accompanied by increased striatal BOLD signal during reward as well as punishment 
events. To this latter end we assessed drug effects on valence-independent BOLD signal. 
One well established challenge for drug research is the large individual variability 
of drug effects (Cools and D’Esposito, 2011). Bromocriptine’s effects on this task 
have been shown to depend on baseline dopamine levels as measured with 
neurochemical PET, improving reward relative to punishment learning in 
low-dopamine participants, while impairing it in high-dopamine participants 
(Cools et al., 2009). Similar opposite effects of both dopamine receptor agonists as 
well as antagonists have repeatedly been observed as a function of working 
memory capacity (Kimberg et al., 1997; Frank and O’Reilly, 2006), which has been 
shown to correlate with  baseline dopamine synthesis capacity as measured with 
neurochemical PET(Cools et al., 2008b; Landau et al., 2009). Accordingly, given this 
baseline-dependency principle of drug efficacy(Cools and D’Esposito, 2011), we 
stratified our drug effects with baseline working memory capacity to take into 
account putative individual differences in drug response.
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Methods and materials 
Participants 
Twenty-eight healthy participants gave informed consent approved by the local 
research ethics committee (“Comissie Mensgebonden Onderzoek”, Arnhem-Nijmegen, 
number: 2008/078, date: 09-09-2008) and were compensated for participation. 
Six participants were excluded from analysis. One participant withdrew after the 
first session; two participants showed excessive head movements in the scanner 
(greater than twice the voxel size, e.g. translation > 6mm); two full fMRI datasets 
were unusable due to technical reasons; one non-native Dutch speaker was 
excluded from analyses, because good practice of the Dutch language was essential 
for optimal assessment of baseline working memory capacity. The remaining 22 
participants were right-handed, European Caucasians (mean age 23.1, range 
18.9-30.3 years, 11 men) with no relevant medical/psychiatric history three years 
prior to testing. Two participants completed only two drug sessions (sulpiride-bro-
mocriptine, and sulpiride-placebo). Accordingly, the sulpiride-bromocriptine and 
the placebo-sulpiride comparisons were computed using data from 21 participants 
(11 and 10 men, respectively) and the remaining comparisons were computed 
using data from 20 participants (10 men). During intake, all participants were 
screened to assess their medical/psychiatric status (See supplementary information). 
A Dutch version of the listening span test (Salthouse et al., 1991) was taken and the 
reversal learning task was practised during a short structural MRI scan.
Pharmacological design and general procedure
Participants were tested on four occasions separated by at least one week. Starting 
time of the sessions (8.30 or 10.30 AM) was kept constant across sessions within 
participants. Participants abstained from alcohol and nicotine 24 hours before 
testing and from caffeine on the day of testing. Upon arrival, participants were 
asked about their compliance with the above mentioned restrictions and were 
given a light breakfast one hour before ingestion of the drugs. Participants were 
tested after placebo, sulpiride (Dogmatil®, sanofi-aventis, 400mg), bromocriptine 
(Parlodel®, Novartis, 1.25mg) and a combination of bromocriptine and sulpiride. 
Administration order was randomized according to a counterbalanced, place-
bo-controlled, double-blind design (see Supplementary information for details on 
administration orders). A double-dummy design was employed; all participants 
received two different opaque, gelatin capsules on two separate time points a day. 
Participants received placebo or bromocriptine thirty minutes after receiving 
placebo or sulpiride. Dose selection was based on previous studies, which revealed 
significant effects and good tolerance (Mehta et al., 2004b; Mehta et al., 2008; Cools 
et al., 2009; Dodds et al., 2009). Timing was optimized to have maximal effects 
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during both the fMRI paradigm and a subsequent behavioural paradigm (reported 
elsewhere (van Holstein et al., 2011)). The reversal learning task started ~2¼ hours 
after first drug intake (i.e. sulpiride) with a duration of ~60 minutes.  Mean time to 
maximal plasma concentration of sulpiride is ~3 hours, with a plasma half-life of 
~12 hours (Mehta et al., 2003). Mean time to maximal plasma concentration of 
bromocriptine is ~2¼ hours with a plasma half-life of ~7 hours (Deleu et al., 2002). 
Accordingly, time of testing coincided with the time-window of maximal drug 
effects. 
Subjective mood ratings were measured with the Bond and Lader visual analogue 
scales (Bond and Lader, 1974). Mood measures, blood pressure and heart rate were 
taken ~30 minutes before, ~2 hours after and ~6 hours after first drug intake. 
Blood samples were taken ~30 minutes before and ~2 hours after first drug intake 
and were used to determine the change in prolactin levels due to dopamine D2 
receptor binding (Fitzgerald and Dinan, 2008b). 
Background neuropsychological tests (block completion, number cancellation, 
verbal fluency and digit span) were assessed at the end of the day, approximately 5 
hours after drug intake. The current paradigm was part of a larger protocol, 
including the assessment of a behavioural task after the fMRI session (van Holstein 
et al., 2011). 
Baseline working memory
Baseline working memory capacity was defined as the average score of 4 assessments 
of the digit span(Groth-Marnat, 1997), which was measured approximately 5¼ 
hours after first drug intake. Drugs did not affect digit span as revealed by ANOVA 
with the factors drug (4) and span (forward, backward) (main drug: F
21
 = .46, p = .71, 
drug × span: F
21
 = 1.14. p = .34). The average total span across the four drug sessions 
correlated significantly with the Dutch version of the listening span (Salthouse et 
al., 1991) (r
22
 = .56, p = .003), which was measured during intake. The average digit 
span was selected for drug effect stratification, because it was thought to provide 
a more reliable estimate of working memory capacity due to the fact that it was 
administered repeatedly. Supplementary analyses were done to confirm working 
memory-dependent drug effects with measures taken during intake (listening 
span) and during placebo only (digit span) (Supplementary information). 
Experimental design
The reversal learning task (Figure 1) was similar to that used previously (Cools et 
al., 2006; Cools et al., 2009; Robinson et al., 2010a; van der Schaaf et al., 2011), 
programmed with Presentation software (Version 10.2 Neurobehavioral Systems, 
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Inc) and presented on a screen that was visible via a mirror on the head coil in the 
scanner. On each trial, participants were presented with two simultaneously 
presented vertically adjacent stimuli, a face and a scene (location randomized). 
One of these stimuli was associated with reward and the other with punishment. 
Unlike standard probabilistic reversal paradigms, participants did not choose 
between the two stimuli. Instead, one of the stimuli was selected by the computer 
(highlighted with a black border) and participants were asked to predict the 
outcome associated with this preselected stimulus. After the prediction, indicated 
with a right index or middle finger button press (counterbalanced across 
participants), the actual outcome was presented. Note that these outcomes did not 
depend on participants’ responses but were directly coupled to the highlighted 
stimulus. Accordingly, task contingencies were Pavlovian rather than instrumental. 
Stimuli were presented until a response was made. After a 1000 msec delay, the 
actual outcome was presented (100% deterministic) for 500 msec, followed by an 
inter-trial interval of 1500-6000 msec. If participants did not respond within 1500 
msec, a “Too late” message was presented for 500 msec. The stimulus-outcome 
contingencies reversed after 4, 5, or 6 consecutive correct predictions. Such 
reversals were signalled by either an unexpected punishment (presented after a 
previously rewarded stimulus was highlighted) or an unexpected reward 
(presented after a previously punished stimulus was highlighted). Accuracy on the 
trials directly following these unexpected outcomes (reversal trials) reflect how 
well participants updated stimulus-outcome associations after either unexpected 
rewards or unexpected punishments. Reward consisted of a green smiley with a 
“+¼100” sign. Punishment consisted of a red sad smiley and a “-¼100” sign. 
Participants were not compensated proportionally to the winnings, because the 
number of rewards and punishments was equated in the end, and did not depend 
on participants’ performance. However, similar neural effects have been reported 
for real and hypothetical rewards (Bray et al., 2010; Miyapuram et al., 2012), 
supporting the use of fictive monetary outcomes in combination with smiley’s as a 
good alternative in the present study (for further details on stimulus presentation 
see Supplementary information).Participants performed four experimental 
blocks, each consisting of one acquisition stage until the first reversal and a 
variable number of reversal stages depending on the participant’s performance. 
Average number of reversal trials was 33 (± 9) for punishment and 33 (± 8) for 
reward. The task finished when 592 trials were completed (~60 min). Our dependent 
variable was the proportion of correct responses on reversal trials following the 
unexpected outcomes. On these reversal trials, the same stimulus was highlighted 
again such that requirements for motor switching and prediction updating were 
matched between reward and punishment conditions. This enabled direct 
comparisons between reward and punishment reversals. Valence-dependent and 
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valence-independent reversal scores were calculated by computing, respectively, 
the difference between, and the average of reward and punishment reversal scores.
Image acquisition and analysis
Structural (T1-weighted MP-RAGE sequence, TE/TR = 3.03/2300 ms, flip angle =  8°, 
field of view (FOV) = 256 mm × 256 mm × 192 mm, voxel size = 1 mm isotropic, 
GRAPPA acceleration factor 2) and functional images (whole brain gradient echo 
planar Imaging (EPI) sequence; TE/TR = 25/1890 ms, flip angle = 80°, FOV = 212mm 
x 212 mm x 122 mm, matrix = 64 x 64, 37 ascending transverse slices; voxel size = 
3.3 x 3.3 x 3.0 mm, 0.3 mm gap between slices) were collected using a 3-tesla 
SIEMENS MRI scanner with an 8 channel head coil. To reduce signal drop-out and 
geometric distortions, we used a short TE and reduced echo-train length by means 
Figure 1   Experimental design.
a) Two stimuli, a face (F) and a scene (S), were presented simultaneously. One of the two 
stimuli was highlighted with a black border and the participant’s task was to predict, with 
a right or left button press, whether this stimulus was followed by a reward (rw, a happy 
smiley with a + €100 sign) or a punishment (pn, a sad smiley with a -€100 sign). The actual 
outcome was presented after the participant’s prediction (100% deterministic). b) An example of 
a trial sequence. The participant learned to predict reward and punishment for the face and 
scene respectively; expected reward (ER) or expected punishment (EP). After 4-6 consecutive 
correct predictions, the stimulus-outcome associations were reversed which was signalled 
by either unexpected reward (UR) or unexpected punishment (UP). Performance was 
measured on reversal trials (rev) immediately after the unexpected outcomes.
+
ITI:  1500-6000 ms
Stimulus: until response
max 1500 ms
Outcome: 500 ms
- €100
Delay: 1000 ms
Selected stim: F F S F S S F S F S S F     
Correct prediction: rw rw pn rw pn rw pn rw pn rw pn rw
Outcome: R R P R R R P R P P P R          
Trial type: ER ER EP ER UR rev EP ER EP UP rev ER    
a
b
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of factor 2 accelerated GRAPPA (Griswold et al., 2002). Images were analyzed using 
SPM5 (Wellcome Department of Cognitive Neurology, London UK). Images were 
realigned to the first volume, co-registered to the structural MR image, normalized 
to the standard Montreal Neurological Institute (MNI) template, re-sampled into 2 
mm isotropic voxels and smoothed with an isotropic 8 mm full-width half 
maximum Gaussian kernel.
Event-related responses were modelled with a canonical hemodynamic response 
function and time locked to the presentation of the outcome. For each drug session, 
a general linear model was defined including six task-related parameters, their 
temporal derivatives and nine noise parameters. The following parameters were 
included: (i) unexpected punishment, (ii) unexpected reward, (iii) correctly predicted 
expected punishment, (iv) correctly predicted expected reward, (v) incorrectly 
predicted or missed expected punishment and (vi) incorrectly predicted or missed 
expected reward, (vii-xii) six head movement parameters (obtained from the 
realignment procedure) and (xii – xv) three parameters to model global intensity 
changes (the time series of the mean signal from the white matter, cerebral spinal 
fluid and out of brain segments)(Verhagen et al., 2008). Time series were high-pass 
filtered (cut-off 128s). The parameter estimates, derived from the mean least squares 
fit of the model to the data, reflect the strength of covariance between the data and 
the canonical response function for a given trial-type of interest. 
Individual contrasts maps between parameter estimates for different events of 
interest, were calculated for two contrasts per drug condition:  (i) one representing 
 valence-independent BOLD signal ([unexpected reward– correctly predicted expected 
reward]+[unexpected punishment – correctly predicted expected punishment]), 
and (ii) valence-dependent BOLD signal ([unexpected reward – correctly predicted 
expected reward]–[unexpected punishment – correctly predicted expected 
punishment]). By contrasting all unexpected outcomes with expected outcomes, 
we controlled for processes related to visual stimulation (e.g. reward and 
punishment). For both contrasts, individual drug-difference maps were calculated 
for all six pair-wise drug comparisons (bromocriptine – sulpiride, sulpiride – 
placebo, bromocriptine – placebo, sulpiride – combined administration, 
bromocriptine – combined administration and placebo – combined administration), 
which were then taken to second level random-effects group analyses. 
Second level group analysis was performed, using simple regression procedures, as 
implemented in Statistical Parametric Mapping software (SPM5, http://www.fil.
ion.ucl.ac.uk/spm), to investigate working memory dependent drug effects on 
valence dependent and valence-independent BOLD signal. To this end, individual 
Chapter 2
48
drug difference maps were submitted to a second-level one sample T-test and 
individual working memory scores were entered as a covariate of interest. 
Significant voxels revealed by the covariate of interest represent brain regions 
where there is a linear relationship between individual measures of working 
memory and drug effects on valence-dependent or valence-independent BOLD 
signal. Working memory independent effects of drug were assessed using similar 
one-sample T-tests, without the covariate. 
Because simple regression analysis better captures the linear nature of the association 
between working memory and drug effects on BOLD signal, this method was chosen 
over a more commonly used median split analysis, in which drug effects on BOLD 
signal are compared between two groups with high and low working memory 
participants. To ensure that the results from the simple regression analysis were not 
statistical artefacts driven by e.g. outliers, supplementary analyses were done using 
the median split procedure (See Supplementary information). 
Testing of the different drug comparisons were done in a fixed a-priori defined 
order. We focused our first analyses on comparisons between bromocriptine versus 
sulpiride to assess differences between dopamine receptor stimulation and 
dopamine receptor blockade. If this analysis resulted in significant effects, each 
single-drug sessions was then compared with placebo. To assess whether any such 
drug effects were attenuated by co-administration of both drugs, we assessed 
comparisons between the combined bromocriptine/sulpiride session versus each of 
the single-drug sessions and placebo. 
Statistical inference (P<.05) was performed at the voxel level, family-wise error 
(FWE) correcting for multiple comparisons over the search volume (the whole 
brain [p
wb_fwe
] or the anatomically defined small volume (SV) of interest, the 
striatum [p
sv_fwe
]). The striatum was defined anatomically as the bilateral putamen 
and caudate nucleus selected from the Automated Anatomical Labelling atlas 
(Tzourio-Mazoyer et al., 2002). In addition, MarsBar software (Brett et al., 2002) was 
used to extract mean parameter estimates from the anatomically defined striatum. 
Drug effects on mean parameter estimates (i.e. difference between unexpected 
reward and expected reward and unexpected punishment and expected 
punishment) were assessed with repeated measures ANOVA with the factors drug 
(4 levels) and valence (reward and punishment), and span (mean centred) as 
covariate of interest. Subsequent parametric correlation analyses (Pearson’s rho, 
bivariate) were performed to further investigate associations between drug effects 
on BOLD signal, individual differences in working memory capacity and behavioural 
performance. 
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Behavioural analyses
Proportions of correct responses on reversal trials were arcsine transformed (2x 
arcsine(√x)) as is appropriate when the variance is proportional to the mean(Howell, 
1997). Valence-independent and valence-dependent drug effects across the group 
(independent of span) were analyzed with repeated measures ANOVA(SPSS Inc. 
release 15.0.0 for Windows, 2006) with the within-subject factors valence (reward, 
punishment) and drug. Similar to analysis of the neural data, pair-wise drug 
comparisons were done according to an a-priori defined fixed order (see image 
acquisition and analysis). Span-dependent drug effects on behaviour were assessed 
with correlation analysis (Pearson’s rho, bivariate). To this end, individual 
difference scores between two drug sessions of interest (following form the neural 
data) were calculated for valence-independent and valence-dependent reversal 
scores and correlated with individual measures of baseline working memory. 
Greenhouse-Geisser corrections were applied when the sphericity assumption was 
violated(Howell, 1997).
Results 
Dopaminergic drug elicit effects on striatal BOLD signal during both 
reward and punishment reversal learning 
When working memory capacity was taken into account, voxel-wise analyses 
revealed significant span-dependent drug effects on valence-independent BOLD 
signal in the striatum. No span-dependent drug effects were seen on valence-de-
pendent BOLD signal. Specifically, working memory capacity predicted the effect 
of sulpiride relative to bromocriptine on valence-independent BOLD signal in the 
striatum (left striatum x,y,z=-22,18,4, p
sv_fwe
=.03, right striatum x,y,z=32,8,0; p
sv_
fwe
=.045) (Table 1; Figure 2a). Further analyses revealed that these span-dependent 
effects were driven by effects of sulpiride relative to placebo (left striatum 
x,y,z=-30,2,4, p
sv_fwe
=.02; right striatum x,y,z = 24,14,-8, p
sv_fwe
=.04), while there were 
no effects of bromocriptine relative to placebo. Thus, greater working memory 
capacity was associated with greater sulpiride-induced increases in striatal BOLD 
signal during both unexpected rewards and punishments (Figure 2a). No 
significant drug effects on valence-independent or valence-dependent BOLD signal 
were seen when working memory was not taken into account. 
The voxel-wise results were strengthened by analyses on mean BOLD signal 
extracted from the anatomically defined striatum. Repeated measures ANOVA 
with the factors drug(4) and valence(2) and span as covariate revealed a significant 
interaction between drug and span (F
16,3
=4.540, p=.007). These effects were 
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restricted to valence-independent signal, as there was no drug×span×valence 
interaction (F
16,3
=.46, p=.71). There were also no span-independent drug effects 
(main effect of drug: F
16,3
=.56, p=.65; drug×valence interaction : F
16,3
=.03, p=.99). 
Subsequent correlation analyses revealed a highly significant relationship between 
span and drug effects on valence-independent BOLD signal for sulpiride versus 
bromocriptine (r
19
=-.69, p<.001) and for sulpiride versus placebo (r
19
=.6, p =.005) 
(Figure 2b), but not for bromocriptine versus placebo (r
19
=-.06, p=.8). Similar 
relationships were observed when BOLD signal was assessed separately for unex-
pected-expected rewards (bromocriptine–sulpiride: r
19
=.6, p=.005; sulpiride–
placebo: r
19
=.5, p=.02) and for unexpected-expected punishment (bromocriptine–
sulpiride: r
19
=.5, p=.022; sulpiride–placebo: r
19 
=.46, p=.04). 
Critically, these span-dependent effects of sulpiride on striatal BOLD signal were 
attenuated, when participants were subsequently treated with bromocriptine. 
Voxel-wise analyses no longer revealed any significant (span-dependent) effects of 
combined administration of sulpiride+bromocriptine relative to placebo, and 
mean signal analyses confirmed this lack of effect (r
18
=.3, p=.2). In addition, 
voxel-wise direct comparison between sulpiride and sulpiride+bromocriptine 
revealed a trend towards span-dependent effects on valence-independent signal 
(left striatum x,y,z =-26,14,-6, p
sv_fwe
=.06). This was supported by mean signal 
analyses, which revealed a similar trend (r
18
=.4, p=.096). See supplementary 
Table 1   Span-dependent drug effects on valence-independent BOLD-signal.  
MNI-coordinates
Region N voxels T-value x y z
Sulpiride – bromocriptine (positive)
Putamen L 357 4.97 -22 18 4
4.75 -24 14 6
Putamen R 124 4.77 32 8 0
Sulpiride - placebo (positive)
Putamen L 292 5.25 -30 2 4
L 4.39 -16 6 -6
L 4.27 -20 10 -8
Putamen R 53 4.85 24 14 -8
Effects are presented that reached significance after correction for multiple comparisons within our 
small volume of interest (anatomical defined striatum) (P
fwe_sv
 < .05) and an extent threshold of > 10 
voxels. L = left side, R = right side.
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information for confirmation of these effects with a median split analysis and with 
a correlation analysis using baseline working memory measures taken during 
intake and placebo only.
Dopaminergic drugs elicit differential effects on reward and 
punishment reversal learning
Consistent with previous work (Cools et al., 2006; Cools et al., 2009), we found 
differential dopaminergic drug effects on behavioural measures of reward versus 
punishment based reversal learning (Table 2). Repeated measures ANOVA on 
reversal scores across participants (irrespective of span) revealed a valence-dependent 
effect of sulpiride relative to bromocriptine. This was evidenced by a drug 
(bromocriptine versus sulpiride) by valence interaction (F
1,20
=4.6, p=.045), due to 
better reward relative to punishment based reversal learning after sulpiride 
compared with bromocriptine. Comparisons of the valence-dependent effects of 
sulpiride, and of bromocriptine with placebo did not reach significance (sulpiride 
versus placebo: F
1,20
=.3, p=.6; bromocriptine versus placebo: F
1,19
=1.8, p=.2). Valence- 
dependent reversal scores in the combined sulpiride/bromocriptine session did not 
differ from those in the bromocriptine session (drugxvalence: F
1,19
=.08, p= .8), from 
those in the sulpiride session (drugxvalence: F
1,19
=2.7, p=.1), or from those in the 
placebo session (drugxvalence: F
1,19
=1.4, p=.3).  Together, these data show opposite 
effects of sulpiride and bromocriptine on reward relative to punishment based 
reversal learning across participants. 
Critically, as was the case for the neural effects, the behavioural effects of sulpiride 
(versus placebo) could also be predicted from working memory capacity. Thus there 
was a significant positive relationship between working memory capacity and 
effects of sulpiride (relative to placebo) on valence-dependent reversal scores 
(reward minus punishment based reversal) (r
19
=.5, p=.03). Greater working memory 
Table 2   Drug effects on reversal learning.  
 Punishment Reward
Placebo 0.87(0.03) 0.90(0.02)
Sulpiride 0.89(0.02) 0.94(0.01)
Bromocriptine 0.92(0.01) 0.91(0.02)
Sulpiride + bromocriptine 0.90(0.02) 0.90(0.02)
Values represent mean proportion (standard error of the mean) of correct responses on the reversal trials 
immediately after the unexpected reward or punishment (raw proportion scores).
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Figure 2   Working memory capacity predicts dopaminergic drug effects during reward 
and punishment reversal learning.
a) Results from simple regression analyses showing regions where there is a linear relationship 
between working memory and effects of sulpiride relative to bromocriptine (left), sulpiride 
relative to placebo (middle) and sulpiride relative to combined administration (right) on 
striatal BOLD signal during unexpected-expected outcomes (data presented at puncorrected 
<.001 , effects are significant within our small volume of interest (psv_fwe <.05)). b) Linear 
relationship  between working memory and drug effects on average striatal BOLD signal 
change (extracted parameter estimates from the striatum,  anatomically defined as the 
bilateral caudate and putamen selected from the AAL-atlas) for bromocriptine relative to 
sulpiride (left), sulpiride relative to placebo (middle) and sulpiride relative to combined 
administration of sulpiride and bromocriptine (right). c) Correlation between working 
memory and effects of sulpiride (relative to placebo) on reward versus punishment learning. 
d) Correlation between effects of sulpiride (relative to placebo) on striatal BOLD signal during 
both unexpected outcomes and effects of sulpiride (relative to placebo) on reward versus 
punishment learning. Diamonds indicate individual data points. ** = p<.005, * = p<.05, ^  = p <.1.
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capacity was associated with greater sulpiride-induced increases on reward relative 
to punishment based reversal learning (Figure 2c). See supplementary information 
for confirmation of this effect with baseline working memory measures taken 
during intake and placebo only.
Dopaminergic drug effects on striatal signal are associated with 
differential effects on reward and punishment learning
Next we investigated brain-behaviour associations between the effects of sulpiride 
on striatal BOLD signal (extracted from the anatomically defined striatum) and on 
reversal scores. Intriguingly, the effect of sulpiride (relative to placebo) on valence- 
independent striatal signal during both reward and punishment was positively 
correlated with the effect of sulpiride (relative to placebo) on valence-dependent 
(reward versus punishment) reversal scores (r
19
=.5, p=.02) (Figure 2d). Sulpiride- 
induced increases in striatal BOLD signal during unexpected reward and 
punishment were associated with sulpiride-induced improvement in reward 
relative to punishment based reversal learning. Conversely, sulpiride-induced 
decreases in striatal signal during unexpected reward and punishment were 
associated with sulpiride-induced impairments on reward relative to punishment 
based reversal learning. 
Physiology, mood and background neuropsychology
Physiological effects were as predicted, with large prolactin increases after intake 
of sulpiride (Time2 – Time1: T
20
 = -9.2 p <.001) or sulpiride + bromocriptine (Time2 
– Time1: T
20
 = -9.7, p <.001), and prolactin decreases (Time2 – Time1: T
20
 = 3.4, p = .003) 
and systolic blood pressure decreases (Time3 – Time1: T
21
 = -3.32, p = .003) after 
intake of bromocriptine (Table S1). The absolute prolactin decreases after 
bromocriptine and increases after sulpiride or combined administration were 
Figure 2   Continued.
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consistent and in the same direction for all participants. Drug effects were not 
attributable to non-specific drug effects on mood and global cognitive functioning, 
as drugs did not affect general cognitive performance or mood (Table S2 and S3). 
Discussion 
In the present study, pharmacological fMRI was used to investigate effects of cate-
cholaminergic drugs on striatal signals during reward and punishment reversal 
learning. The data add significantly to previous work on the effects of dopaminergic 
drugs on reward and punishment learning in three ways. First, previous work did 
not allow conclusions about the dopamine-dependency of the effects.  Here, we 
demonstrate that effects of the dopamine receptor antagonist sulpiride on striatal 
BOLD signal during reward and punishment learning are partly attenuated by 
co-administration with the dopamine receptor agonist bromocriptine. This 
evidences the neurochemical specificity of the effects. Second, existing studies 
have provided conflicting data regarding drug effects on striatal responses during 
punishment. We show that sulpiride-induced increases in striatal BOLD signal 
during both rewards and punishments were associated, on a subject by subject 
basis, with opposite effects on behaviour, i.e. improvement in reward versus 
punishment reversal learning. Finally, our findings extend existing observations 
that behavioural effects of dopamine agents on learning depend on working 
memory capacity (Frank and O’Reilly, 2006; Cools and D’Esposito, 2011), presumably 
reflecting baseline dopamine synthesis capacity (Cools et al., 2008b; Landau et al., 
2009). Here we show that not only behavioural, but also neural effects on learning 
in the striatum strongly depend on individual differences in working memory 
capacity.  
The present findings concur generally with previous work by Jocham et al. (Jocham 
et al., 2011), who have shown beneficial effects of the dopamine receptor antagonist 
amisulpiride on reward based choice. The degree to which sulpiride enhanced the 
ability to select the better of two rewarding options correlated with the degree to 
which sulpiride potentiated reward prediction error signals during learning in 
the striatum (c.f. (Frank and O’Reilly, 2006) for similar behavioural effects). 
However, this striatal finding by Jocham et al. (2011) was in direct contrast with 
that reported by Pessiglione et al. (2006), who showed that, relative to l-dopa, the 
catecholamine antagonist haloperidol impaired reward learning and attenuated 
reward prediction error signals in the striatum. The present study suggests that 
these paradoxical effects on striatal processing might reflect individual differences 
in the baseline state of the system. Thus, the dopamine receptor antagonist 
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sulpiride potentiated reward and punishment related BOLD signal in the striatum 
in participants with high working memory capacity, while attenuating striatal 
BOLD signal in participants with low working memory capacity. 
No previous studies revealed drug effects on striatal signals during punishment 
learning. This lack of effects had suggested a particularly important role for 
striatal dopamine in reward, but not punishment learning. By contrast, the 
present study demonstrates that dopamine affects both reward and punishment 
prediction error signals in the striatum in the same direction. Unlike these 
previous studies, we might have revealed effects during both outcomes because in 
our paradigm, reward and punishment events were matched in terms of frequency 
of occurrence as well as the need for behavioural adjustment. Importantly, these 
changes in valence-independent striatal BOLD signal were directly associated with 
valence-dependent reversal learning. Thus, drug-related increases in striatal signal 
during both rewards and punishments were associated with drug-related increases 
in reward relative to punishment learning. At first sight, this finding might seem 
surprising,  given studies that argue that striatal responses represent valence-inde-
pendent signals associated with a mismatch between expected and actual 
outcomes, saliency or valence non-specific switching (Redgrave et al., 1999b; Zink 
et al., 2003b; Jensen et al., 2007; Matsumoto and Hikosaka, 2009). However, if the 
striatal signal had reflected such non-specific processing, then its potentiation 
should have been associated with behavioural improvement in both reward and 
punishment learning. Instead we observed that its potentiation was associated 
with improved reward relative to punishment learning. Accordingly, we argue that 
our parallel effects likely reflect modulation of overlapping and/or intermingled 
representations or reward and punishment prediction errors (Seymour et al., 
2007b; Robinson et al., 2010a).  This interpretation concurs with recent insights 
suggesting that striatal BOLD signal increases with increased dopamine release 
(Knutson and Gibbs, 2007; Schott et al., 2008; Duzel et al., 2009). Indeed we have 
previously shown that increased dopamine activity is associated with increased 
reward relative to punishment learning (Cools et al., 2009). Furthermore, striatal 
BOLD signal has been proposed to relate specifically to postsynaptic D1 signalling 
(Knutson and Gibbs, 2007). This is particularly interesting because theoretical 
modelling work suggests that improvement in reward relative to punishment 
learning might reflect a shift in the balance between D1-receptor mediated GO 
pathway processing and D2-receptor mediated NOGO pathway processing (Frank, 
2005). Thus, sulpiride-induced changes in striatal BOLD might reflect a shift in the 
D1/D2-receptor signalling balance, such that increases in striatal BOLD reflect a 
shift in favour of the D1-mediated GO pathway processing, improving reward 
relative to punishment learning  and decreases in striatal BOLD reflect a shift 
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away from the D1-receptor mediated GO-pathway, impairing reward relative to 
punishment learning.  In this context it is not surprising that changes in reward 
relative to punishment learning are accompanied by parallel changes in striatal 
signal during both rewards and punishments. 
Moreover, the present study employed a Pavlovian task, which required the 
prediction of outcomes rather than the use of outcomes for instrumental action 
control. Similar above-baseline striatal signals for reward as well as punishment 
prediction errors were observed previously in non-drug studies, mostly in studies 
using Pavlovian tasks (Seymour et al., 2005; Seymour et al., 2007b; Delgado et al., 
2008; Robinson et al., 2010a). Indeed, accumulating evidence indicates sensitivity 
of Pavlovian control to dopamine manipulation (Dickinson et al., 2000; Wyvell 
and Berridge, 2000; Flagel et al., 2011).
The effects depended on baseline working memory capacity. Greater working 
memory capacity was associated with greater sulpiride-induced improvement on 
reward versus punishment learning and with greater potentiation of striatal 
signals. Based on prior work (Cools et al., 2008b; Cools et al., 2009), we argue that 
this dependency on working memory capacity reflects dependency on baseline 
dopamine synthesis capacity, so that greater improvement with the dopamine 
receptor antagonist sulpiride was particularly prominent in participants with 
higher baseline dopamine levels. Such individual differences in drug effects might 
reflect individual differences in pre- versus postsynaptic D2 receptor sensitivity 
(Frank and O’Reilly, 2006; Cools et al., 2009), with high-dopamine participants 
being particularly sensitive to the presynaptic effects of sulpiride. Thus, D2-receptor 
blockade with sulpiride might have improved reward versus punishment learning 
in high-dopamine participants, because it blocked presynaptic autoregulation of 
dopamine levels, leading to a net increase in postsynaptic (D1) receptor stimulation. 
Similarly, it has been argued that low doses of a D2-receptor antagonists might in 
fact act as a stimulant, acting on the more sensitive presynaptic autoreceptors, 
when administered in healthy participants (Frank and O’Reilly, 2006; Santesso et 
al., 2009; Jocham et al., 2011). However, a definitive account of the direction of 
drug effects remains a major challenge in dopaminergic drug research, because 
the determinants of pre- versus postsynaptic action of dopamine receptor agents 
are unknown. Accordingly, we refrain here from definitively interpreting the 
direction of the drug effect. 
Co-administration of the dopamine receptor antagonist sulpiride and the 
dopamine receptor agonist bromocriptine diminished the neural effects of 
sulpiride, suggesting that sulpiride exerted its effects via action at dopamine 
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receptors that are targeted by both sulpiride and bromocriptine. Because both 
bromocriptine and sulpiride have high affinity for D2-receptors, these effects are 
likely mediated by D2-receptor mechanisms in the striatum. Previous human 
pharmacological work did not provide such evidence, because the drugs used were 
not neurochemically specific. Bromocriptine itself had no significant effect on 
striatal signals when tested relative to placebo. Perhaps effects did not reach 
significance due to the timing of testing relative to administration. Time of testing was 
optimized for the current fMRI paradigm as well as for a subsequent behavioural 
task. Accordingly, participants were tested 1¾ hours after bromocriptine 
administration, relative to 2½ hours in our prior study, which did reveal effects of 
bromocriptine(Cools et al., 2009). Similar to that previous study, bromocriptine 
(but not sulpiride) did affect performance on the subsequent  set-shifting task 
administered 3½ hours after bromocriptine intake in the same participants (van 
Holstein et al., 2011). This suggests that effects did not reach significance due to 
the timing of testing relative to administration. However, combined administration 
of bromocriptine did abolish effects of sulpiride, suggesting that effects of 
bromocriptine were nevertheless sufficient for blocking the effects of sulpiride. 
Moreover, the lack of a significant effect of bromocriptine relative to placebo is 
important for the interpretation of our results because, it demonstrates that the 
neural effect of sulpiride is blocked instead of masked (or averaged out) by 
bromocriptine. The implication of this pattern of findings is that we can assert 
that sulpiride exerted, at least part of, its effects via action at dopamine (D2-) 
receptors. 
In summary, the present study investigated dopaminergic drug effects on striatal 
BOLD signalling during reward and punishment learning. Results revealed that 
sulpiride induced parallel working memory dependent changes on striatal BOLD 
signal during unexpected rewards and punishments. These effects were partially 
dopamine-dependent as they were blocked by co-administration with bromocriptine. 
Moreover, sulpiride-induced increases in striatal BOLD signal during both outcomes 
were associated with behavioural improvement in reward versus punishment 
reversal learning. These results support current theories suggesting that drug 
effects on reward as well as punishment learning are mediated by striatal 
dopamine (Frank, 2005). 
These results have implications not just for understanding how dopamine alters 
learning, but also for (the treatment of) dopamine-related disorders in psychiatry. 
For example, sulpiride is used commonly to treat psychosis. One mechanism by 
which dopaminergic abnormality might elicit psychosis is by inducing aberrant 
assignment of salience or motivational importance to irrelevant stimuli (Kapur 
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et al., 2005). Our results suggest that sulpiride might remediate psychosis in 
schizophrenia by attenuating aberrant reward relative to punishment prediction 
updating and associated striatal processing in a dopamine-dependent fashion 
(Morrison and Murray, 2009). This hypothesis concurs with the observation that 
schizophrenia is accompanied by low working memory capacity (Barch and Ceaser, 
2011). More generally, our findings highlight the need for individual tailoring of 
dopaminergic drug administration in psychiatry.
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Supplementary methods and results
Intake Screening 
During intake, all participants were screened. This screening included the Mental 
International Neuropsychiatric Interview (Sheehan et al., 1998) and a physical 
examination for weight, pulse rate, blood pressure and an electrocardiogram to 
exclude major psychiatric, neurological or medical illness. Verbal intelligence was 
determined with the Dutch adult reading test (Schmand et al., 1991). A Dutch 
version of the listening span test (Salthouse et al., 1991) was taken and Personality 
traits were assessed with the NEO-Five Factor Inventory (NEO-FFI) (McCrae and T., 
2004), Eysenck Personality Scales (Sanderman et al., 1995), the state/trait anxiety 
inventory (STAI) (Spielberger, 1970) and the Barratt Impulsiveness Scale (Patton et 
al., 1995). Depression was assessed using the Beck Depression Inventory (Beck et al., 
1961b). 
Baseline neuropsychological measures and questionnaires taken during the 
intake session revealed that our sample of participants resembled that tested in 
prior studies in terms of verbal IQ (mean ± SEM IQ 101.07±1.5) and personality 
traits as measured with NEO and EPQ. Furthermore, they did not exhibit clinical 
anxiety (mean ± SEM STAI trait: 29.5±1.4), depression (mean ± SEM Beck depression: 
2.0±0.4), or extreme impulsivity (mean ± SEM Barratt: 61.3±1.7). 
Pharmacological design, administration order
Administration order was randomized according to a counterbalanced, place-
bo-controlled, double-blind design. Four different orders were used: 1) placebo, 
sulpiride, bromocriptine, combined (six participants), 2) sulpiride, combined, 
placebo, bromocriptine (five participants), 3) bromocriptine, placebo, combined, 
sulpiride (six participants) and 4) combined, bromocriptine, sulpiride, placebo (six 
participants).
Experimental design, additional information 
Stimulus presentation was random with the following restrictions: (i) after an 
unexpected outcome the highlighted stimulus remained the same as on the 
previous trial; (ii) The same picture was never highlighted more than three times 
in a row; (iii) The outcome signalling the reversal was never the same more than 
three times in a row and (iv) reversals occurred only when the prediction of the 
stimulus preceding the unexpected outcome was correct according to the old 
contingency. Outcome-response mappings were kept constant across sessions and 
were balanced across participants; 12 participants predicted reward with the right 
finger, 10 participants predicted punishment with the right finger.
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Supplementary median split analysis 
A supplementary median split analysis was performed to ensure that effects 
revealed by the simple regression analysis were not statistical artifacts driven by 
e.g. outliers. To this end, all subjects with complete fMRI sessions (N=20) were split 
into a high (18.9 ±1.6, range: 17.5 - 22.8) and low (14.8 ± 1.8, range: 12.5 – 17.3) 
working memory group using a median split based on the average total digit span. 
Working memory dependent drug effects were assessed for valence-dependent and 
valence-independent reversal-related BOLD signal using a second-level full factorial 
model with the within subjects factors drug (4 levels) and valence ([unexpected- 
expected reward], [unexpected – expected punishment]) and between subject 
factor span (high and low working memory). Statistical inference (P<.05) was 
performed at the voxel level, family-wise error (fwe) correcting for multiple 
comparisons over anatomically defined small volume [p
sv_fwe
] of interest, the 
striatum, defined anatomically as the bilateral putamen and caudate nucleus 
selected from the Automated Anatomical Labelling atlas (Tzourio-Mazoyer et al., 
2002).
Results revealed a significant drug (4 levels) by span (high and low) interaction in 
the left striatum (xyz = -24, 14, -2, F = 8.01, p
sv_fwe
= .030) (Figure S1A), supporting 
differential drug effects on valence-independent reversal-related BOLD signal (i.e. 
unexpected – expected outcomes) in high and low working memory groups. 
Consistent with the simple regression analyses reported in the main text, 
subsequent pair-wise comparisons revealed significant drug (2) by span interactions 
for sulpiride relative to bromocriptine (xyz = -22,18,-2, T = 4.69, p
sv_fwe
= .003), 
sulpiride relative to placebo (xyz = -26,12,-2, T = 3.94, p
sv_fwe
= .026) and a trend for 
sulpiride relative to combined administration (xyz = -24,14,-4, T = 3.41, p
sv_fwe
= .12) 
in overlapping areas in the left striatum (Figure S1). No significant effects were 
seen for bromocriptine relative to placebo, and placebo relative to combined 
administration. There were no drug effects on valence-dependent reversal-related 
BOLD signal as no significant voxels were seen for the drug (4) by valence by span 
or drug (4) by valence interactions. 
Taken together, supplementary median split analysis with high and low working 
memory groups replicated the working memory dependent drug effects of sulpiride 
as revealed by the simple regression analyses reported in the main text. 
Supplementary baseline working memory analysis
Working memory dependent drug effects, as revealed with the average digit span 
across all four drug sessions, were generally confirmed with the digit span scores 
measured during placebo only (DS-P) and the listening span (LP) measured during 
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Figure S1   Working memory capacity predicts dopaminergic drug effects during reward 
and punishment reversal learning.
a) Drug (4 levels) x Span (high, low) interaction for unexpected-expected outcomes. b) Bar plot 
showing the beta-values extracted from the drug by valence interaction region shown in A for 
each drug condition and span group. c) Drug (2 levels) by span (high, low) interactions for the 
pair-wise drug comparisons –sulpiride - bromocriptine (left), sulpiride - placebo (middle) and 
sulpiride - combined administration of both drugs (right). d) Visualization of the linear 
relationship between working memory capacity and beta-values extracted from the drug (4) by 
valence (2) interaction region shown in A for the pair-wise drug comparisons –sulpirode - 
bromocriptine (left), sulpiride - placebo (middle) and sulpiride - combined administration of both 
drugs (right). Diamonds indicate individual data points.
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intake. Correlation analysis between span and mean signal change extracted from 
the anatomically defined striatum confirmed working memory dependent effects 
of sulpiride relative to bromocriptine (DS-P: r
21 
= .59, p = .005; LP: r
21 
= .45, p = .043) 
and sulpiride relative to placebo (DS-P: r
21 
= .63, p = .002; LP: r
21 
= .57, p = .008) but 
not the trend for sulpiride relative to combined administration (DS-P: r
20 
= .27, p = .26; 
LP: r
20 
= .28, p = .23). Correlation analysis between span and behavior confirmed the 
working memory dependent effects of sulpiride relative to placebo on valence- 
dependent reversal learning (DS-P: r
21 
= .51, p = .01; LP: r
21 
= .47, p = .017).  
Figure S1   Continued.
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Table S1   Physiological measurements. 
intake  
session
placebo sulpiride bromocriptine sulpiride/
bromocriptine
Heart Rate T1 79.1(2.5) 69.7(2.6) 71.2(2.6) 70.3(1.9) 68.8(2.0)
T2 67.3(2.3) 66.6(2.1) 68.3(2.2) 64.9(1.8)
T3 69.7(2.6) 69.5(2.1) 72.0(2.6) 71.8(2.2)
Systolic BP T1 116.9(2.5) 118.3(2.5) 117.6(2.7) 117.3(2.6) 118.7(2.8)
T2 110.9(2.7) 111.9(2.7) 105.6(2.5) 109.9(2.5)
T3 113.1(2.6) 111.9(2.5) 103.0(2.6) 111.8(2.7)
Diastolic BP T1 72.2(1.9) 68.2(1.5) 68.1(1.5) 67.9(1.8) 66.7(1.9)
T2 72.0(1.5) 69.5(2.0) 70.3(1.5) 70.5(1.7)
T3 65.8(1.8) 63.7(1.8) 60.4(2.1) 64.9(2.0)
Prolactin T1 343(30) 339(26) 362(31) 365(37)
T2 250(17) 2473(238) 184(14) 2591(237)
Values represent means (standard error of the mean). BP = Blood pressure, T1 = ~30 minutes before drug 
intake, T2 = ~2 hours after first drug intake, T3 = ~6 hours after first drug intake.
2Dopaminergic modulation of striatal BOLD
67
Table S2   Mood ratings during the drug sessions. 
Placebo Sulpiride Bromocriptine Sulpiride/ 
bromocriptine
Alertness T1 32.9(3.9) 32.4(3.1) 34.5(4.1) 31.7(3.3)
T2 41.5(3.9) 39.7(4.0) 40.0(4.1) 42.1(3.9)
T3 27.9(3.0) 31.4(4.0) 29.3(3.3) 34.0(4.4)
Calmness
T1 17.4(2.6) 22.0(3.6) 20.7(2.6) 19.5(3.1)
T2 17.8(2.7) 21.3(2.9) 27.1(3.4) 17.3(2.7)
T3 29.3(4.2) 27.7(4.1) 34.9(4.5) 30.7(4.1)
Contentedness
T1 23.4(2.5) 27.5(2.7) 24.7(2.6) 23.7(2.4)
T2 24.5(2.7) 24.0(2.7) 26.5(2.7) 26.2(2.7)
T3 22.8(2.1) 22.9(2.3) 23.9(2.5) 25.6(2.7)
Values represent means (standard error of the mean), T1 = ~30 minutes before drug intake, T2 = ~2 hours 
after first drug intake, T3 = ~6 hours after first drug intake.
Table S3   Drug effects on background neuropsychological tests and self-report scores. 
Placebo Sulpiride Bromocriptine Sulpiride/
Bromocriptine
Digit span Forward 8.5(2.1) 8.4(1.8) 8.5(1.9) 8.7(2.1)
Backward 8.3(2.8) 7.8(1.9) 7.8(2.3) 7.6(1.9)
Total 16.9(4.3) 16.3(3.4) 16.3(3.6) 16.3(3.5)
Block Completion Time 1:09:51  
(0:18:02)
1:09:35  
(0:18:21)
1:09:35  
(0:17:54)
1:09:48  
(0:16:15)
Number 
cancellation
Time 3:21:31  
(0:28:08)
3:24:07  
(0:37:07)
3:24:07  
(0:24:46)
3:31:12  
(0:32:44)
Miss 2.9(2.4) 2.7(3.2) 2.7(2.8) 2.6(3.7)
DAT Total words 41.8(11.0) 42.4(10.8) 42.4(12.1) 41.3(11.5)
Repetition 1.3(1.6) 0.8(1.4) 0.8(1.1) 1.5(1.9)
Values represent mean (standard deviation). Drug effects were tested with repeated measured ANOVA with 
the factor drug (4) for each measure and revealed no significant differences between the drug sessions. 
Abbreviations: DAT = Letter Fluency, STAI = state anxiety inventory, PANAS = Positive (PA) and Negative 
(NA) Affect Scale, BIS/BAS = the Behavioral Inhibition/Behavioral Activation Scale, Barratt = the Barratt 
Impulsiveness Scale.
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Abstract 
Dopamine in the striatum is known to be important for reversal learning. However, 
the striatum does not act in isolation and reversal learning is also well accepted to 
depend on the orbitofrontal cortex (OFC) and the amygdala. Here we assessed 
whether dopaminergic drug effects on human striatal BOLD signalling during 
reversal learning is associated with anatomical connectivity in an orbitofrontal- 
limbic-striatal network, as measured with diffusion tensor imaging. By using a 
fibre-based approach, we demonstrate that dopaminergic drug effects on striatal 
BOLD signal varied as a function of fractional anisotropy (FA) in a pathway 
connecting the OFC with the amygdala. Moreover, our experimental design 
allowed us to establish that these white-matter dependent drug effects were 
mediated via D2 receptors. Thus, white matter dependent effects of the D2 receptor 
agonist bromocriptine on striatal BOLD signal were abolished by co-administration 
with the D2 receptor antagonist sulpiride. These data provide fundamental insight 
into the mechanism of action of dopaminergic drug effects during reversal 
learning. In addition, they may have important clinical implications by suggesting 
that white matter integrity can help predict dopaminergic drug effects on brain 
function, ultimately contributing to individual tailoring of dopaminergic drug 
treatment strategies in psychiatry.
3White matter predicts dopaminergic drug effects
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Introduction 
Adequate dopamine neurotransmission is well known to be important for reward 
and reversal learning and accumulating evidence indicates that the effects of 
dopamine on such learning implicate the striatum. Consistent with current 
theoretical modelling work (Badre and Frank, 2012), pharmacological functional 
magnetic resonance imaging (fMRI) studies have revealed dopaminergic drug 
effects on striatal BOLD signals during reversal learning (Cools et al., 2001; Cools 
et al., 2007; Dodds et al., 2008; van der Schaaf et al., 2012). In addition, positron 
emission tomography (PET) studies have demonstrated that reversal learning 
depends on striatal dopamine synthesis capacity (Cools et al., 2009) and D2 receptor 
availability in the striatum (Groman et al., 2011).  
However, the striatum does not act in isolation and reversal learning is also well 
accepted to depend on the interaction between striatum, orbitofrontal cortex 
(OFC) and amygdala (Iversen and Mishkin, 1970; Jones and Mishkin, 1972; Holland 
and Gallagher, 2004; Schoenbaum et al., 2009; Murray and Wise, 2010). This 
interaction is thought to be modulated by dopamine. Specifically, medium spiny 
neurons in the striatum and amygdala that receive glutamatergic projections 
from limbic and cortical regions also receive converging dopaminergic projections 
from the midbrain (Pennartz et al., 1994; Rosenkranz and Grace, 2002; Sesack et 
al., 2003; Haber and Knutson, 2010). Animal studies have suggested that the effects 
of dopamine on these glutamatergic inputs are receptor specific, such that 
orbitofrontal inputs to the striatum are modulated by D2 receptor stimulation 
(Del Arco et al., 2007; Grace et al., 2007; Del Arco and Mora, 2009; Sesack and 
Grace, 2010) while orbitofrontal inputs to the amygdala and amygdala inputs to 
the striatum are modulated by D1 receptor stimulation (Rosenkranz and Grace, 
2002; Ambroggi et al., 2008; Sesack and Grace, 2010). These observations have led 
to the suggestion that dopamine regulates the degree to which the striatum, 
amygdala and OFC interact to integrate information about reward value, 
motivation and expectation and to ultimately facilitate adaptive and flexible 
behaviour (Grace et al., 2007; Haber and Knutson, 2010; Pennartz et al., 2011). 
Here we aim to provide evidence for such network effects of dopamine during 
human reversal learning by revisiting our recent pharmacological fMRI study that 
showed dopaminergic drug effects on striatal BOLD signal during reversal learning 
(van der Schaaf et al., 2012) (see Chapter 2). Specifically, we ask whether these 
previously reported effects of dopamine on the striatum during reversal learning 
are associated with  anatomical connectivity in an orbitofrontal-limbic-striatal 
network, as measured with diffusion tensor imaging (DTI). A demonstration that 
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drug effects are associated with  individual differences in anatomical connectivity 
will not only address the question about whether dopamine’s effects are associated 
with an orbitofrontal-limbic-striatal network of regions, but will also help elucidate 
individual trait factors that contribute to the known large variability in dopaminergic 
drug effects(Cools and D’Esposito, 2011). Thus individual differences in anatomical 
connections between the OFC, amygdala and striatum might predict the extent 
and direction of dopaminergic drug effects on reversal learning.
DTI is a non-invasive method to measure structural connectivity in humans and 
measures the diffusion of water in tissue, which depends on the tight packing of 
cellular axons and myelin sheets that encapsulate the axon fibres. Two measures 
are generally obtained; fractional anisotropy (FA) and mean diffusivity (MD). FA is 
a measure of the directionality of water diffusion and has been associated with 
dense coherent bundling and myelination of axons. MD reflects the general 
presence of barriers to free diffusion and has been associated with overall cell 
density. Collectively, FA and MD provide information on the microstructural 
integrity and communicational efficacy of white matter fibre bundles (Beaulieu, 
2002; Thomason and Thompson, 2011). 
The hypothesis that individual differences in functional effects depend on 
anatomical connectivity as measured with DTI is grounded in prior work linking 
anatomical connectivity with individual differences in functional effects 
(Boorman et al., 2007; Cohen et al., 2008; Harsay et al., 2011; Samanez-Larkin et al., 
2012). In addition, we have previously shown that dopaminergic drug effects on 
striatal BOLD signals during attention-shifting are associated with  white matter 
integrity of dorsal fronto-striatal-thalamic pathways (van Schouwenburg et al., 
2013). These results concur with the known role of dorsal fronto-striatal-thalamic 
pathways in cognitive functions such as attention shifting (Dias et al., 1996). By 
contrast, reversal learning depends on a ventral orbitofronto-limbic-striatal 
network (Dias et al., 1996). In the present study we used a fibre based approach 
(Mandl et al., 2012) to substantiate the observation that dopaminergic drug effects 
can be predicted from anatomical connectivity, while also showing the neuro-
anatomical specificity of such findings. Based on the literature reviewed above, we 
predict that drug effects on striatal BOLD signal during reversal learning will 
depend on a ventral orbitofronto-limbic-striatal network and not on a dorsal 
fronto- thalamic-striatal network. 
A final aim of this study was to assess the receptor specificity of the effects 
(Feldman et al., 1997). As described above, work with experimental animals has 
suggested that the dopaminergic modulation of interactions between the OFC, 
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amygdala and striatum is dopamine receptor specific (Rosenkranz and Grace, 
2002; Del Arco et al., 2007; Grace et al., 2007; Ambroggi et al., 2008; Del Arco and 
Mora, 2009; Sesack and Grace, 2010). In addition, it has been demonstrated that 
reversal learning in monkeys specifically depends on D2 and not D1 receptor 
functioning (Lee et al., 2007).  To address this issue in humans we employed a coad-
ministration design. All subjects were scanned on four occasions: after 
administration of placebo; after administration of the dopamine D1/D2 receptor 
agonist bromocriptine; after administration of the dopamine D2 receptor 
antagonist sulpiride; and after combined administration of both sulpiride and 
bromocriptine. If drug effects are mediated by D2 receptors, then any significant 
effect of bromocriptine relative to placebo should be abolished by coadministration 
of sulpiride. If effects of bromocriptine are mediated by D1 receptors, then they 
should not be abolished by coadministration of sulpiride.
Methods
Subjects
The present study represents an extension of a previously published pharmacolog-
ical fMRI study (van der Schaaf et al., 2012) (see Chapter 2) with diffusion tensor 
images that were acquired from the same subjects during an intake session prior 
to the drug sessions. For this study, twenty-eight healthy right handed volunteers 
with no relevant medical/psychiatric history three years prior to testing were 
tested after a medical screening (for screening procedure and exclusion criteria 
see Chapter 2, (van der Schaaf et al., 2012). They gave written informed consent 
approved by the local ethics committee (Commissie mensgebonden onderzoek, 
Arnhem-Nijmegen, number 2008/078, date 09-09-2008) and were compensated for 
participation. In total, 8 subjects were excluded from the fMRI analysis due to 
personal issues (1), technical issues (4), excessive head movement (2) and insufficient 
practice of the Dutch language (1) (see chapter 2, (van der Schaaf et al., 2012) for 
further details on these exclusions). Complete datasets including both DTI and all 
four fMRI sessions were available for twenty subjects (10 males, mean age: 22.7, 
range: 18.9-29.1). 
Procedures and pharmacological design
Subjects were tested on four occasions, separated by at least one week. They were 
tested after oral intake of placebo, bromocriptine (Parlodel, Novartis®, 1,25mg), 
sulpiride (Dogmatil, sanova-aventis®, 400mg), and a combination of bromocriptine 
and sulpiride (sulpiride was administered 30 minutes prior to bromocriptine). 
Administration was randomized according to a counterbalanced, placebo controlled, 
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double blind, double dummy design. The reversal learning task started 2¼ hour 
after first drug intake with a duration of 60 minutes. Blood pressure, heart rate 
and subjective mood ratings (visual analogue scales (Bond and Lader, 1974)) were 
taken 30 minutes before, 2 hours after and 6 hours after first drug intake. Blood 
samples were taken to determine the change in prolactin levels (Fitzgerald and 
Dinan, 2008a) and were taken 30 minutes before and 2 hours after first drug 
intake. Background neuropsychological tests (block completion, number 
cancellation, verbal fluency and digit span) were assessed 5 hours after first drug 
intake. Drug effects on physiological measures were as expected with prolactin 
increases after intake of sulpiride and combined administration and prolactin and 
systolic blood pressure decreases after intake of bromocriptine. Analyses of the 
questionnaires and background neuropsychology are described in our previous 
report and revealed no significant drug effects on mood or general cognitive 
functioning. For further details on the screening and session procedures, 
physiology, mood and background neuropsychology see chapter 2 (van der Schaaf 
et al., 2012).
Reversal learning task
On each trial, subjects were presented with two simultaneously presented 
vertically adjacent stimuli, a face and a scene (location randomized). One of these 
stimuli was associated with reward and the other with punishment. One of the 
stimuli was selected by the computer (highlighted with a black border) and 
subjects were asked to predict the outcome associated with this preselected 
stimulus. After the prediction, indicated with a right index or middle finger 
button press (counterbalanced across subjects), the actual outcome was presented 
(100% deterministic). Note that these outcomes did not depend on subjects’ 
responses but were directly coupled to the highlighted stimulus. The stimulus- 
outcome contingencies reversed after 4, 5, or 6 consecutive correct predictions. 
Such reversals were signalled by either an unexpected punishment (presented 
after a previously rewarded stimulus was highlighted) or an unexpected reward 
(presented after a previously punished stimulus was highlighted). On the trials 
directly following these unexpected outcomes (reversal trials), the same stimulus 
was highlighted again such that requirements for motor switching and prediction 
updating were matched between reward and punishment conditions. Accuracy on 
these reversal trials reflects how well subjects updated stimulus-outcome 
associations after either unexpected rewards or unexpected punishments. The 
dependent variables used for the current report were striatal BOLD signalling 
during unexpected outcomes and the proportion of correct responses on reversal 
trials (see below).
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Image acquisition and preprocessing
Structural images were collected before the start of the experiment during 
screening using a 3-tesla Siemens MRI scanner with an 8 channel head coil. For 
each subject, a high resolution T1-weighted MP-RAGE anatomical scan (TE/TR = 
3.03/2300 ms, flip angle = 8°, FOV = 256 mm × 256 mm × 192 mm, voxel size = 1 mm 
isotropic, GRAPPA acceleration factor 2) was obtained. Diffusion tensor images 
were acquired using a twice refocused spin-echo-planar imaging sequence to 
reduce spatial distortions caused by eddy currents (Reese et al., 2003). Sixteen 
subjects were scanned with the following protocol: 64 slices interleaved acquisition 
mode, TE/TR = 89/6700 ms, flip angle =  90°, FOV = 220 mm, voxel size = 2,2 mm 
isotropic). Acquisition consisted of 7 images without diffusion weighting (b = 0) 
and 61 images with diffusion weighting (b = 1000 s/mm2) applied along the 
non-colinear directions. Four subjects were scanned with slightly modified 
protocol in which the TR was 8500ms and images were acquired with partial 
instead of full Fourier with a slightly lower band width. 
Raw diffusion weighted imaging (DWI) data were pre-processed using in-house 
software (Zwiers, 2010). The DTI images were realigned using rigid body transfor-
mations and mutual information as a cost function (SPM8). Susceptibility induced 
echo-planar imaging distortions were corrected by warping the images along the 
phase-encoding direction to the distortion-free T1 reference images (Studholme et 
al., 2000) using an in-house developed implementation(Visser et al., 2010). 
Diffusion tensors were then estimated using a robust artefact-insensitive compute 
algorithm (Zwiers, 2010). Fractional anisotropy (FA) and mean diffusivity (MD) 
measures were computed from the diffusion tensor eigenvalues. FA and MD maps 
were normalized to the T1 ICBM-template (MNI-space) using the unified 
segmentation parameters of the co-registered structural image. Images were then 
smoothed with a Gaussian kernel of 8 mm full width half maximum and masked 
with a full brain mask. Imaging parameters, pre-processing and analysis of the 
functional images, obtained during the drug sessions, are described elsewhere 
(van der Schaaf et al., 2012).
General analysis strategy
In our prior work we reported dopaminergic drug effects on striatal BOLD signal 
during reward and punishment reversal learning (Chapter 2) (van der Schaaf et al., 
2012). These BOLD effects were centred on the ventral lateral putamen, a region 
that receives convergent inputs from both orbitofrontal cortex and the amygdala 
(Draganski et al., 2008; Haber and Knutson, 2010). Here, we revisit our data and ask 
whether the observed dopaminergic drug effects on striatal BOLD signalling is 
associated with  anatomical connections between the striatum, OFC and amygdala. 
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Thus, we investigated individual differences in white matter integrity of 
anatomical pathways in an orbitofronto-limbic-striatal network, as indexed by 
diffusion tensor images that were acquired from the same subjects during an 
intake session prior to the drug sessions. 
We used a fibre-based approach (Mandl et al., 2012) and focused on three anatomical 
white matter pathways of interest – (i) a pathway connecting the OFC with the 
striatum (Ongür and Price, 2000; Ogar and Gorno-tempini, 2007; Haber and 
Knutson, 2010; Balleine et al., 2011), (ii) a pathway connecting the amygdala with 
the striatum (Robbins et al., 1989; Everitt et al., 1991; Ambroggi et al., 2008) and 
(iii) a pathway connecting the OFC with the amygdala (Baxter et al., 2000; Stalnaker 
et al., 2007) -,  and one anatomical white matter pathway of no interest for control 
purposes (a pathway connecting the dorsal PFC (dPFC) with the striatum (Haber 
and Knutson, 2010)). As described in the introduction, this additional pathway was 
included to demonstrate specificity of the effects to orbitofronto-limbic-striatal 
pathways, involved in reward processing and stimulus-outcome valuation. Thus 
we anticipated that any effects would not extend to dorsal fronto-striatal pathways 
that have instead been associated with more cognitive processes and motor control 
(Alexander et al., 1990; Haber and Knutson, 2010). These study-specific anatomical 
volumes of interest were first created using probabilistic tractography (see 
probabilistic tractography section below) and average FA and MD values were 
extracted from each pathway. These FA and MD values were then used as 
independent predictor variables in multiple regression analyses with the 
drug-related change in striatal BOLD signal during reversal learning as the 
dependent variable (see statistical analysis section below). 
Dependent variable I: Selection of striatal BOLD signal
Striatal BOLD signal was extracted for each drug session from the locus that exhibited 
the significant drug effect during reversal learning, as reported previously (chapter 2) 
(van der Schaaf et al., 2012). This drug effect was centred on the left ventral 
putamen (x,y,z, = -22, 18, 4, p
fwe
 = .03) (Figure 2a) and reflected opposite modulation 
by the dopamine receptor antagonist sulpiride and the dopamine receptor agonist 
bromocriptine of BOLD signal change during unexpected relative to expected 
outcomes. Mean beta estimates from this peak voxel were extracted with MarsBar 
software (Brett et al., 2002) for each drug session. The use of such a functionally 
defined timeseries is justified because the aim of our investigation was to account 
for variability in exactly this signal. Drug-related change in the extracted 
beta-values (representing signal during unexpected versus expected outcomes) 
was then used as a dependent variable in linear regression analysis with the 
DTI-measurements as predictor variables (see below). 
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Dependent variable II: Selection of the behavioural values
The behavioural measures of interest were the valence-dependent and valence- 
independent reversal learning scores. These were calculated by computing, respectively, 
the difference between, and the average of the proportion of correct responses 
on reward and punishment reversal trials. The accuracy scores were arcsine 
transformed (2× arcsine(√x)) as is appropriate when the variance is proportional 
to the mean (Howell, 1997). 
Probabilistic tractography: Selection of frontal-striatal-limbic pathways 
Orbitofronto-limbic-striatal pathways are not yet included in white matter atlases. 
Accordingly, these study-specific anatomical pathways were created using 
probabilistic tractography as implemented in FMRIB’s diffusion toolbox (See also 
(de Zeeuw et al., 2011; Mandl et al., 2012; Peper et al., 2012) for similar procedures). 
In total four pathways were created; OFC – striatum, OFC – amygdala, amygdala – 
striatum and dorsal PFC – striatum. Masks used for tractography were defined in 
standard space using the AAL-template (Tzourio-Mazoyer et al., 2002)( Figure1a). 
Because the locus of the drug effects was centred on the left striatum we focussed 
our analysis on pathways in the left hemisphere. The left amygdala was defined as 
AAL-region 41, the left OFC as the gyrus rectus and orbito gyrus regions (Ogar and 
Gorno-tempini, 2007)) (AAL-regions 5, 9, 15, 25 and 2), the left dPFC as all left 
superior, middle and inferior frontal gyrus regions (AAL-regions 3, 7, 13, 23) and 
the left striatum  as the left putamen and caudate nucleus (AAL-regions 71 and 73). 
Ventral and dorsal striatal subregions are not clearly separated by anatomical 
boundaries and best defined by its afferent projections from cortical areas (Haber 
and Knutson, 2010). Accordingly, we seeded our tractography from the OFC, dPFC 
and amygdala and used the whole striatum as waypoint mask. 
For each pathway, waypoint (a.k.a. inclusion) and exclusion masks were defined as 
followed: (i) OFC-Striatum: Seed = OFC, waypoint = striatum, exclusion = dPFC, 
amygdala and planes excluding x>1 and y<-18. (ii) Amygdala-Striatum: Seed = 
amygdala, waypoint = striatum, exclusion = OFC, dPFC and planes excluding x>1 
and y<-18. (iii) OFC-Amygdala: Seed = OFC, waypoint = amygdala, exclusion = dPFC, 
striatum, and planes excluding x>1, and y<-18. (iiii) dPFC-striatum: Seed dPFC, 
waypoint: striatum, exclusion: OFC, amygdala and planes excluding x>1 and y<-18. 
These masks were brought back into native space, using the inverse of the computed 
normalization parameters to create individual probabilistic diffusion pathways. 
Using FMRIB’s diffusion toolbox (FMRIB’s Software Library (FSL), bedpostx), fibre 
orientation probabilistic density functions were estimated at each voxel, allowing 
for multiple fibre directions (Behrens et al., 2007). 5000 streamline samples per 
seed voxel were drawn through the probability density functions to form an 
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estimate of the probability distribution of connections from each seeded voxel 
(‘probtrackx’ with a curvature threshold of 0.2). All pathways from the seed region 
that passed through the exclusion mask and all pathways that did not pass through 
the waypoint mask were discarded from the calculation of the connectivity 
distribution. The resulting connectivity distribution files are images in which the 
values at each voxel represent the number of samples between the seed and 
waypoint mask that passed through that voxel. These images were then brought 
back to standard space, using individual normalization parameters, thresholded 
to include voxels through which at least 1% of the samples passed, binarized and 
summed across subjects. The 4 study-specific anatomical VOI’s were created at the 
group level representing those pathways that were present in at least 75% of all 
subjects (Figure 1b). These are commonly used thresholds and are similar or more 
conservative compared with thresholds used in other fibre-based DTI tractography 
studies (Leh et al., 2007; Gutman et al., 2009; Mandl et al., 2012; Peper et al., 
2012{Mandl, 2012 #20).  Finally, the individual mean FA and MD values were 
extracted from each pathway. 
Statistical analysis
Because we used different scanning protocols, the extracted FA and MD values of 
each pathway were first residualized with respect to protocol. Multiple linear 
Figure 1   Selection of fronto-striatal-limbic pathways.
a) Seed and waypoint masks that were used for probabilistic tractography, displayed on a 
MNI-template. b) The four study-specific anatomical ROIs used for FA and MD data extraction. 
Coloured masks represent the binarized group masks for pathways that were present in at 
least 75% of all subjects.  Abbreviations: dPFC = dorsal prefrontal cortex, OFC – Orbitofrontal 
cortex.
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regression analysis (SPSS, version 19.0.0) was done with the residualized FA values 
from the four pathways as predictor variables and the drug-related difference in 
beta values (BOLD) as dependent variable. A stepwise procedure was applied to 
include only those predictors that significantly contributed the model. The 
probability to enter or remove a predictor was set at .05 and .1, respectively 
(default). Consistent with our previous report, assessments of the different drug 
comparisons were done in a fixed a priori defined order. First, we investigated 
which of the pathways contributed to the effects of dopamine receptor stimulation 
(bromocriptine) relative to dopamine receptor blockade (sulpiride) on striatal 
BOLD. Next, for the pathways that were revealed in the first step, we assessed 
whether their contribution was driven by effects of bromocriptine relative to 
placebo or by effects of sulpiride relative to placebo. Finally, to establish the D2 
receptor dependency of the observed effects, we assessed whether they were 
blocked by combined administration. The same procedures were used to assess 
associations between drug effects on behaviour and FA values from these pathways. 
To further support the nature of our FA findings we also assessed the association 
between drug effect on BOLD and mean diffusivity (MD) values in the pathways 
that yielded a significant relationship from the analysis described above. While FA 
values represent the orientation-dependence of water diffusion, which is 
directional in white matter fibres, MD values represent the overall magnitude of 
water diffusion. MD depends on fibre and membrane density and, in white matter, 
increases in MD have been associated with the degeneration of fibre bundles 
(Beaulieu, 2002; Thomason and Thompson, 2011). Accordingly, when, across 
subjects, higher FA values in white matter are accompanied by lower MD values, 
this likely reflects higher levels of fibre and membrane density within non-crossing 
fibre bundles. Conversely, when across subjects, higher FA values are accompanied 
by higher MD values, this possibly reflects selectively lower levels of fibre and 
membrane density within of one of the fibre bundles in a crossing fibre region. 
Finally, for completion, main effects of drugs on behaviour were assessed with 
repeated measures ANOVA with the within-subjects factors drug and valence 
(reward and punishment). The order of drug comparisons were assessed in the 
same a priori defined order as described above. 
Supplementary analysis
In addition to the volume of interest analyses, we conducted supplementary 
voxel-wise regression analysis at the whole-brain level, using random effects 
multiple regression procedures in SPM8 ( http://www.fil.ion.ucl.ac.uk/spm). This 
allowed us to visualize the (physiological plausibility of) effects that were revealed 
to be statistically significant using the volume of interest analyses. To this end, 
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individual FA-maps were submitted to a second-level one sample T-test and the 
drug-related changes in striatal BOLD signal were entered as a covariate of interest. 
Scan-protocol was entered as a covariate of no-interest. Voxels revealed by the 
covariate of interest represent white matter regions that exhibit a linear 
relationship between individual FA-values and drug effects on striatal BOLD. 
Effects are displayed for visualization purposes only at a threshold of p <.001 
uncorrected for multiple comparisons (Figure 3). Next, probabilistic diffusion 
tractography (FMRIB’s diffusion toolbox) was used to visualize the pathways 
connecting with the FA region revealed by the voxel-wise regression analysis as a 
seed. To this end, the FA seed region was defined as a 4 mm sphere around the peak 
voxel of the FA region (xyz = -34, 8, -6) revealed by the regression analysis. For each 
subject, this region was brought back into native space, using the inverse of the 
computed normalization parameters and used as a seed region for probabilistic 
tractography (same settings as above). The resulting connectivity distribution 
images were brought back to standard space, using individual normalization 
parameters, and tractography maps were thresholded to include only voxels 
through which at least 1% of all samples had passed. These individual maps were 
then binarized and summed across subjects to produce group probability maps. 
Results
Linear regression analysis revealed a significant positive relationship between 
drug effects on striatal BOLD (bromocriptine – sulpiride) and FA values from the 
OFC-amygdala pathway (F
1,19 
= 8.33, R2 = .32, adjusted R2= .28, beta = .56, T = 2.89, 
p = .010). No significant contribution of the OFC-striatum (beta = .06, T = .22, p = .82), 
dPFC-striatum (beta = .01, T =-.03, p = .98) or the amygdala-striatum pathways (beta 
= -.04, T = -.18, p = .86) were revealed. FA values from the OFC-amygdala pathway 
were associated with the effects of bromocriptine relative to placebo on striatal 
BOLD (F
1,19 
= 5.63, R2 = .24, adjusted R2 = .19, beta = .48, T = 2.37, p = .029), but not 
of sulpiride relative to placebo (beta = - .14, p = .55). Moreover, these white- 
matter dependent effects of bromocriptine on striatal BOLD were abolished by 
co-administration of both drugs; FA-values from the OFC–amygdala pathway 
correlated significantly with the effects of bromocriptine relative to combined 
administration on striatal BOLD (F
1,19 
= 10.73, R2= .37, adjusted R2= .34, beta = .61, T 
= 3.28, p = .004), but not with the effects of placebo relative to combined 
administration on striatal BOLD (beta = -.23, p = .34) (Figure 2b). 
Subsequent correlation analyses with MD-values from the OFC–amygdala pathway 
revealed a negative relationship between the effect of bromocriptine relative to 
sulpiride on striatal BOLD and MD-values from the OFC-amygdala pathway (beta = 
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-.61, p = .004). Thus, the found associations with FA were accompanied by 
associations with fibre density within the OFC-amygdala pathway. Taken together, 
these data show that bromocriptine increased reversal-related striatal BOLD in 
subjects with high FA-values in the OFC-amygdala pathway, while it decreased 
striatal BOLD in subjects with low FA-values in this pathway. These effects were 
likely mediated via D2 receptor stimulation, as effects were abolished by co- 
administration with sulpiride. 
Figure 2   Relationship between drug effects on BOLD and FA-values, revealed by ROI 
analyses.
a) Shown are effects of bromocriptine relative to sulpiride on striatal BOLD signal during 
unexpected outcomes in the reversal learning task [(unexpected - expected rewards) + 
(unexpected – expected punishments)] (x,y,z, = -22, 18, 4, p
fwe_striatum
 = .03). These effects were 
reported previously by Van der Schaaf et al. (2012) (see chapter 2) and depended on working 
memory capacity. b) Linear relationship between FA values in the OFC-amygdala pathway 
and the effects of bromocriptine relative to sulpiride (left), bromocriptine relative to placebo 
(middle) and bromocriptine relative to combined administration of both drugs (right) on 
striatal BOLD. Only significant effects are shown. * p < .05 Abbreviations: Pla = placebo, 
Bro = bromocriptine, Sul = sulpiride, SB = combined administration of bromocriptine and 
sulpiride.
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There were  no associations between FA-values and drug  effects (reported here 
are effects of bromocriptine relative to placebo) on behavioural measures of 
 valence-dependent reversal learning (OFC-amygdala: beta = -.10, p = .68; OFC-striatum: 
beta = -.23, p = .34; dPFC-striatum: beta = -.03, p = .89; Amygdala-striatum: beta = 
-.27, p = .25) or valence-independent reversal learning (OFC-amygdala: beta = -.34, 
p = .14; OFC-striatum: beta = -.23, p = .33; dPFC-striatum: beta = -.25, p = .30; amygdala- 
striatum: beta = -.06, p = .81). 
Figure 3   Relationship between drug effects on BOLD and FA-values, revealed by whole 
brain analyses.
a) White matter regions showing a linear relationship between FA-values and the effects of 
bromocriptine relative to sulpiride (left), bromocriptine relative to placebo (middle) and 
bromocriptine relative to combined administration of both drugs (right) on striatal BOLD. b) 
Summed tractography maps of the individual pathways that originate from the FA-region 
displayed in figure 3a (left). Probabilistic tractography from this region revealed an extensive 
network of pathways between the OFC, amygdala and striatum. Image is thresholded to 
present those tracks that were present in at least 25% of the subjects.
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For completeness, we also assessed drug effects on behaviour irrespective of FA 
values. This revealed a trend towards opposite effects of bromocriptine and 
sulpiride on reward and punishment reversal learning (drug × valence: F
1,19
 = 4.2, 
P = 0.054). This was due to better punishment relative to reward learning after 
bromocriptine (raw accuracy scores±standard error of the mean:  reward: 0.90±0.02; 
punishment: 0.92±0.01), but better reward relative to punishment learning after 
sulpiride (reward: 0.93±0.02; punishment: 0.90±0.02). However no drug by valence 
effects were seen when comparing bromocriptine with placebo (reward: 0.90±0.02; 
punishment: 0.89±0.03) (drug × valence: F
1,19
 = 1.8,  P = .20).  
Supplementary analyses
Results from the brain-wide voxel wise regression analyses and subsequent 
tractography concurred with the results from the volumes of interest analyses 
reported above. Thus brain-wide analysis revealed that FA in a region within the 
uncinate fasciculus, as identified with the JHU white matter tractography atlas, 
predicted drug effects on striatal BOLD signal (bromocriptine – sulpiride: xyz = 
-34, 8, -6, T = 4.87, p
unc 
< .001; bromocriptine – placebo: xyz = -30, 10, -8, T = 3.84, p
unc 
< .001; bromocriptine- combined: xyz = -26, 4, -12, T = 6.51, p
unc 
< .001 ) (Table 1, 
Figure 3a). Probabilistic tractography from this region revealed an extended 
Table 1   Whole brain results from voxel-wise regression analysis. 
MNI
 Side N voxels T-value x y z
Bromocriptine - sulpiride (positive)
L 14 5.12 -34 0 42
L 35 4.87 -34 8 -6
R 16 4.77 26 40 14
L 13 4.43 -10 38 46
L 17 4.34 -30 -20 -46
Bromocriptine - placebo (positive)
R 13 5.32 16 -28 44
L 73 3.84 -30 10 -8
Bromocriptine - combined(positive)
L 196 6.51 -26 4 -12
L 14 4.48 -30 -14 -46
L 11 3.93 -18 -54 12
Results reflect FA regions that showed a linear correlation with drug effects on striatal BOLD. The regions 
that fell within our anatomically defined pathways are printed in bold. Data is presented with p<.001 
uncorrected and extended threshold of >10 voxels.
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network of pathways between the OFC, amygdala and striatum. Other pathways 
revealed by tractography included connections with the insular cortex and a 
pathway along the inferior longitudinal fasciculus along the hippocampus and 
towards the visual cortex. No pathways towards the thalamus or midbrain regions 
were seen. These tractography findings further support that our findings likely 
involve white matter integrity in the OFC-amygdala pathway, rather than direct 
fronto-striatal pathways, as the latter typically also involve thalamic connections 
(Haber and Knutson, 2010) (Figure 3b). 
Discussion
Dopaminergic drug effects have been shown to vary greatly between individu-
als(Cools and D’Esposito, 2011). Here we provide evidence for an important link 
between dopaminergic drug effects during reversal learning and neuroanatomi-
cal integrity of connections between the OFC and amygdala. More specifically, we 
demonstrate that dopaminergic drug effects on striatal BOLD signal during 
reversal learning vary as a function of fractional anisotropy (FA) and mean 
diffusivity (MD) in a pathway connecting the OFC with the amygdala. FA and MD 
rely on several microstructural properties, including the level of axon myelination, 
intact axonal membranes and fibre density (Beaulieu, 2002). Accordingly, our 
results support the hypothesis that dopaminergic drug effects on human striatal 
BOLD signal are associated with  the neuronal communication efficiency of 
cortico-limbic projections. The implication of these findings is twofold. First, the 
data provide fundamental insight into the mechanism of action of dopaminergic 
drug effects on reward related processing and reversal learning.  Specifically, 
effects of D2 receptor stimulation during reversal learning involve an orbitofron-
to-limbic-striatal network. Second, they may have important clinical implications 
by suggesting that measures of white matter integrity can help predict 
dopaminergic drug effects on brain function, thus contributing ultimately to the 
individual tailoring of dopaminergic drug treatment strategies in psychiatry.
The drug effects on striatal BOLD signal were associated with white matter 
integrity of the pathway connecting the orbitofrontal cortex with the amygdala 
(i.e. part of the uncinate fasciculus), and not by that of direct orbitofronto-striatal 
or amygdala-striatal projections. These findings extend previous non-pharmaco-
logical human DTI studies demonstrating that reward related striatal BOLD 
responses (Camara et al., 2010) and associated functional connectivity (Cohen et 
al., 2008) are associated with white matter integrity of orbitofrontal-limbic-striatal 
pathways. Furthermore, we also showed that the drug effects during reversal 
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learning were not associated with white matter integrity of dorsal fronto-striatal 
connections, which are suggested to be involved in more cognitive and motor 
processing (Alexander et al., 1990; Haber and Knutson, 2010). Indeed, our findings 
complement those from a recent study (van Schouwenburg et al., 2013), in which 
we demonstrated that white matter integrity of a dorsal fronto-striatal-thalamic 
pathway was associated with drug effects on striatal BOLD signals during a form 
of attention-shifting that did not involve reward. Together, these data establish 
that associations between dopaminergic drug effects and white matter integrity 
are neuroanatomically specific and depend on task demands. 
Our results are consistent with animal lesion work that has repeatedly 
demonstrated the crucial role of OFC-amygdala interactions in reversal learning 
(Baxter et al., 2000; Stalnaker et al., 2007; Schoenbaum et al., 2009). The OFC has 
originally been suggested to rapidly encode new associations and regulate reversal 
learning by directly driving areas such as the striatum  (Thorpe et al., 1983). 
However, accumulating evidence indicates that the OFC instead contributes 
indirectly to the updating of stimulus-outcome associations by providing 
information about expected outcomes to other down-stream areas such as the 
amygdala (Stalnaker et al., 2007; Schoenbaum et al., 2009; Takahashi et al., 2009). 
Amygdala projections to the ventral striatum might then, in turn, mediate the 
effects of (updated) outcome-predictive stimuli on action selection. Indeed, electro-
physiological responses in the ventral striatum (and associated behavioural 
responding) to relevant sensory stimuli critically depend on concomitant amygdala 
and dopamine inputs (Robbins et al., 1989; Everitt et al., 1991; Ambroggi et al., 
2008; Pennartz et al., 2011). Accordingly, our results highlight the importance of 
indirect OFC-amygdala pathways in reversal learning by showing that 
dopaminergic modulation of striatal BOLD responses during reversal learning are 
not associated with  white matter integrity of direct fronto-striatal pathways, but 
instead are associated with  white matter integrity of the OFC-amygdala pathway. 
Together, these results provide fundamental insight into the mechanism by which 
dopamine changes brain function during reversal learning. 
In addition, our experimental design allowed us to establish that these white-matter 
dependent drug effects were mediated by D2 receptors. Effects of the D2 receptor 
agonist bromocriptine on striatal BOLD signal were abolished by co-administration 
with the D2 receptor antagonist sulpiride. This generally concurs with animal 
work demonstrating that reversal learning in monkeys is selectively mediated by 
D2 receptors but not D1 receptors (Lee et al., 2007). In addition, animal work has 
demonstrated that the effects of dopamine on the output of amygdala neurons are 
at least partially mediated by D2 receptors (Rosenkranz and Grace, 1999; Grace 
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and Rosenkranz, 2002; Rosenkranz and Grace, 2002; Bissière et al., 2003).While D2 
receptor stimulation was found to potentiate sensory driven amygdala outputs to 
the striatum, D1 receptor stimulation was found to attenuate PFC inhibitory 
influences on amygdala output neurons (Rosenkranz and Grace, 1999; Rosenkranz 
and Grace, 2002). Based on such experimental animal work, we speculate that 
bromocriptine potentiated sensory-driven amygdala output excitability to a greater 
extent in subjects with high communicational efficacy within the OFC-amygdala 
pathway than in those with low OFC-amygdala connectivity. It might be noted 
we cannot provide definitive evidence for this latter hypothesis, because DTI 
is inconclusive with regard to the direction in which information travels. 
Nevertheless, our results do converge with prior animal work and highlight the 
importance of D2 receptor stimulation for reversal learning.
One caveat of our study is that we did not find evidence for a direct relationship 
between white matter integrity of the OFC-amygdala pathway and drug effects on 
behavioural updating of stimulus-outcome associations. This is particularly 
surprising given that experimental animal work has demonstrated that the OFC 
and  amygdala (Iversen and Mishkin, 1970; Jones and Mishkin, 1972) and their 
interaction (Baxter et al., 2000; Stalnaker et al., 2007) are crucial for behavioural 
performance on reversal learning tasks.  Accordingly, we believe that our failure 
to observe correlations with drug effects on behaviour might reflect a relative lack 
of sensitivity. Future work should reveal whether the present finding that white 
matter integrity of orbitofrontal-limbic-striatal pathways is associated with drug 
effects on brain function extends to behaviour. 
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Abstract 
Increased use of stimulant medication, such as methylphenidate, by healthy 
college students has raised questions about its cognitive enhancing effects. 
 Methylphenidate acts by increasing extracellular catecholamine levels and is 
generally accepted to remediate cognitive and reward deficits in patients with 
attention deficit hyperactivity disorder. However, the cognitive enhancing effects 
of such “smart drugs” in the healthy population are still unclear. Here, we 
investigated effects of methylphenidate (Ritalin®, 20 mg) on reward and 
punishment learning  in healthy students (N=19) in a within-subjects, double-blind, 
placebo-controlled cross-over design. Results revealed that methylphenidate 
effects varied both as a function of task demands and as a function of baseline 
working memory capacity. Specifically, methylphenidate improved reward versus 
punishment learning in high working memory subjects, while it impaired reward 
versus punishment learning in low working memory subjects. These results 
contribute to our understanding of individual differences in the cognitive 
enhancing effects of methylphenidate in the healthy population. Moreover, they 
highlight the importance of taking into account both inter- and intra-individual 
differences in dopaminergic drug research.
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Introduction 
Psychostimulants such as methylphenidate (MPH) are the first-line medication 
treatment of attention deficit hyperactivity disorder (ADHD). In the clinical 
context, MPH decreases symptoms of inattention and hyperactivity (Faraone and 
Buitelaar, 2010) and may improve attentional and academic performance (Marcus 
and Durkin, 2011; Wigal et al., 2011). However, recent surveys report that healthy 
college students also increasingly use these stimulants to enhance concentration 
and study performance (Smith and Farah, 2011; Bundt et al., 2012). This raises 
questions about their cognitive enhancing effects in the healthy population 
(Greely et al., 2008). MPH primarily acts by blocking the dopamine transporter 
(DAT), which removes excessive dopamine from the synaptic cleft, resulting in 
increases of extracellular dopamine levels (Volkow et al., 2002). In ADHD, MPH is 
thought to be effective by restoring deficient catecholamine levels. However, 
effects are still unclear in the healthy population, in which catecholamine levels 
are generally assumed to be relatively optimized compared to individuals with 
disorders that implicate dopamine. 
There is large variability in the cognitive enhancing effects of psychostimulants 
in healthy adults (Smith and Farah, 2011) and there are numerous factors that may 
contribute to this variability. First, dopaminergic drug effects can vary as a 
function of task demands, so that some tasks are improved while other tasks are 
impaired (Cools and D’Esposito, 2011). For example, administration of dopamine 
receptor agonists improves learning from reward while impairing learning from 
punishment in the same subjects (Frank and O’Reilly, 2006; Bodi et al., 2009; Cools 
et al., 2009). This concurs with observations that psychostimulant treatment such 
as methylphenidate improves reward but not punishment learning in patients 
with ADHD (Frank et al., 2007b). Such differential effects likely reflect distinct 
optimal levels of striatal dopamine, with high dopamine levels facilitating 
learning from reward and low dopamine levels facilitating learning from 
punishment (Frank, 2005). Here we assessed whether methylphenidate also has 
opposite effects on reward and punishment learning in healthy adults, thus 
extending methylphenidate’s therapeutic effects in ADHD (Frank et al., 2007b) to 
effects of so-called cognitive enhancers in the healthy population. A second factor 
is the large inter-individual variability in drug response (Cools and D’Esposito, 
2011). The same drug and doses can have different, even opposite effects between 
different individuals depending on clinical condition (Mehta et al., 2004a; Voon et 
al., 2010a), baseline working memory capacity (Kimberg et al., 1997; Mehta et al., 
2000; Mehta et al., 2001; Frank and O’Reilly, 2006; van der Schaaf et al., 2012) and 
baseline levels of dopamine function as measured with positron emission 
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tomography (PET) (Cools et al., 2009). For example, bromocriptine was shown to 
improve reward learning in subjects with low baseline levels of dopamine synthesis 
capacity, while impairing it in subjects with high baseline levels of dopamine 
synthesis capacity (Cools et al., 2009). Accordingly, it has been suggested that the 
effects of dopamine receptor agents depend on the baseline state of the system 
(Cools and D’Esposito, 2011). By analogy, effects of MPH might also depend on the 
baseline state of the system. 
To test these hypotheses, we administered a single dose of methylphenidate and 
placebo to healthy controls in a double-blind, placebo-controlled cross-over design 
and we stratified our drug effects by baseline working memory capacity; a  measure 
that has previously been shown to be positively associated with striatal dopamine 
synthesis capacity (Cools et al., 2008b; Landau et al., 2009). The direction of the 
relationship between MPH effects and baseline working memory capacity might 
parallel that seen for dopamine receptor agonists (Mehta et al., 2000; Mehta et al., 
2001; Frank and O’Reilly, 2006; Cools et al., 2009), with greater improvements in 
reward versus punishment learning in low than high working memory subjects. 
Alternatively, it has been proposed that DAT blockade leads to larger increases in 
extracellular dopamine in subjects with a higher rate of dopamine release (Volkow 
et al., 2002). This is supported by animal work showing baseline-dependent effects 
of DAT blockade on extracellular dopamine concentrations (Hooks et al., 1992). 
Accordingly, together with the literature reviewed above, an alternative hypothesis 
would be that MPH would induce larger improvements on reward versus 
punishment learning in subjects with high working memory capacity.
Methods
Subjects
Twenty-four subjects, recruited via campus advertisements, gave written informed 
consent approved by the local research ethics committee (“Commissie Mensgebonden 
Onderzoek”, Arnhem-Nijmegen, number 2010/283) and were compensated for 
participation. The current task was part of a larger protocol and was preceded by a 
functional magnetic resonance imaging (fMRI) experiment and followed by two 
behavioural experiments (reported elsewhere). Five non-native Dutch speakers (i.e. 
German) were excluded from analysis because good practice of the Dutch language 
was essential for optimal assessment of baseline working memory capacity as 
measured with the listening span and digit span. The remaining nineteen subjects 
(mean age: 20.9, range: 19.0-24.4) were healthy, righthanded men (9) and women (10) 
with no relevant medical/psychiatric history or a history of drug abuse and/or 
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dependence. Other exclusion criteria included fulfilment of ADHD criteria, family 
history of schizophrenia, bipolar disorder, depression or neurological abnormalities, 
alcohol use of more than 20 units per week, habitual smoking (>20 cigarettes per 
week), use of prescribed or over-the-counter medication within the last month (with 
the exception of occasional paracetamol and anti-conceptive medication)use of 
recreational drugs within 2 weeks prior to testing and a history of frequent use of 
recreational drugs or psychotropic medication (Cannabis: more than biweekly on 
average or periods using more than weekly; other recreational drugs (e.g. cocaine, 
amphetamines): more than 5 times ever; psychotropic medication: more than 
biweekly or periods of using more than 5 times weekly). 
Intake procedure
During a first intake, all subjects were screened by a medical doctor (NtH) and 
psychologist (MvdS) which included physical examination of weight, pulse rate 
and blood pressure, medical examination and  administration of the Mini-Interna-
tional Neuropsychiatric Interview (M.I.N.I.) (Sheehan et al., 1998), to exclude 
psychiatric, neurological and medical history. Subjects were requested to complete 
questionnaires including the Beck Depression (Beck et al., 1961a), Trait anxiety 
inventory (STAI) (Spielberger, 1970) and Barratt Impulsiveness Scale (BIS) (Patton et 
al., 1995). Symptoms of hyperactivity and attention deficits were assessed with the 
ADHD self report screening questionnaire (DuPaul et al., 1998). Verbal Intelligence 
was assessed with the Dutch Adult reading test (NLV) (Schmand et al., 1991). A 
baseline measure of working memory capacity was assessed during intake with a 
Dutch version of the listening span (Daneman and Carpenter, 1980) and the digit 
span (Groth-Marnat, 1997). 
Pharmacological design and session procedures
A within-subjects, double-blind, placebo-controlled cross-over design was employed. 
Subjects were tested after administration of MPH (Ritalin®, 20 mg) or placebo on 
two different occasions, separated by at least one week.  All subjects abstained 
from alcohol or over-the-counter medication 24 hours prior to testing and caffeine 
on the day of testing. They were asked to have a light breakfast one hour prior to 
arrival, similar across both sessions. The reversal learning task was assessed ~2¾ 
hour after drug intake for ~20 minutes, directly followed by the digit span. Ritalin® 
is effective for ~4 hours with peak plasma levels 1½ hour after dosing (Swanson et 
al., 2003). Although time of testing was optimized for the preceding fMRI 
paradigm, assessment of the current task coincided with the active time window 
of drug effects. Physiology and mood were assessed ~15 minutes prior (T1), ~30 minutes 
after (T2) and ~3½ hour (T3) after drug intake. See Supplementary Materials and 
Methods for analyses and results of physiology and mood.  
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Baseline working memory capacity
Baseline working memory capacity was assessed with the digit span (Groth-Marnat, 
1997) during intake and both drug sessions. As in our previous report (van der 
Schaaf et al., 2012), the average total digit span across all three assessments was 
selected for drug stratification, because it was thought to provide a more reliable 
estimate of working memory capacity due to the fact that is was administered 
repeatedly. For each session, the individual total score on the digit span forward 
and digit span backward was calculated. These total scores were averaged across 
the three assessments and used as a covariate of interest in the behavioural 
analysis (see further below). In addition to the digit span, the listening span 
(Daneman and Carpenter, 1980) was assessed during intake (2 missing values). To 
confirm our baseline-dependent results, supplementary analyses were done with 
listening span and the digit span assessed during intake (Supplementary Materials 
and Methods).
Reversal learning paradigm
We employed a reversal learning task used previously (Cools et al., 2006) (Figure 1). 
Two stimuli, a face and a scene were presented simultaneously on the screen 
(location randomized). One of these stimuli was associated with reward and the 
other with punishment (or reward omission, note that we cannot disentangle the 
two). Subjects were required to learn these deterministic stimulus-outcome 
associations. Unlike standard (probabilistic) reversal paradigms, subjects did not 
choose between the two stimuli. Instead, one of the stimuli was already selected 
by the computer (highlighted with a black border) and subjects were asked to 
predict the outcome of this preselected stimulus. After the prediction, indicated 
with a right index or middle finger button press (counterbalanced between 
subjects), the actual outcome was presented after a 1000 ms delay for 500 ms at the 
location of the stimulus. There was no time limit to provide a response. Reward 
consisted of a green smiley with a “+$100” sign. Punishment consisted of a red sad 
smiley and a “-$100” sign. Note that this outcome did not depend on subjects’ 
responses but was directly coupled to the stimulus. After 4-6 consecutive correct 
predictions the stimulus-outcome contingency reversed. This was either signalled 
by an unexpected reward, presented after the previously punished stimulus was 
highlighted, or by an unexpected punishment, presented after the previously 
rewarded stimulus was highlighted. Accuracy on the trials directly following 
these unexpected outcomes (reversal trials) represents how well subjects updated 
their stimulus-outcome associations. After unexpected outcomes, the same 
stimulus was highlighted again, such that behavioural and cognitive requirements 
were matched between valence conditions.
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Figure 1   Task design.
a) Example of a reward trial. Two stimuli, a face and a scene, were presented simultaneously. 
One of the two stimuli was highlighted with a black border and the task was to predict, 
whether this stimulus was followed by reward or punishment, after which the actual outcome 
was presented (100% deterministic). b) Example of a trial sequence for the unexpected 
reward and unexpected punishment condition. The participant learned to predict rewards 
(rw) and punishments (pn) for the scene and face. Stimulus-outcome associations reversed 
after 4-6 consecutive correct predictions, signalled by either unexpected reward or 
unexpected punishment. Measure of interest was the accuracy on reversal trials immediately 
following the unexpected outcomes.
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+ €100 
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Each participant performed 4 experimental blocks that contained 120 trials: two 
blocks in which reversals were signalled by unexpected rewards (reward condition) 
and two blocks in which reversals were signalled by unexpected punishment 
(punishment condition). Each block consisted of one acquisition stage until the 
first reversal and a variable number of reversal stages, depending on the 
participant’s accuracy. On average, each participant performed 23.5 (± 5.4) and 
23.3 (± 4.7) reversal stages in the punishment and reward condition, respectively. 
On each session, subjects performed two practice blocks to familiarize them with 
the paradigm. Performance in the experimental blocks was above chance level 
(>70% correct) for all subjects and there we no test-retest effects. See Supplementary 
Materials and Methods for test-retest effects and information about randomization 
and practice blocks. 
Behavioural data analysis
There were three trial types per valence condition: reversal, non-reversal reward 
and non-reversal punishment. Reversal trials were defined as those trials following 
an unexpected outcome. Non-reversal trials are defined as those trials following 
expected outcomes and preceding expected rewards (non-reversal reward) or 
expected punishments (non-reversal punishment). Only trials from the reversal 
stages (after the first unexpected outcome) and trials following correct predictions 
were included in the analysis. 
Proportions of correct responses per trial-type were arcsine transformed (2x 
arcsine(√x)) as is appropriate when the variance is proportional to the mean 
(Howell, 1997). To investigate whether effects of MPH on reversal learning depend 
on baseline working memory, we employed a repeated measures ANOVA with the 
within-subject factors drug (placebo, MPH), valence (reward, punishment) and 
trial-type (reversal, non-reversal reward, non-reversal punishment); and baseline 
working memory capacity (mean centred) as covariate of interest. Green-
housse-Geiser correction was applied when sphericity assumption was violated. 
Linear relationships between valence-dependent learning and baseline working 
memory capacity were further assessed using Pearson correlation analysis. To this 
end, valence-dependent reversal learning scores were calculated by computing the 
difference between the proportion of correct responses on reward and punishment 
reversal trials. This measure was then correlated with individual measures of 
baseline working memory. We specifically focused our analyses on relative scores 
because this measure controls for non-specific drug effects such as changes in 
effort, attention or alertness.  The only measure of interest that was not normally 
distributed was the relative (valence-dependent) reversal score in the MPH 
condition (Shapiro-Wilk test: p = .016, uncorrected for multiple comparisons). 
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Therefore we also report the nonparametric (Spearman’s Rho) correlation for our 
primary effect of interest. 
Supplementary win-stay lose-shift analysis
Both reward and punishment reversal trials required response alternation. 
Therefore, it could be argued that changes on valence-dependent learning reflect 
changes in the adoption of a win-stay/lose-shift strategy, i.e., the tendency to 
maintain responding after reward (win-stay) and to alternate responses after 
punishment (lose-shift). Thus, improvements on reward relative to punishment 
learning could reflect a bias away from a win-stay/lose-shift strategy or a bias 
towards a win-shift/lose-stay strategy, rather than increased ability to update 
reward relative to punishment predictions. To test this alternative hypothesis, we 
measured the adoption of a win-stay/lose-shift strategy on the non-reversal trials. 
We calculated accuracy scores for the following four trial-types averaged across 
valence conditions: non-reversal reward trials after correctly predicted rewards 
(win-stay) and correctly predicted punishment trials (lose-shift) and non-reversal 
punishment trials after correctly predicted rewards (win-shift) and correctly 
predicted punishments (lose-stay).  Drug effects were assessed with repeated 
measures ANOVA with the within-subjects factors drug (placebo, MPH), strategy 
(stay, shift) and outcome (reward, punishment) and working memory capacity as 
covariate. Direct associations between drug effects on valence-dependent reversal 
learning and strategy were assessed with correlation analyses. To this end, 
individual levels of a win-stay/lose-shift strategy was calculated as [(win-stay+lose-
shift)–(win-shift+lose-stay)], where higher values reflect a greater adoption of a 
win-stay/lose-shift strategy. 
Results
Subjects
All nineteen subjects were healthy and none met DSM-IV criteria for ADHD as 
measured with the self report symptom questionnaire (symptoms of inattention 
Child: 1.3±1.6, range: 0–6; Adult: 0.6±0.8, range: 0–3; symptoms of hyperactivity 
Child: 1.7±1.6, range: 0–5; Adult: 1.3±1.3, range: 0–5) or depression as measured 
with the Beck Depression Inventory (1.4±2.0, range: 0–5). All had normal levels of 
trait anxiety (STAI:30.1±5.5, range:22-42) and impulsivity (BIS:61.1±8.0, range:41-74). 
There were no associations between these baseline measures and MPH-induced 
changes on valence-dependent reversal learning (all p>.1). 
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Effects of MPH on reward versus punishment learning varied as a 
function of baseline working memory capacity
MPH was predicted to alter reward versus punishment reversal learning as a 
function of baseline working memory capacity. This was confirmed statistically by 
a significant drug × valence × trial-type × span interaction (F
16,2
=12.8, p<.001). A 
breakdown of this interaction confirmed that the drug × valence × span interaction 
was significant for the reversal trials (F
17,1
=23.77, p<.001), but not for the non-reversal 
Figure 2   Linear relationship between baseline working memory capacity (digit span) 
and MPH effects on reward versus punishment learning (r = .69, p <.001).
Data on the y-axis reflect arcsine transformed valence-dependent reversal scores (i.e. 
accuracy on reward relative to punishment reversal trials) after administration of methyl-
phenidate (MPH) relative to placebo. Diamonds represent individual data points.
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Table 1   Behavioural data on the reversal learning task.  
  Placebo MPH
Reward  
condition
Reversal 0.95(0.01) 0.98(0.01)
non-reversal reward 0.96(0.01) 0.96(0.01)
non-reversal punishment 0.95(0.01) 0.97(0.01)
Punishment  
condition
Reversal 0.95(0.02) 0.96(0.01)
non-reversal reward 0.94(0.01) 0.97(0.01)
non-reversal punishment 0.94(0.01) 0.96(0.01)
Values represent raw accuracy scores (standard error) per trial-type and drug condition, averaged across 
all subjects (N = 19). Reversal trials are presented in bold. MPH = Methylphenidate.
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reward (F
17,1
=.02, ns) or non-reversal punishment trials (F
17,1
=2.36, p=.2). Correlation 
analysis revealed a positive relationship between working memory capacity and 
MPH effects on valence-dependent reversal learning scores (r
19, Pearson
=.76, p <.001; 
r
19, Spearman’s rho
 =  .72, p <.001). Thus, we show that MPH improved reward versus 
punishment learning in high working memory subjects, while the opposite was 
seen in low working memory subjects (Figure 2; Table1; Figue S1).  All baseline- 
dependent effects were replicated with the digit span and listening span assessed 
during intake (Supplementary Materials and Methods). MPH did not affect digit 
span itself (drug×span: F
18,1
=.11, ns, main effect of drug: F
18,1
=1.12, p =.3), also not as 
a function of digit span assessed during intake (drug × baseline × span: F
18,1
=.11, ns) 
(Table 2). 
Subjective mood and physiology effects were as predicted with higher reports of 
subjective alertness and positive affect as well as heart rate, systolic and diastolic 
blood pressure increases after administration of MPH relative to placebo across all 
subjects (Table S1). These MPH-induced changes on mood and physiology were not 
associated with MPH-induced changes on valence-dependent reversal learning (all 
p > .1) (see Supplementary Materials and Methods for details). 
Supplementary win-stay, lose-shift analysis
Effects on valence-dependent reversal learning could not be attributed to overall 
MPH-induced changes on the adoption of a win-stay/lose-shift strategy. Thus, 
analysis of MPH effects on win-stay/lose-shift strategy did not reveal any 
span-dependent effects. There was no drug × strategy × outcome × span interaction 
(F
17,1
=.004, ns). Furthermore, correlation analysis revealed that MPH-induced 
changes on valence-dependent reversal learning were not associated with 
MPH-induced changes on a win-stay/lose-shift strategy (r
19 
= .015, ns). 
 An additional analysis was conducted to assess whether there were MPH 
effects on response strategy irrespective of working memory capacity. This analysis 
Table 2   Digit span.  
 Intake Placebo MPH Average
Forwards 8.37(1.92)* 9.32(2.31) 9.79(1.93) 9.16(1.62)
Backwards 7.58(1.54)* 8.21(2.1) 8.47(1.74) 8.09(1.57)
Total 15.95(2.91)*^ 17.53(3.73) 18.26(3.14) 17.25(2.84)
Values represent forward, backward and total span scores (standard deviation) averaged across subjects 
(N=19) measured during intake, placebo and methylphenidate session and averaged across all measurements. 
* Differs significantly (p<.05) from the methylphenidate session. ^ Differs significantly (P<.05) from the 
placebo session. MPH = Methylphenidate.
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revealed a significant drug × strategy × outcome interaction (F
17
 = 6.77, p = .019). 
Post-hoc pair wise comparisons for each of the four trial-types separately revealed 
that MPH selectively decreased accuracy on win-shift trials (T
18
 = -4.17, p <.001), 
while having no effects on win-stay (T
18
 = .053, p = .95), lose-stay (T
18
 = .25, p = .8) and 
lose-shift trials (T
18
 = 5, p = .63) (Table 3).
Discussion 
The increased use of licensed stimulants like MPH by students in educational 
settings has raised questions about its cognitive enhancing effects in the healthy 
population (Greely et al., 2008). One major issue is the large variability in the 
effects of such smart drugs on learning and cognition, both within and across 
individuals. Here, we show that effects of MPH on reversal learning vary as 
function of baseline working memory capacity. Moreover, as predicted, effects of 
MPH were valence-dependent, so that MPH altered reward relative to punishment 
learning. Specifically, it improved reward versus punishment learning in high 
working memory subjects, while impairing it in low working memory subjects. 
These effects could not be accounted for by non-specific drug effects, for example 
on alertness or other subjective effects. These results elucidate two factors that 
contribute to the high variability of smart drug efficacy in the healthy population. 
First, they demonstrate that effects of MPH on learning vary within individuals as 
a function of the specific demands of the task, with differential effects on reward 
and punishment learning. Second, they demonstrate that effects of MPH on 
learning vary between individuals as a function of baseline working memory 
capacity, with opposite MPH effects in high and low working memory subjects. 
These results help understand the nature of the large inter- and intra-individual 
differences in the response to smart drugs like MPH.
Table 3   Raw accuracy scores on win-stay, lose-stay, win-shift and lose-shift trials.
 MPH Placebo
win-stay 0.86(0.03) 0.86(0.03)
lose-stay 0.86(0.04) 0.85(0.03)
win-shift 0.82(0.04)* 0.85(0.04)
lose-shift 0.82(0.04) 0.81(0.06)
Values represent raw accuracy scores (standard error) per trial-type and drug condition, averaged across 
all subjects (N = 19). MPH = Methylphenidate. * Differs significantly (P < .001 from the placebo session). 
MPH = Methylphenidate. 
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Our results are generally consistent with previous work demonstrating opposite 
effects of dopaminergic drugs on reward and punishment learning in healthy 
subjects (Frank and O’Reilly, 2006; Cools et al., 2009; van der Schaaf et al., 2012) 
and further support computational modelling work, which suggests that striatal 
dopamine shifts the balance between reward and punishment learning (Frank, 
2005; Maia and Frank, 2011). More specifically, we observed that MPH induced a 
larger improvement in reward versus punishment learning in subjects with 
higher baseline working memory capacity. This observation is particularly 
relevant in the context of smart drug use in universities (Greely et al., 2008; Maher, 
2008; Smith and Farah, 2011) given the large body of evidence supporting a 
substantial relationship between working memory capacity and general fluid 
intelligence (e.g. (Engle et al., 1999)). Thus, general fluid intelligence might help 
predict whether smart drugs help or hurt. Baseline working memory capacity has 
been previously shown to be a putative proxy of baseline dopamine synthesis 
capacity in the striatum (Cools et al., 2008; Landau et al 2009). Accordingly, the 
dependency on working memory capacity might reflect dependency on dopamine 
synthesis capacity, with larger improvements in reward versus punishment 
learning in subjects with higher dopamine synthesis capacity. Our results are 
therefore consistent with the dopamine cell-activity hypothesis (Volkow et al., 
2002),  suggesting that  DAT blockade induces larger dopamine increases, and thus 
larger improvements in reward versus punishment learning (Frank, 2005; Maia 
and Frank, 2011), in subjects with high relative to low dopamine cell activity 
(Volkow et al., 2002). Furthermore, it is also in line, albeit indirectly, with prior 
work revealing larger MPH-induced impairments on punishment-based reversal 
learning in subjects with larger MPH-induced increases in dopamine release 
(Clatworthy et al., 2009). 
It might be noted that the present study revealed MPH-induced impairments in 
reward versus punishment learning, presumably associated with decreases in 
dopamine (Frank, 2005), in subjects with low working memory capacity. This 
aspect of our findings is not easily accounted for by the above described cell-activity 
hypothesis, unless MPH acts more readily via autoregulatory (D2) systems in low 
than in high working memory/dopamine synthesis subjects. Further investigation 
is needed to elucidate involvement of these additional mechanisms in the observed 
span-dependent effects of MPH. Accordingly we refrain here from definitively 
interpreting the MPH induced impairments in mechanistic terms.  Instead, we 
emphasize the relevance of the findings in the context of smart drug use by healthy 
adults, by suggesting that baseline working memory capacity may provide a 
valuable prediction measure for individual MPH effects. 
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At first sight, our findings might appear inconsistent with recent work showing 
beneficial effects of MPH on cognitive processing speed and stop signal reaction 
times, respectively, in subjects who perform poorly at baseline (Eagle et al., 2007; 
Finke et al., 2010), consistent with the well-known inverted-U-shaped relationship 
between dopamine and cognitive performance (Arnsten, 1997) . However, it should 
be noted that our study did in fact also reveal improvement in performance in low 
span subjects, but only if performance is calculated in terms of punishment versus 
reward learning. This illustrates one important take home message of the present 
study, that effects of MPH improve or impair cognition depending on current task 
demands. 
We did not find any MPH effects on working memory capacity itself, as measured 
with the digit span. This is consistent with our previous report (van der Schaaf et 
al., 2012) and various other reports (Schmedtje et al., 1988; Oken et al., 1995; Silber 
et al., 2006) but see (Agay et al., 2010), but in apparent contrast with other studies 
reporting stimulant effects on more complex spatial working memory tasks 
(Mehta et al., 2000; Clatworthy et al., 2009). In addition, the direction of our 
(positive) association between digit span and MPH’s effects on reward versus 
punishment learning is also in contrast with that observed previously for spatial 
working memory (Mehta et al., 2000). Thus, Mehta et al. (2000) have reported a 
negative rather than a positive association between digit span and MPH’s effects 
on spatial working memory. One explanation for this apparent discrepancy could 
be that the tasks have different cognitive requirements. Indeed, together with 
prior work by Clatworthy et al. (2009), the current study indicates that the nature 
of the relationship between the cognitive effects of MPH and the baseline state of 
the system depends critically on task demands.  
MPH sustained subjective feelings of alertness and positive affect over time and 
increased heart rate and blood pressure across all subjects. Importantly, these 
nonspecific effects of MPH could not explain the effects of interest on valence-de-
pendent learning, because, unlike our effects of interest, they did not depend on 
working memory capacity. One possibility is that these effects reflect modulation 
of (prefrontal) noradrenalin, known to be involved in sympathetic control, 
attention and executive functioning (Arnsten, 1997).
Effects on valence-dependent reversal learning could not be attributed to 
MPH-induced changes on the adoption of a win-stay/lose-shift strategy as measured 
on the non-reversal trials. Supplementary analysis did reveal that MPH selectively 
decreased the tendency to shift responding (on non-reversal punishment trials) after 
non-reversal reward trials, suggesting enhanced stickiness or response perseveration 
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after reward. Although these results are potentially interesting, our task was not 
designed to directly assess MPH effects on instrumental response strategy. 
Accordingly, these results should be considered as preliminary and future studies 
specifically designed to assess instrumental response strategy should further 
explore these potential MPH effects. Stimulant medication has been shown to 
ameliorate reward versus punishment learning deficits in patients with ADHD 
(Frank et al., 2007b). ADHD has been associated with low (spatial) working memory 
(Barkley, 1997) and striatal dopamine deficiency (Volkow et al., 2009). Thus, the 
MPH-induced improvement in ADHD seems at odds with the present finding that 
MPH impaired reward relative to punishment learning in healthy adults with low 
working memory capacity.  This discrepancy might reflect the fact that beneficial 
effects of MPH on reward learning have been shown only in ADHD patients who 
have received long-term stimulant treatment. Long-term stimulant treatment 
might have effects that are quite different from those of acute administration 
(Robbins, 2002). Indeed long-term stimulant treatment might induce changes in 
DAT expression (Fusar-Poli et al., 2012) and/or dopamine signalling (Grace, 1991; 
Volkow et al., 2012). Accordingly, the current study of acute MPH administration 
in the healthy population provides a better model of MPH use in healthy adults, 
who likely take smart pills only on particular occasions (Smith and Farah, 2011) 
and not on the longer term.
The finding that MPH has differential effects on reward and punishment learning 
might have relevance to other task domains, given that many tasks load on either 
reward or punishment learning. Thus, improved reward (relative to punishment) 
learning might well translate to enhanced attribution of positive value to study 
material and thus increase student interest and motivation in schoolwork.  In line 
with that, mesolimbic dopamine is thought to modulate the attribution of 
incentive salience to stimuli that drive behaviour and become the focus of 
goal-directed behaviour (Berridge and Robinson, 1998). This is further supported 
by a positive correlation between MPH-induced extracellular dopamine increases 
and subjective ratings of interest, excitement and motivation for a mathematical 
task (Volkow et al., 2004). Conversely, improved punishment (relative to reward) 
learning might translate to enhanced attribution of negative value, something 
characteristic of mood-disorders like depression (Clark et al., 2009; Robinson et al., 
2011). This also raises concerns about possible negative side effects of MPH and 
highlights the need for further evaluation of both potential risks and benefits of 
cognitive enhancement in the healthy population. Moreover, future studies are 
needed to further unravel how changes in reward and punishment learning might 
contribute to academic performance.  

Chapter 4
Supplementary information
(Working memory capacity predicts effects of methylphenidate on  
reversal learning)

4Effects of methylphenidate in healthy adults
107
Supplementary Materials and Methods
Randomization details
The order of administration was randomized with nine participants receiving methyl-
phenidate and 10 participants receiving placebo on the first session, balanced for 
gender. Subjects starting time (e.g. the session started at 9.00 AM) was kept constant 
between sessions and differed with maximal one hour. Task response-mappings 
were counterbalanced across participants and kept constant between sessions. Nine 
participants predicted reward with their index finger and ten participants with their 
middle finger. Order of the valence conditions (2 × reward followed by 2 × punishment or 
vice versa) was kept constant within subjects and was counterbalanced across subjects. 
Practice blocks
A practice block consisted of one acquisition stage and one reversal stage. The 
acquisition stage lasted until participants reached the learning criterion of 20 
correct predictions. The practice block terminated if the participant reached the 
learning criterion of 20 correct predictions in the reversal stage or if the maximum 
of 80 trials was performed. If necessary, oral feedback was provided or an additional 
practice block was performed until the task was understood.  
Test-retest effects on the reversal learning task
There were no test-retest effects on the experimental blocks or the reversal learning 
task. Repeated measures ANOVA with the within-subject factors session (session1, 
session2), valence (reward, punishment) and trial-type (reversal, non-reversal reward, 
non-reversal punishment)  and working memory capacity as covariate did not reveal 
any session × valence × trial-type × span interaction (F
17,2
= .59, ns) or session × valence × 
trial-type interaction (F
17,2
= .67, ns). 
Replication of span-dependent MPH-effects with intake measures
All baseline-dependent effects were replicated with the digit span (N=19) or 
listening span (N=17) assessed during intake. Mixed ANOVA revealed a significant 
drug × valence × trial-type × span interaction (digit span: F
16,2
 =  7.71, p =.002; 
listening span: F
14,2
 =  8.04, p =.002) and breakdown of this interaction confirmed 
that the drug × valence × span interaction was significant for the reversal trials 
(digit span: F
17,1
 =  10.413, p =.005; listening span: F
15,1
 = 12.94 , p =.003) but not for 
the non-reversal reward (digit span: F
17,1
 =  .15, ns; listening span: F
15,1
 = .19 , p = ns) 
or non-reversal punishment trials (digit span: F
17,1
 =  2.252, p =.2; listening span: 
F
15,1
 = 1.35 , p = .26). Correlation analysis revealed a positive relationship between 
working memory capacity and MPH effects on valence-dependent reversal learning 
scores (digit span: r
19
 = .62, p =.005; listening span: r
17
 = .68, p = .003).
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Baseline working memory
There was a general test-retest effect on the digit span across session days. Repeated 
measures ANOVA with the factor session (intake, session1, session2) and span 
(forward, backward) revealed a significant main effect of session day (F
17,2
 = 6.01, p 
= .006). Post-hoc pair-wise comparisons revealed only a significant difference 
between intake and the first (T
18
= 2.72, p = .014) and second (T
18
= 2.17, p = .044) 
session day. Importantly, there was no difference between the two sessions days 
(T
18
= .593, ns). Thus, drug did not affect digit span performance. This lack of effect 
could not be explained by a ceiling effect as none of the participants reached the 
highest score on any assessment (=28) (Table2 in the main text). Consistent with 
our previous report, we found a direct relationship between the digit span and 
listening span, both for the average total digit span across all three assessments 
(r
pearsons rho, 17
 = .62, p = .008) and for the digit span taken during intake only (r
pearsons 
rho, 17
 = .57, p = .018). 
Physiology and mood
Physiological measures (heart rate and blood pressure), subjective mood measures 
(VAS)(Bond and Lader, 1974)) and the the Positive and Negative Affect Scale (PANAS, 
(Watson et al., 1988) were assessed ~15 minutes prior (T1), ~30 minutes after (T2) 
and ~3½ hour (T3) after drug intake. Heart rate, systolic and diastolic blood 
pressure were analysed across all subjects with repeated measures ANOVA with 
the within-subjects factors drug (placebo, MPH) and time (T1, T2, T3) and working 
memory capacity as covariate. The VAS scales were reduced to the 3 subscales 
alertness, calmness and contentedness (Bond and Lader, 1974). These subscales and 
the PANAS were analyzed across all subjects with repeated measures ANOVA with 
the within-subjects factors drug and time and working memory capacity as 
covariate. Additional Pearsons correlation analysis were done to investigate 
whether MPH effects on physiology and mood ([MPH_T3–MPH_T1]–[placebo_T3–
placebo_T1]) were associated with MPH effects on valence-dependent reversal 
learning (MPH–placebo). 
There were significant drug × time interactions for alertness (F
17,2
=5.67, p=.015), 
positive affect (F
17,2
=4.3, p=.038), heart rate (F
17,2
=4.99, p=.029), and blood pressure 
(systolic: F
17,2
=4.02, p=.027, ; diastolic: F
17,2
=4.49, p=.018), across all subjects. MPH 
sustained higher levels of alertness and positive affect relative to placebo. Alertness 
decreased significantly over time during the placebo session (T1-T3: T
18
=3.04, 
p=.007), while no such decrease was seen after administration of MPH (T1-T3: 
T
18
=-.25, ns). At T3, subjects were less alert after administration of placebo than 
after administration of MPH (T
18
=2.27, p=.036). Positive affect significantly 
decreased during the placebo session (T1-T3: T
18
=3.54, p=.003), while no such 
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decrease was seen after administration of MPH (T1-T3: T
18
=.6, ns). Physiology effects 
were as predicted with heart rate (T3 –T1: T
18
=2.19, p=.039), systolic (T3 –T1: T
18
=3.11, 
p=.005) and diastolic (T3 –T1: T
18
=2.96, p=.007) blood pressure increases after 
administration of MPH relative to placebo. No drug × time interactions were seen 
for negative affect (F
17,2
=.03, ns), calmness(F
17,2
=.13, ns) or contentness (F
17,2
=.01, ns). 
There were no drug × time × span interactions (all p>.05) and MPH-induced changes 
on physiology and mood were not associated with MPH-induced changes on 
 valence-dependent reversal learning (all p>.1) ) (Table S1). 
Figure S1   Linear relationship between baseline working memory capacity (digit span) 
and MPH effects on reward (black triangles) and punishment (grey circles) 
learning.
Data on the y-axis ref lect arcsine transformed reversal scores after administration of 
 methylphenidate (MPH) relative to placebo.
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Table S1   Subjective mood and physiology. 
MPH Placebo
T1 T2 T3 T1 T2 T3
Heart Rate 72(12) 64(7)* 68(9) 73(11) 67(7)* 63(11)*
Systolic BP 114(10) 116(11) 120(10)*^ 116(11) 114(9) 114(10)
Diastolic BP 72(7) 72(9) 80(8)*^ 72(8) 71(7) 74(6)
PA 29.3(5.1) 28.7(5.1) 28.5(6.4) 31.1(4.5) 30.1(4.2)* 26.6(4.2)*
NA 12.9(4.5) 12.4(3.1) 12.2(3.2) 12.6(3) 12.2(2.8) 12(2.7)
Alertness 70.5(12.8) 66.2(12) 71.2(17.6)^ 72.8(12.9) 71.1(14.4)* 61(17.2)*
Calmness 78.1(16.7) 74.3(21.6) 79.4(20.1) 81.8(16.8) 81.5(19.7) 82.5(13.9)
Contentness 82.3(8.6) 78.7(12.9) 79.6(13) 80.7(12.8) 78.5(8.9) 77.8(12.2)
Values represent heart rate, systolic and diastolic blood pressure, mood measurements as measured with 
the positive and negative affects scales and Bond and Lader visual analogue scales (standard deviation), 
* differs significantly (p<.05) from T1, ^ differs significantly (p<.05) from placebo at the same time point. 
PA = Positive affect, NA = Negative affect.
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Abstract 
Rationale: Abnormal reward processing in attention deficit hyperactivity disorder 
(ADHD) has been associated with aberrant dopamine signalling in the striatum. 
Objective: Here we investigated effects of methylphenidate, one of the most 
frequently prescribed treatments for ADHD, on reward learning in individuals 
with ADHD using a reversal learning task. Methods: ADHD participants were tested 
twice, once after withdrawal of long-term use of sustained-release methylpheni-
date Concerta® (N = 15) or immediate-release methylphenidate Ritalin® (N = 8), and 
once on (a replacement by) Ritalin®. Performance of patients was compared with 
that of healthy controls (N=26). Results: Deficient reward processing was restricted 
to adults with ADHD who withdrew from sustained-release methylphenidate, 
while no such effects were seen in individuals using immediate-release 
preparations. Conclusions: These preliminary results raise the hypothesis that 
deficient reward processing in ADHD might reflect effects of treatment with 
slow-release MPH, highlight the importance of taking into account medica-
tion-type in methylphenidate withdrawal studies and emphasize the need for 
further investigation of potential long-term consequences of these preparations.
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Introduction
Attention deficit hyperactivity disorder (ADHD) is one of the most frequently 
diagnosed childhood-onset psychiatric disorders and is characterized by symptoms 
of inattention, impulsivity and hyperactivity ((American Psychiatric Association, 
2000), DSM-IV-TR). In more than 15% of children with ADHD, symptoms persist 
into adulthood (Faraone et al., 2006).  Current  models propose that ADHD is 
associated not only with deficits in executive functioning (e.g. (Barkley, 1997), but 
also with deficits in motivational and reward processing (Sonuga-Barke, 2003; 
Luman et al., 2005; Castellanos et al., 2006). Such executive and reward deficits 
have been attributed to abnormal dopamine transmission in cortico-striato-thala-
mo-cortical pathways (Alexander et al., 1990; Sonuga-Barke, 2003; Castellanos et 
al., 2006; Kelly et al., 2007; Haber and Knutson, 2010). ADHD is most commonly 
treated with psychostimulants, such as methylphenidate (MPH). MPH acts mainly 
by blocking the dopamine transporter (DAT), which removes dopamine from the 
synaptic cleft (Volkow et al., 2005). One theory proposes that MPH increases tonic 
(sustained low-amplitude) dopamine, while phasic (transient high-amplitude) 
dopamine bursts in the striatum, in response to rewarding and salient stimuli, are 
dampened down via activation of pre-synaptic auto-receptors (Grace, 1991; Seeman 
and Madras, 2002). However, despite the widespread and increasing use of psycho-
stimulants today (e.g. (Robison et al., 1999; McCarthy et al., 2012), the precise 
neurochemical mechanisms underlying its therapeutic effects are still under 
debate.
According to current theorizing in the domain of addiction, hyperactive and 
impulsive behaviour might result from a combination of augmented reward 
processing, associated with aberrant phasic dopamine functioning in the striatum 
and impaired inhibitory control, associated with, among other things, reduced 
tonic dopamine in cortical frontal regions (e.g. (Jentsch and Taylor, 1999)). By 
analogy, ADHD has been argued to be accompanied by a combination of abnormal 
reward-driven behaviour and reduced executive inhibitory control (Sonuga-Barke, 
2005; Castellanos et al., 2006). Accordingly, these abnormalities have been 
proposed to reflect, respectively, increased phasic DA bursting in limbic-striatal 
subcortical brain structures in response to salient and reward-associated stimuli, 
and deficient tonic DA transmission in frontal cortical structures (Bilder et al., 
2004; Cools, 2011). Following this reasoning, MPH might exert its therapeutic 
effects on executive inhibitory functioning by restoring deficient tonic DA 
transmission in frontal cortical structures (Bilder et al., 2004; Arnsten, 2006). 
Further, in the long term, MPH might lead to normalize reward processing by 
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paradoxically dampening down aberrant phasic DA release in the striatum (Grace, 
1991; Robbins, 2002; Seeman and Madras, 2002; Bilder et al., 2004).
Empirical evidence indicates that ADHD is indeed associated with altered reward 
processing (Luman et al., 2010).  For example, individuals with ADHD have been 
shown to exhibit a relatively strong preference for small immediate rewards over 
larger delayed rewards (e.g. (Rapport et al., 1986; Sonuga-Barke et al., 1992), to 
exhibit reduced striatal response in anticipation of rewards (Scheres et al., 2007; 
Ströhle et al., 2008; Plichta, 2009; Hoogman et al., 2011) and to be impaired in 
positive reinforcement learning (Frank et al., 2007b). However, as most of these 
studies were conducted in groups of patients who have temporarily been 
withdrawn from their regular medication (Frank et al., 2007b; Scheres et al., 2007; 
Plichta, 2009; Hoogman et al., 2011), it is unclear whether findings of deficient 
reward processing reflect aspects that are inherent to the disorder, or instead 
reflect the long-term use of medication and consequent down-regulation of phasic 
DA release. Indeed, research with experimental animals has shown that repeated 
exposure to MPH in adolescent rats results in decreased responsiveness to natural 
rewards (Marco et al., 2011) and reduced preference for environments associated 
with cocaine seeking behaviour (Andersen et al., 2002).  
Here we investigated effects of methylphenidate on reward learning in individuals 
with ADHD using a reversal learning task. Results revealed reduced reward 
learning in ADHD participants who withdrew from their regular medication, but 
these effects were revealed only when medication history was taken into account. 
Specifically, deficient reward processing was restricted to adults with ADHD who 
withdrew from sustained-release preparations of MPH (i.e. Concerta®), while no 
such effects were seen in individuals using immediate-release preparations (i.e. 
Ritalin®). Accordingly, these preliminary results support the hypothesis that 
deficient reward processing might reflect long-term effects of treatment with 
slow-release MPH. These results are further discussed in the light of possible 
differential long-term effects of continuous and intermittent treatment regimen 
on dopamine functioning (Post, 1980; Samaha et al., 2008).   
Methods
Subjects
Twenty-nine participants diagnosed with ADHD and twenty-eight healthy controls 
(HC) were selected from a sample recruited from the department of Psychiatry of 
the Radboud University Nijmegen Medical Centre (Nijmegen, the Netherlands) for 
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a (non-pharmacological) genetic imaging study (Hoogman, 2011) and invited for a 
separate medication withdrawal study. Time between the genetic imaging study 
and the current study ranged between 3 and 25 months. For inclusion in the 
genetic imaging studies all subjects underwent a diagnostic interview for ADHD 
in adults (DIVA, (Kooij and Francken, 2007)) and the Structured Clinical Interview 
for DSM-IV Axis I disorders (SCID-I)(Van Groenestijn et al., 1996) and the Structured 
Clinical Interview for DSM-IV Axis II Personality disorders (SCID-II) (Weertman et 
al., 1996)) by a trained psychologist (MO, MH) for assessment of ADHD-criteria, 
co-morbidities and personality disorders. Additional measures taken from this 
assessment for current analyses were age of diagnosis and start of medication, 
duration of medication use, IQ (WAIS-III) and education level. 
All ADHD participants met criteria for current ADHD with childhood onset and 
persistence into adulthood, as confirmed by the DIVA, and were using MPH on 
prescription at the time of testing. Inclusion criteria for HC were no diagnosis for 
ADHD and no relatives with ADHD and no history of neurological or psychiatric 
disease or substance abuse (except for nicotine). HC were matched with the ADHD 
group for age, IQ (WAIS-III) and gender. All participants were native Dutch 
speakers, gave written informed consent as approved by the Dutch Ethics 
Committee (CMO Arnhem-Nijmegen 2009/058, NL27180.091.09) and were 
compensated for participation.
Six ADHD participants were excluded from analysis. Three for incomplete sessions 
due to no-show on the second session day, two for incorrect compliance to the 
medication prescriptions (see general procedure) and one for below chance 
performance (< 60% correct responses). From the HC group, two participants were 
excluded from analysis because of below chance performance (< 60% correct 
responses) and above threshold score on the ADHD self report symptom 
questionnaire (>6 of 18 items, 5 were hyperactive/impulsive, see general 
procedures). In total twenty-three participants were included in the ADHD group 
(12 men, age: 34.4 ± 11.0, range 20-53) and twenty-six participants were included in 
the HC group (12 men, age: 37.8 ± 9.5, range 24-57). 
For subsequent post-hoc analysis, the ADHD group was split based on the release 
characteristics of their regular medication to take into account possible effects of 
within-day treatment kinetics; one group (N= 15) used sustained-release MPH (i.e. 
Concerta ®, one in combination with sustained-release MPH Equasym XL ®) and 
one group (N = 8) used immediate release MPH (i.e. Ritalin ®, including two 
participants who also reported to use Concerta®). Concerta releases an initial 
immediate bolus of MPH (22%) within 1-2 hours, followed by controlled first-order 
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ascending release of MPH (osmotic-release oral system [OROS] technology) between 
2-10 hours, with peak plasma concentrations 6-8 hours after dosing. Ritalin® is 
effective for 3-4 hours with peak plasma levels 1½ hour after dosing (Swanson et 
al., 2003). At the time of testing, all ADHD participants used medication for at least 
9 months. Duration of medication use did not differ between the Concerta (42±6.7 
months, range: 9-100) and Ritalin (45±12.4 months, range: 9-120) group (Z
Mann whitney 
U 
= .517, p = .636). Doses of medication did not differ between the Concerta 
(converted dose (see below): 13.5±5.8, range: 10 – 30) and Ritalin group (12.8±4.5, 
range: 5 – 20) (Z
Mann whitney U 
= .501, p = .616). Age at which ADHD participants started 
their medication did not differ between the Concerta (29.5±3.1, range: 12.9 – 51.3, 
one subject <18) and Ritalin (31±3.0, range: 19.3 – 47.6) group (Z
Mann whitney U 
= .516, 
p = .638).
All subject characteristics are listed in Table 1. DIVA assessment was missing for 
one participant from the Concerta group and one participant from the Ritalin 
group. DIVA and SCID assessments were missing for 2 HC. Comparisons of the HC 
and Concerta, HC and Ritalin or Concerta and Ritalin groups did not reveal any 
statistical differences in terms of IQ, age, education, or in their distribution of 
smokers, gender, handedness, co-morbidities (SCID) or ADHD-Type (DIVA) (all p >.05). 
There were also no differences in the study-design related factors medication 
order, response mapping (whether they predicted reward with the index or middle 
finger) or task order (whether they started with the reward or the punishment 
condition) between the groups (all p > .05). 
General procedure
ADHD participants were tested twice, once off and once on MPH in a randomized, 
counterbalanced order (Table 1). The two sessions were separated by at least 1 week 
and took place within two months. The starting time of the two sessions was kept 
similar within participants (0:24 ±0.54, range: 0-3 hours). HC were tested twice 
without medications to control for possible test-retest effects. All participants were 
asked to abstain from caffeine and nicotine 1 hour before testing and not to deviate 
from normal routines regarding caffeine, nicotine and alcohol the night before 
the experiment. For the off session, ADHD patients were asked to refrain from 
Concerta® 48 hours before testing and from Ritalin® 24 hours before testing. For 
the on session, Concerta® users received three doses of Ritalin® corresponding to 
their usual Concerta® dose (0.275 * Concerta® dose, in accordance with the 
recommended conversion from the Concerta to immediate release methylphedi-
date (http://www.drugs.com/pro/concerta.html)). All participants were asked to 
take one dose of Ritalin® 30 minutes prior to arrival and the other two doses 
dispersed over the day according to their own individual medication protocol. 
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On arrival, participants gave informed consent, completed the self report symptom 
questionnaire (DuPaul et al., 1998) for assessment of attention deficit (AD) and 
hyperactivity and Impulsivity (HI) symptoms and the Bond and Lader visual 
analogue scales (Bond and Lader, 1974) for assessment of mood. The Barratt 
Impulsiveness scale (BIS-II) (Patton et al., 1995) was administered on the first 
session day. Time and dose of last medication intake was recorded. General 
cognitive functioning was assessed with the box completion task (Salthouse, 1996), 
digit vigilance test (Lewis, 1995) and letter fluency (DAT). The present study was 
part of a larger protocol including a neuroimaging study (in preparation) 
performed prior to the current behavioural task. The reversal learning task was 
performed ~1¾ hours after arrival, followed by neuropsychological testing. 
Reversal learning task 
We employed a reversal learning task used previously (Cools et al., 2006). Two 
stimuli (a face and a scene) were presented simultaneously on the screen. One 
stimulus was associated with a reward outcome (happy smiley with a +€100 sign) 
and the other stimulus with punishment outcome (sad smiley with a -€100 sign). 
One of the stimuli was selected by the computer and highlighted with a black 
border. Participants were asked to predict the outcome of this preselected stimulus, 
after which the actual outcome was presented (100% deterministic). After 4-6 
consecutive correct predictions the stimulus-outcome contingency reversed which 
was either signalled by an unexpected reward or an unexpected punishment. 
Accuracy on the trials directly after these unexpected outcomes represents how 
well participants updated their prediction. After unexpected outcomes, the same 
stimulus was highlighted again such that behavioural requirements (i.e. a 
behavioural switch) were matched between reward and punishment reversal 
trials (Figure 1). Each participant performed 4 experimental blocks of each 120 
trials: two blocks in which reversals were signalled by unexpected rewards (reward 
condition) and two blocks in which reversals were signalled by unexpected 
punishment (punishment condition). Each block consisted of one acquisition stage 
until the first reversal and a variable number of reversal stages, depending on the 
participant’s accuracy (reversals occurred after 4, 5 or 6 consecutive correct 
predictions). Prior to the experimental blocks, participants performed two practice 
blocks. A practice block consisted of one acquisition stage and one reversal stage. 
The acquisition stage lasted until participants reached the learning criterion of 20 
correct predictions. The practice block terminated if the participant reached the 
learning criterion of 20 correct predictions in the reversal stage or if the maximum 
of 80 trials was performed. If necessary, oral feedback was provided during these 
practice blocks or an additional practice block was performed until the participant 
understood the purpose of the task. Participants who still performed below chance 
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level (< 60% correct responses) across the four experimental blocks were excluded 
from analysis (N = 3). 
Figure 1   Task design.
a) Example of a punishment trial. Two stimuli, a face and a scene, were presented 
simultaneously. One of the two stimuli was highlighted with a black border and the task 
was to predict, with a button press, whether this stimulus was followed by a reward or a 
punishment, after which the actual outcome was presented (100% deterministic). b) Example 
of a trial sequence for the unexpected punishment and unexpected reward condition. The 
participant learned to predict rewards (rw) and punishments (pn) for the scene and face. 
Stimulus-outcome associations reversed after 4-6 consecutive correct predictions, signalled 
by either unexpected reward or unexpected punishment. Measure of interest was the 
accuracy on reversal trials immediately after the unexpected outcomes. Abbreviations: 
rw = reward prediction; pn = punishment prediction; ns-r = non-reversal reward trial; 
ns-p = non-reversal punishment trial; sw-r = reversal trial after an unexpected reward; 
sw-p = reversal trial after an unexpected punishment.
+
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Behavioural analysis
There were six trial types in total, three trial types per valence condition: reversal, 
non-reversal reward and non-reversal punishment. Reversal trials were defined as 
those trials following an unexpected outcome. Accuracy on these trials indicates 
how well participants updated stimulus-outcome contingencies when reversals 
were signalled by either an unexpected reward or an unexpected punishment. 
Non-reversal reward and non-reversal punishment trials were defined as those 
trials preceding, respectively, expected rewards and expected punishments and 
following expected outcomes. Only trials from the reversal stages (after the first 
unexpected outcome) and trials following correct predictions were included in the 
analysis. Proportions of correct responses per trial-type were arcsine transformed 
(2x arcsine(√x)) as is appropriate when the variance is proportional to the mean 
(Howell, 1997). Following previous reports (Cools et al., 2006; Cools et al., 2009; van 
der Schaaf et al., 2011) we expected valence-dependent drug effects (i.e. differential 
drug effects on reward and punishment trials) on reversal trials, and no effects on 
non-reversal trials. 
Statistical analyses were performed using SPSS (IBM SPSS, Statistics Inc., version 
19.0). Valence-dependent drug and group effects were assessed across all trial-types 
with repeated measures ANOVA. Drug effects within the ADHD group were 
assessed with repeated measures ANOVA with the factors drug (on, off), valence 
(reward, punishment) and trial- type (reversal, non-reversal reward and 
non-reversal punishment) as within-subjects factors. Treatment effects were 
investigated post-hoc by adding  medication-type (Concerta, Ritalin) as a be-
tween-subjects factor. 
HC performed on average better on the second day (mean accuracy across all 
trial-types = 2.826, SD = .078) than on the first day (mean accuracy across all 
trial-types = 2.764, SD = .081) (F
25,1
 = 6.844, p = .015). However, repeated measures 
ANOVA with the factors session (session 1, session 2), valence (2) and trial- type (3) 
did not reveal any test-retest effects on valence-dependent reversal learning. 
Thus, there were no interactions of day with valence (F
25,1
 = .380, p = .543), trial-type 
(F
25,1
 = .166, p = .891) or valence×trial-type (F
24,2
 = 1.90, p = .160). Accordingly, for 
comparisons between HC and the ADHD group, data of HC were averaged across 
the two days to control for these test-retest effects. 
Group effects (ADHD versus HC) were analyzed with mixed ANOVA with the 
factors, valence (2) and trial-type (3) as within subjects factors and group (ADHD, 
HC) as a between subjects factor. Greenhousse-Geiser correction was applied when 
sphericity assumption was violated. Given the small sample size of the Ritalin 
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Table 1   Subject characteristics (standard deviation). 
  Concerta Ritalin Healthy 
Controls
N Total 15 8 26
Subject  
characteristics
Age 33.6 (11.9) 36.0 (9.6) 37.7 (9.45)
Gender (% Male) 47% 63% 46%
Handedness (% Right handed) 87% 100% 88%
IQ (raw score WAIS-III) 12.0 (2.3) 11.6 (1.7) 12.3 (2.9)
Education 4.6(0.7) 4.8(1.0) 4.9 (0.9)
Smoking (% smokers) 60% 63% 31%
Task  and  
design factors
Medication Order (% 1st session ON) 40% 63%
Mapping (% reward right) 47% 50% 50%
 Task order (% 1st block reward) 33% 63% 42%
SCID-I&II 
N Total 15 8 24
axis-I co-morbidities Depression % 80% 50% 21%
Dysthyme disorder % 13%
Psychotic symptoms % 13% 4%
Drug abuse % 20% 25% 13%
Anxiety disorder % 27% 13% 8%
Obsessive-Compulsive disorder % 4%
PTSS % 7% 25% 4%
Eating Disorder % 13% 25%
axis-II personality 
disorders
Obsessive-Compulsive % 7%
Borderline % 13%
 Antisocial % 13%
DIVA
N Total 14 7 24
ADHD Sub-type Combined % 79% 57%
Inattentive % 14% 29%
Hyperactive % 7% 14%
Number of symptoms Inattentive Childhood 7.07 7.44 0.50
(max = 9) Hyperactive Childhood 6.27 5.78 0.16
Inattentive Adulthood 7.07 7.33 0.50
 Hyperactive Adulthood 7.07 7.33 0.50
Categorical variables are presented as percentage of the whole (medication) group. SCID-I&II = Structured 
Clinical Interview for DSM-IV. Only diagnoses that were present in the groups are presented. WAIS = Wechsler 
Adult Intelligence Scale,  DIVA = Diagnostic Interview for ADHD, Adults. Two SCID assessments were missing from 
the healthy controls. Four DIVA assessments were missing; two from the healthy controls, 1 from the Concerta 
group and one from the Ritalin group. 
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group, parametric tests were supplemented with non-parametric tests on the 
measures of interest (i.e. accuracy on reward and punishment reversal trials). To 
this end, we calculated the valence-dependent reversal scores (accuracy on reward 
minus punishment reversal trials) and valence-independent reversal scores (accuracy 
in reward plus punishment reversal scores) (van der Schaaf et al., 2011) and 
compared these values with Mann-Whitney U and Wilcoxon’s tests for between 
and within group comparisons, respectively. 
Win-stay lose-shift analysis
The stimulus that was highlighted prior to an unexpected outcome was highlighted 
again on the following reversal trial. Accordingly, both reward and punishment 
reversal trials require response alternation. A change in performance on reversal 
trials could therefore reflect a change in the tendency to alternate responses after 
reward relative to punishment (i.e. a win-stay, lose-shift strategy). Therefore, we 
assessed whether there were any drug or group effects on the adoption of such a 
win-stay-lose-shift strategy on the non-reversal trials. To this end we calculated 
accuracy scores on non-reversal reward and non-reversal punishment trials after 
correct reward predictions (win-stay and win-shift trials respectively) and after 
correct punishment predictions (lose-stay and lose-shift trials respectively). Drug 
effects were tested with repeated measures ANOVA with the within-subject factors 
strategy (stay, shift), outcome (win, lose) and drug (on, off). Group effects were 
assessed with mixed ANOVA with the within-subject factors strategy (stay, shift) 
and outcome (win, lose) and the between-subject factor group (ADHD, HC).
Results
Withdrawal of Concerta, but not Ritalin is associated with impaired 
reward versus punishment reversal learning in ADHD 
Results are presented in Figure 2 and Table 2. Repeated measures ANOVA with the 
factors drug (2), trial-type (3) and valence (2) revealed no significant drug× 
 valence×trial-type interaction when tested across all ADHD participants (F
1,22
 = 
1.769, p = .18). However, post-hoc analysis revealed that the withdrawal effect 
varied as a function of medication type. Thus, mixed ANOVA with medication-type 
(Ritalin®, Concerta®) as between-subject’s factor and drug (2), valence (2) and 
trial-type (3) as within-subjects factors revealed a significant drug×valence×trial- 
type×medication-type interaction (F
2,20
 = 3.81, p = .03). This interaction was due to 
a drug×valence×trial-type interaction in the Concerta group (F
2,13
 = 6.51, p = .005), 
and no drug effects in the Ritalin group (F
2,6
 = .62, p = .55). Concerta users showed 
a valence-dependent drug effect on reversal trials as revealed by a significant 
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drug×valence interaction for reversal trials (F
1,13
 = 8.99, p = .01) but not for 
non-reversal reward (F
1,13
 = 1.72, p = .22) or non-reversal punishment (F
1,13
 = .085, 
p = .76) trials. MPH selectively improved accuracy on reward reversal trials (T
14
 = 
4.41, p = .001) while it had no effect on punishment reversal trials (T
14 
= .22, p = .83). 
The drug×valence interaction on reversal trials was confirmed by non-parametric 
tests. Drug effects on valence-dependent reversal learning scores differed between 
Concerta and Ritalin users (Z
Mann-Whitney U, 22
 = -2.03, p
exact
 = .048), with a valence- 
dependent drug effect in the Concerta group (Z
wilcoxon, 14
 = -2.54, p
exact
 = .008) but not 
in the Ritalin group (Z
wilcoxon, 7
 = -.56, p
exact
 = .63). No significant drug effects were 
seen on valence-independent reversal learning (Concerta: Z
wilcoxon, 14
 = -1.76, p
exact
 = .09; 
Ritalin: Z
wilcoxon, 7
 = -.28, p
exact
 = .84).  
Direct comparisons of the Concerta group with HC also revealed a group×valence× 
 trial-type interaction when Concerta users were off MPH (F
2,28
 = 5.14, p = .016), but 
not when they were on MPH (F
2,38
 = .46, p = .63). Further analysis on this comparison 
revealed a significant group×valence interaction on the reversal trials (F
1,39
 = 4.27, 
p = .046), which was due to a significant difference between HC and Conterta users 
on reward reversal trials (T
39
 = -2.67, p = .011), but not on punishment reversal trials 
(T
39
 = -.32, p = .75). No group×valence effects were seen for non-reversal punishment 
trials (F
39,1
 = .37, p = .55) or non-reversal reward trials (F
39,1
 = 2.4, p = .13). 
Figure 2   Accuracy on reward and punishment reversal trials for healthy controls (HC) 
and for the ON and OFF session of the Concerta group and Ritalin group.
Error bars represent standard error of the mean. * = p<.05, **= p<.005.
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No differences were seen between Ritalin users and HC either off MPH (F
2,34
 = .62, 
p = .53) or on MPH (F
2,34
 = .51, p = .6), which was confirmed by non-parametric tests 
on valence-dependent reversal learning (on: Z
Mann-Whitney, 36
 = -.53, p
exact
 = .61; off: 
Z
Mann-Whitney, 14
 = -.24, p
exact
 = .82) and valence-independent reversal learning (on: 
Z
Mann-Whitney, 36
 = -.81, p
exact
 = .42; off: Z
Mann-Whitney, 14
 = -.83, p
exact
 = .41). 
Because two subjects in the Ritalin group reported to use Concerta as well, a 
supplementary analysis was done to assess whether the withdrawal effects 
remained significant when these two subjects were included in the Concerta 
group. To this end, drug effects were tested within all non-Ritalin users (N=17). 
This analysis also revealed a significant drug×trialtype×valence interaction (F
15,2
 = 
3.422, p = .045) with a drug×valence interaction for the reversal trials (F
15,2
 = 5.50, 
p = .032), but not for the non-reversal reward (F
2,15
 = 2.12, p = .16) or non-reversal 
punishment trials (F
2,15
 = .1, p = .76). MPH improved performance on the reward 
reversal trials (T
16
 = 3.7, p = .002) but not punishment reversal trials (T
16
 = .53, p = .6). 
Drug effects did not depend on timing of last drug intake
Concerta and Ritalin users were instructed to stop their medication 48 and 24 
hours prior to testing, respectively. Accordingly, time since last drug intake (off 
period) was longer for the Concerta group (51.3 hours ± 4.3, range: 38.5 - 54.2) than 
for the Ritalin group (37.5 hours ± 10.5, range: 25.8 - 45.3) (Z
Mann_whitney U, 22
 = -3.359, p 
<.001). One might argue that a shorter off period might have prevented reward 
deficits in the Ritalin-group. However, the active period for Ritalin is also shorter 
(4 hours) than for Concerta (12 hours) (Swanson et al., 2003; Wolraich and Doffing, 
2004). Thus, for both groups withdrawal duration should have been sufficient for 
the drug to be cleared from the system (three times T½). When we subtracted the 
active period from the off period to correct for the medication-specific active 
period, off periods did not differ between medication groups (Z
Mann_whitney U, 22
 = .65, 
p <.54). Efficient medication withdrawal in both groups is further supported by 
equal symptom increase as measured with self-report symptom questionnaires 
(see below). Furthermore, no associations were found between the (corrected) off 
period and valence-dependent reversal learning, as tested with correlation analysis 
within the Concerta (r
spearsmans’ rho, 14
 = -.23, p = .41) or the Ritalin group (r
spearsmans’ rho, 7
 
= -.05, p = .99) or within the whole ADHD group (r
pearson, 14
 = .12, p = .60). Accordingly, 
it is unlikely that larger reward deficits in the Concerta relative to the Ritalin 
group are attributable to differences in the off period. 
For the ON session, comparison of time since last drug intake between the two 
medication groups revealed a trend (Z
Mann_whitney U, 22
 = 1.93, p = .056). Time since last 
(experimental) Ritalin intake was slightly shorter for the Concerta group (2.4 
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hours ± .3, range: 2.0 – 2.7) than for the Ritalin group (2.7 hours ± .3, range: 2.2 – 
3.1). However, this difference cannot account for the between-group difference of 
interest as significant effects were restricted to the off session. In addition, no 
association was found between time since last Ritalin intake and valence-depen-
dent reversal learning (r
spearsmans’ rho, 22
 = -.157, p = .474).   
There were no associations between doses of medication and drug effects on va-
lence-dependent reversal learning (Concerta and Ritalin: r
pearson(22)
 = -.18,  p =.42; 
Concerta: r
pearson(14)
 = -.10,  p = .73; Ritalin; r
spearman(7)
 = -.59,  p = .13) or valence-depen-
dent reversal learning during the off session (Concerta and Ritalin: r
pearson(22)
 = -.07, 
p =.75; Concerta: r
pearson(14)
 = -.04,  p = .88; Ritalin; r
spearman(7)
 = -.13,  p = .76).
Drug effects within the Concerta group are not explained by effects 
on win-stay lose-shift strategy
To assess whether withdrawal effects in the Concerta group could be attributed to 
differential adoption of a win-stay-lose-shift strategy we tested the adoption of 
such a strategy on the non-reversal trials. Repeated measures ANOVA with strategy 
(2) and outcome (2) as within-subject factor and drug (on,off) as within-subject 
factor or group (Concerta, HC) as between-subject factor did not support drug or 
group effects on a win-stay-lose-shift strategy. There was no strategy×out-
come×group interaction (F
1,39
 = .01, p = .91) or strategy×outcome×drug interaction 
(F
1,14
 = .14, p = .71). 
Self report, mood measure, questionnaires and general cognitive 
functioning
Self report and mood measures assessed during the sessions are reported in Table 
3. ADHD diagnosis was confirmed by the self-report symptom questionnaires and 
did not differ between the medication groups.  ADHD participants reported 
significantly more symptoms of inattentiveness (I) and hyperactivity (H) than HC 
when OFF MPH (I: T
47
 = 12.2, p <.001; H: T
45
 = 9.76, p <.001). MPH reduced reported 
symptoms in ADHD participants (I: T
22
 = -6.25, p <.001; H: T
22
 = -5.25, p <.001). 
However, they still reported more symptoms compared with HC when ON MPH (I: 
T
47
 = 4.05, p <.001; H: T
47
 = 4.03, p <.001). Self-reported symptoms did not differ 
between the medication groups, neither when on MPH (I: Z
Mann-Whitney, 23
 = -.66, p
exact
= 
-.54; H: Z
Mann-Whitney, 23
 = -.83, p
exact
= -.41) or off MPH (I: Z
Mann-Whitney, 23
 = -.098, p
exact
= -.94; 
H: Z
Mann-Whitney, 23
 = -.36, p
exact
= -.76). 
Analysis of mood measurements revealed that ADHD participants reported being 
less alert (T
46
 = -4.31, p<.001), less content (T
46
 = -2.46, p<.02) and less calm (T
46
 = -4.77, 
p<.001) than HC, when off MPH. MPH increased alertness (T
21
 = 4.08, p<.001), but 
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had no significant effect on contentness (T
21
 = 1.82 p = .08) or calmness (T
21
 = 1.36, 
p = .19). On MPH, ADHD participants reported being less calm (T
47
 = -3.55, p<.001) 
than HC, but there was no difference on contentness (T
47
 = -1.61, p<.12) or alertness 
(T
47
 = -1.33, p<.19). There were no differences on mood between the two medication 
groups, either on MPH (calmness: Z
Mann-Whitney, 23
 = -.61, p
exact
= -.56; contentness: 
Z
Mann-Whitney, 23
 = -.61, p
exact
= -.56; alertness: Z
Mann-Whitney, 23
 = -.84, p
exact
= -.42) or off MPH 
(calmness: Z
Mann-Whitney, 23
 = -1.59, p
exact
= -.12; contentness: Z
Mann-Whitney, 23
 = -.74, p
exact
= 
-.48; alertness: Z
Mann-Whitney, 23
 = -1.09, p
exact
= -.3). Mood measures were missing for one 
session (off MPH) for one participant in the ADHD group. There were no session 
effects on symptom or mood reports in ADHD or HC. 
On the Barratt Impulsiveness Scale, ADHD participants scored significantly higher 
than HC on attentional impulsiveness (AI) (T
47
 = 6.03, p <.001), motor impulsiveness 
(MI) (T
47
 = 5.64,  p <.001), nonplanning impulsiveness (NI) (T
47
 = 2.69,  p  = .010) and 
the total score (T
47
 = 5.3,  p <.001). There were no differences between medication- 
groups on these scales (AI: Z
Mann-Whitney, 23
 = -.13, p
exact
= .91; : MI: Z
Mann-Whitney, 23
 = -.032, 
p
exact
= .99; NI: Z
Mann-Whitney, 23
 = -.777, p
exact
= .44; Total: Z
Mann-Whitney, 23
 = -.64, p
exact
= .56). 
There were no associations between self-report symptoms, mood or BIS-II score 
and valence-dependent reversal learning (all p >.05).
Drug effects reported above are not attributable to non-specific effects on global 
cognitive functioning, there were no drug effects on background neuropsycholog-
ical testing as assessed with the block completion, number cancellation and verbal 
fluency, and no differences on performance for these tasks were seen between the 
medication groups and HC. 
Discussion
The present study investigated reward and punishment based reversal learning in 
individuals with ADHD using MPH. We found deficient reward processing in 
ADHD participants when they were OFF their medication, but these reward deficits 
were revealed only when medication-history was taken into account. Thus, after 
withdrawal, reward deficits were restricted to ADHD participants who used 
 sustained-release MPH, while no deficits were observed in individuals who used 
immediate-release MPH, despite similar symptom severity. These preliminary 
results fit within the theoretical framework proposing that sustained release MPH 
exerts its therapeutic effects on reward learning by down-regulation of subcortical 
phasic dopamine release in response to unexpected rewards (King et al., 1993; 
Bilder et al., 2004; Robbins, 2007; Engert and Pruessner, 2008). In addition, the 
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finding that significant withdrawal effects were restricted to the Concerta group 
is in line with animal work demonstrating that dopaminergic drug effects depend 
on the within-day kinetics of long term-treatment (Post, 1980; King et al., 1993; 
King et al., 1994; Ferrario et al., 2008; Samaha et al., 2008; Bédard et al., 2011).
The differential withdrawal effects between the medication groups suggest that 
sustained release and immediate-release MPH have differential effects on reward 
processing. Sustained osmotic-controlled release MPH (Concerta®) elicits 
smooth-rising plasma concentrations through the day, while multiple administra-
tions of immediate-release MPH (ritalin®) elicit peaks and troughs in plasma 
concentrations (Swanson et al., 2003; Spencer et al., 2006). Accordingly, differences 
in these pharmacokinetic properties might underlie different long-term treatment 
effects. Indeed, it is well known that long-term dopaminergic drug effects depend 
on drug kinetics, i.e the number of times that drug levels rise and fall within the 
day (Samaha et al., 2008). Thus, while intermittent treatment with  psychostimulants 
has been associated with sensitisation, continuous treatment with these drugs has 
been associated with tolerance (Post, 1980). By analogy, repeated intermittent 
exposure to addictive drugs of abuse is thought to increase phasic dopamine 
release, associated with increased reward sensitivity and drug-seeking behaviours 
(Jentsch and Taylor, 1999; Wanat et al., 2009), while sustained release MPH has 
been suggested to reduce the risk for substance abuse (Biederman et al., 1999; 
Robbins, 2002; Gill et al., 2012). In line with these observations, feelings of euphoria 
have been associated with immediate-release MPH rather than osmotic- controlled 
release MPH (Spencer et al., 2006) and the abuse potential of oral administration of 
immediate-release MPH has shown to be greater than that of sustained-release 
MPH (Kollins et al., 1998; Kollins, 2003).
One possible explanation of these differential effects is that continuous disruption 
of the dopamine system elicits compensatory mechanisms, while intermittent 
disruptions do not (Samaha et al., 2008). Thus, auto-receptor regulated feedback 
mechanisms that dampen phasic dopamine release are suggested to be more 
sensitive to gradual and tonic than to fast and pulsatile dopamine changes (Grace, 
1991; Seeman and Madras, 2002). Consistent with this, tolerance effects after 
continuous cocaine administration have been associated with autoreceptor super-
sensitivity and reduced cocaine-induced striatal DA efflux during withdrawal 
(King et al., 1993; King et al., 1994). Taken together, these studies support the 
hypothesis that effects of MPH on reward processing in the present study might 
depend on the dynamic nature of MPH treatment. While fast-acting dopaminergic 
drug (of abuse) might lead to increased reward sensitivity and increased phasic 
dopamine signalling, long-term treatment with sustained-release oral MPH 
5Effects of methylphenidate in ADHD
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instead leads to decreased reward sensitivity and decreased phasic dopamine 
release (Grace, 1991; Robbins, 2002; Seeman and Madras, 2002). 
The differential effects of immediate and sustained release MPH on reward 
processing are in contrast with clinical assessments, which did not reveal any 
differential therapeutic effects in terms of teacher, parent and self-report ratings 
of ADHD symptoms of different forms of MPH preparations (see (Faraone and 
Buitelaar, 2010) for a meta-analysis). Furthermore, therapeutic effects on attention 
and symptom relief occur rapidly after acute MPH administration and parallel the 
serum concentrations of MPH, irrespective of the type of MPH (Pelham et al., 1987; 
Volkow and Swanson, 2003; Wolraich and Doffing, 2004). In line with those 
observations, the present study reports similar (acute) changes on self-report 
symptoms for both medication groups. One possibility is that these general effects 
are mediated by different mechanisms than those proposed for reward based 
learning. While abnormalities in reward processing have been associated with 
aberrant phasic dopamine bursts in subcortical brain structures, deficits in 
cognitive function such as working memory maintenance, sustained attention 
and distracter resistance  have been associated with deficient tonic dopamine 
levels in the prefrontal cortex  (Bilder et al., 2004; Robbins, 2007; Engert and 
Pruessner, 2008). Accordingly, differential effects of sustained- and immediate-re-
lease MPH might surface selectively as longer-term consequences for functions 
associated with sub-cortical phasic dopamine release.  
The reward deficits seen in ADHD participants who were withdrawn from 
sustained- release MPH were ameliorated by a daily replacement with immediate- 
release MPH. From the present study it is, however, unclear whether continuation 
of Concerta® would have led to amelioration or persistence of these reward deficits. 
If dampening of phasic dopamine release is part of the therapeutic effects of sus-
tained-release MPH than reward deficits should persist after continuing 
participant’s regular (Concerta®) medications. The relatively fast DAT blockade by 
immediate-release MPH might have resulted in large increases in extracellular 
dopamine (Swanson and Volkow, 2003), facilitating reward reversal learning in 
Concerta users. Such improvements on reward processing could have been 
concealed in Ritalin users because they also have high phasic dopamine when off 
MPH, as revealed by the high accuracy rates for reward reversal trials (94% correct), 
leaving little room for improvement. 
A few important limitations need to be noted. First, the finding that MPH 
withdrawal had differential effects as a function of medication subtype is post hoc 
and our design was not a priori optimized for addressing effects of medication 
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subtype. Accordingly, the sample sizes of the subgroups, and specifically that of 
the Ritalin group, are small, limiting the generalisability of our effects to the 
general population. However, the differential effect of medication-type on reward 
learning was statistically robust, as evidenced by the significant interaction with 
medication-type, i.e. drug effects on reward learning were significantly larger in 
the Concerta-group than in the Ritalin-group. Nevertheless, future studies should 
confirm these findings in larger and equally sized samples. As such this study 
provides a robust albeit posthoc basis for a new hypothesis. Second, the medication- 
type used was based on individual preference and optimal therapeutic effects. 
This might have induced a selection bias related to specific disease characteristics 
or underlying neurobiological mechanisms. However, the lack of a difference in 
terms of symptom severity, ADHD-type, co-morbidities or personality traits 
(assessed with the DIVA, SCID-II and BIS-II) does not support this notion. Moreover, 
many factors might underlie the type of medication used, including socioeconomic 
status and treatment liability that are unrelated to neurobiological characteris-
tics. Third, time till last drug intake was longer for Concerta-users than for 
Ritalin-users. Accordingly, one might argue that a shorter off period might have 
prevented reward deficits in the Ritalin-group. However, off periods did not differ 
between the groups when corrected for their active period of the medication and 
no associations were found between the off period and reward  versus punishment 
based learning. Accordingly, it is unlikely that differential effects were due to 
differences in the off period. Last, treatment duration ranged between 9 months 
and 10 years but possible shifts between medication types during this period were 
not documented and mixed use of immediate- and sustained-release MPH and 
effects of additional medications were not taken into account. This might have 
contaminated the sample. Despite these limitations, the present results highlight 
some important issues concerning possible long-term effects MPH treatments. 
Future studies should confirm our results in larger and better controlled trials, 
including a comparison with never-medicated individuals with ADHD.
This is the first human study that revealed differential effects of immediate and 
sustained-release MPH treatments on reward processing in ADHD. We argue that 
these differential effects depend on the temporal dynamics of the MPH preparation. 
Such insights are relevant for a better understanding for its proposed increasing 
(Jentsch and Taylor, 1999) and decreasing (Biederman et al., 1999; Robbins, 2002) 
effects on drug abuse risk, but also raise concerns about possible detrimental 
effects on reward processing and emotional regulation. For example, preclinical 
animal work revealed that exposure to MPH during adolescence results in 
decreased reward sensitivity but also depressive-like symptoms that persist into 
adulthood (see review (Marco et al., 2011)). Given the increased prescription of 
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 sustained-release MPH in both adults and adolescents, our results emphasize the 
need for larger controlled longitudinal studies with never-medicated patients to 
investigate beneficial and detrimental long term effects of different MPH 
preparations. Furthermore, medication type and history should be reported and 
taken into account in medication withdrawal studies. 
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Abstract 
Abnormalities in value-based decision making during adolescence have often been 
attributed to non-linear, inverted-U shaped development of reward related 
processes. This hypothesis is strengthened by functional imaging work revealing 
an inverted-U shaped relationship between age and reward related activity in the 
striatum. However, behavioural studies have mostly reported linear rather than 
non-linear increases in reward related performance. In the present study, we 
investigated the mechanisms underlying the development of reward  and 
punishment related processing across four age groups using a reversal learning 
task previously shown to depend on striatal dopamine. We demonstrate both 
linear and non-linear age effects on distinct components of reversal learning. 
Specifically, results revealed a linear shift with age in terms of valence-dependent 
reversal learning, with children exhibiting better punishment than reward 
reversal learning, adults exhibiting better reward than punishment reversal 
learning and adolescents exhibiting an intermediate performance pattern. In 
addition, we also observed a non-linear, inverted-U shaped relationship between 
age and valence-independent reversal learning, which was due to aberrant ability 
of adolescents to update behaviour in response to negative performance feedback. 
These findings indicate that the (linear or nonlinear) nature of the relationship 
between age and reward learning depends on the type of reward learning under 
study.
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Introduction 
Adolescence, or the transition period between childhood and adulthood, is 
characterized by increases in risky and reckless behaviour (Arnett, 1999; Casey 
and Jones, 2010). Studies using self-report and observational measures often report 
a peak in risk-taking and reward-seeking during adolescence (Arnett, 1999; 
Steinberg, 2010). Recent advances in developmental neuroscience propose that 
this increase in risk-taking reflects differential developmental trajectories of 
distinct brain regions (Casey et al., 2008; Figner et al., 2009; Somerville et al., 
2010b). Specifically, evolutionary older subcortical regions, like the striatum, 
develop first, followed by development of prefrontal and parietal areas (Casey et 
al., 2008; Shaw et al., 2008). The imbalance between these early maturing 
subcortical regions, critical for the processing of affectively salient information, 
relative to less mature prefrontal areas, involved in top-down control, could 
account for non-linear, inverted-U shaped changes in risk-taking during 
development (Nelson et al., 2005; Casey et al., 2008; Figner et al., 2009; Somerville 
et al., 2010a). In line with this, some neuroimaging studies have shown that 
adolescents display exaggerated reward related responses in the striatum 
compared with children and adults (Galvan et al., 2006; Cohen et al., 2010; Geier et 
al., 2010; Somerville et al., 2010b; Van Leijenhorst et al., 2010a). 
Ernst et al. (2005) have found that adolescents show not only stronger responses to 
rewards in the striatum, but also weaker responses to reward omissions in the 
amygdala than adults. Accordingly, they have suggested that increased risk-taking 
during adolescence might reflect an imbalance between the development of 
reward related mechanisms, such as the striatum, and that of punishment-related 
mechanisms, such as the amygdala (Ernst et al., 2005; Ernst and Fudge, 2009). 
However, this hypothesis is not consistent with studies showing exaggerated 
responses in the amygdala of adolescents to both positive and negative emotional 
faces (Guyer et al., 2008; Hare et al., 2008; Somerville et al., 2010b). Furthermore, 
some studies have reported that reward related striatal responses are attenuated, 
rather than exaggerated in adolescent compared with adults (Bjork et al., 2004; 
Bjork et al., 2010; Geier et al., 2010). Thus, there is discrepancy in the literature 
regarding the nature of the neural response underlying the non-linear, inverted-U 
shaped changes in self-reported risk- and reward related processing during 
development.
In fact, there is also discrepancy regarding the degree to which self-reported 
non-linear changes in risk- and reward related processing are accompanied by 
parallel non-linear changes in terms of performance on well-controlled laboratory 
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tasks. On the one hand, consistent with  self-report data and the suggested 
imbalance between reward  and punishment related mechanisms (Ernst and 
Fudge, 2009), various studies have reported non-linear, inverted-U shaped changes 
in performance on reward related tasks. For example, Cauffman et al. (2010) have 
used an Iowa gambling-like task to show an inverted-U shaped relationship 
between age and learning rates for advantageous decks (albeit not for disadvanta-
geous decks).  Furthermore, adolescents have been shown to exhibit reduced 
capacity to inhibit GO responses to happy faces in a GO-NOGO paradigm, compared 
with both children and adults (Somerville et al., 2010b). By contrast, other studies 
have revealed linear changes, for example, when choosing between high- and 
low-risk gambles or during feedback-based learning, so that performance was 
better in adults than in adolescents (Crone and van der Molen, 2004; Galvan et al., 
2006; Crone et al., 2008; van Duijvenvoorde et al., 2008; van den Bos et al., 2009; 
Cauffman et al., 2010; Van Leijenhorst et al., 2010b; Koolschijn et al., 2011). The 
lack of consistency in the functional neuroimaging data is not surprising given 
this discrepancy in the behavioural data. Indeed any analysis of functional 
neuroimaging data is only as good as the behavioural assay used to probe the 
neural mechanisms. The various tasks employed in these studies differed in terms 
of the particular demands of the task to measure behaviour. Accordingly, the 
differential performance patterns observed in these studies might reflect 
differential developmental trajectories of distinct psychological mechanisms of 
reward related processing. 
Here we aimed to resolve the discrepancy in the behavioural data by employing a 
paradigm that enabled the separate assessment of distinct components of reward 
related processing. We aimed to compare age effects on reward and punishment 
learning, given recent models suggesting that risk-seeking might reflect an 
imbalance in the development of reward and punishment related mechanisms 
(Ernst and Fudge, 2009). To this end we employed a well-assessed paradigm 
measuring reversal learning based on unexpected reward and reversal learning 
based on unexpected punishment. 
There are three distinct advantages of this paradigm. First, the neurobiological 
mechanisms underlying task-performance are well-characterized and known to 
involve striatum during reward reversal and amygdala during punishment-rever-
sal (Robinson et al., 2010a). In addition, task performance has been shown to 
implicate striatal dopamine as evidenced by studies employing neurochemical 
positron emission tomography (PET) (Cools et al., 2009) and dopaminergic 
manipulations (Cools et al., 2006; Cools et al., 2009; Robinson et al., 2010b). This 
enabled us to relate known neurobiological and dopaminergic changes during 
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development (Teicher et al., 1995; Shaw et al., 2008; Doremus-Fitzwater et al., 2010; 
Kuhn et al., 2010; Wahlstrom et al., 2010) with age-related effects on the task. 
Second, reward and punishment learning are well-matched in terms of 
requirements for behavioural adjustment. Thus unlike prior studies, in which the 
expression of adequate punishment-learning depended more readily on 
behavioural shifting than did that of reward learning, our paradigm required 
behavioural shifting in both conditions to the same degree. In fact our paradigm 
enabled the separate assessment of valence-dependent learning (in terms of the 
difference between the reward and punishment conditions), and of behavioural 
shifting (in terms of average performance across both conditions).Third, unlike 
most prior studies, the type of valence-dependent learning required for our task 
depends on Pavlovian rather than on instrumental learning mechanisms, such 
that adequate reversal requires the updating of stimulus-outcome rather than of 
response-outcome associations. This is particularly pertinent given recent 
suggestions that many forms of reward related maladaptive behaviours, including 
enhanced risk-taking, might reflect abnormal Pavlovian control (Dayan et al., 
2006; Flagel et al., 2008). Thus, we reasoned that a Pavlovian task might be more 
sensitive to detecting developmental changes in reward and punishment related 
learning than an instrumental task. Specifically, in accordance with current 
developmental theories (Ernst and Fudge, 2009), we hypothesize  an inverted 
U-shaped relationship between age and valence-dependent learning, due to 
aberrant reward relative to punishment learning during adolescence compared 
with children and adults. 
Methods 
Participants
Sixty-one participants (22 male) between 10 and 25 years old were recruited from 
an elementary school, a high school, and Leiden University, in (the surroundings 
of) Leiden, the Netherlands. Participants were divided into 4 different age groups: 
Age group 1 with 15 participants of 10 or 11 years old (elementary school 7th grade), 
age group 2 with 15 participants of 13 or 14 years old (high school 2nd grade), age 
group 3 with 15 participants of 16 or 17 years old (high school 5th grade) and age 
group 4 with 16 participants between 20 and 25 years old (Leiden University). 
Participants had no (history of) psychiatric disorders or learning problems and did 
not use medication regularly. Written informed consent was given by the caretaker 
when the participant was under the age of 18, otherwise the participants gave 
informed consent themselves. Elementary school children were compensated 
with a bowling day, high school children and students were compensated with a 
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small amount of money (3 and 6 euro’s respectively). Non-verbal intelligence 
quotient (IQ) was measured with the Standard Progressive Matrices (Bauma et al., 
1998; Raven et al., 1998). Also, participants were asked about the highest education 
level of both parents. Education level was scored as follows: 1 = primary education, 
2 = secondary education/high school, 3 = middle-level applied education, 4 = higher 
professional education/bachelor and 5 = scientific education/master. 
Task design
The task used in the present study enabled us to assess the ability to update reward 
and punishmentpredictions for pre-selected stimuli based on unexpected reward 
or unexpected punishment (Cools et al., 2006; Cools et al., 2008a; Cools et al., 2009; 
Robinson et al., 2010b) (Figure 1). Throughout the experiment, participants were 
presented with two vertically adjacent stimuli, a face and a scene. One of these 
stimuli was associated with a reward, while the other was associated with a 
punishment. On each trial, one of the two stimuli was highlighted with a black 
border. The task of the participants was to learn, based on experience, to predict 
whether the highlighted stimulus would be followed by a reward or a punishment. 
Participants indicated their prediction with a button press using the right and left 
hand for reward and punishment respectively (the outcome-response mappings 
were balanced across participants, see Table 1). A reward consisted of a green 
happy smiley, a “+100 euro” sign and a high-frequency jingle tone. Punishment 
consisted of a red sad smiley, a “-100 euro” sign and a low-frequency tone. After the 
prediction, the actual outcome was presented. The outcomes were directly coupled 
with the stimulus (100% deterministic) and did not depend on the participants’ 
response. Accordingly the outcome did not serve as direct performance feedback, 
or reinforcement. Instead, whether their response was correct or wrong had to be 
inferred from a comparison of the actual outcome with the predicted outcome. 
The outcomes administered in this task were abstract and did not correspond to 
actual monetary payoff.  Nevertheless, the assumption that the positive and 
negative outcomes were perceived differentially has been confirmed by the 
empirically observed valence-dependent effects (see results and (Cools et al., 2006; 
Cools et al., 2009; Robinson et al., 2010a))
The stimulus-outcome contingencies reversed multiple times, but only after 
attainment of a variable learning criterion which consisted of between 4, 5 or 6 
consecutive correct predictions, to prevent anticipation of the reversal. This 
learning criterion was selected randomly at the beginning of each reversal stage. 
Reversals were signalled to the subject by either an unexpected punishment 
(presented after a stimulus was highlighted that was previously followed by 
reward) or an unexpected reward (presented after a stimulus was highlighted that 
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was previously followed by punishment). Note that an unexpected outcome could 
represent two types of prediction errors: (i) a Pavlovian prediction error, which 
was positive when the outcome associated with the highlighted stimulus was better 
Figure 1   Task design.
a) Example of a punishment trial. Two stimuli, a face (F) and a scene (S), were presented 
simultaneously. One of the two stimuli was highlighted with a black border and the task was 
to predict, with a button press, whether this stimulus was followed by a reward (R) or a 
punishment (P), after which the actual outcome was presented (100% deterministic). b) 
Example of a trial sequence for the unexpected reward condition. (c) Example of a trial 
sequence for the unexpected punishment condition. The participant learned to predict 
rewards (rw) and punishments (pn) for the scene and the face stimuli. The stimulus-outcome 
associations reversed between 4 and 6 consecutive correct predictions, signaled by either 
unexpected reward or unexpected punishment. Performance was measured on reversal 
trials immediately after the unexpected outcomes. Abbreviations: rw = reward; pn = 
punishment; ns-r = non-reversal reward trial; ns-p = non-reversal punishment trial; sw-r = 
reversal trial after an unexpected reward; sw-p = reversal trial after an unexpected 
punishment.
+
Blank:
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than expected (i.e. unexpected reward) and negative when the outcome associated 
with the highlighted stimulus was worse than expected (i.e. unexpected punishment), 
and (ii) an instrumental prediction error, which in this case was always negative, 
as it represented the fact that the outcome of the response  was worse than expected 
(i.e. incorrect prediction). Performance was measured in terms of the proportion of 
correctly updated predictions on reversal trials after unexpected punishment 
(punishment reversal) and after unexpected reward (reward reversal) (See Data 
Analysis). 
The face and scene were presented on a computer screen (top/bottom location 
randomized) until a (self-paced) response was made, which was followed by a 1000 
ms delay and a 500 ms outcome. After the outcome, the screen was cleared for 500 
ms, and the next pair of stimuli was presented. Each participant performed four 
experimental blocks: two reward blocks, in which reversals were signalled by 
unexpected rewards, and two punishment blocks, in which reversals were 
signalled by unexpected punishment. Participants were not made aware of this 
difference. The order of the conditions was approximately counterbalanced 
between participants (Table 1). Each block consisted of 120 trials (~6.6 minutes), so 
that participants performed 480 trials in total (~30 minutes). 
Each block started with an initial acquisition stage and proceeded with a variable 
number of reversal stages, depending on the participant’s performance. If 
participants made an incorrect response, the same trial was highlighted again on 
the next trial. The stimulus that was highlighted on the first trial of a reversal 
stage (i.e. the trial that was followed by an unexpected outcome signalling a 
reversal) was always highlighted again on the next trial, such that the participant 
was always required to switch responding on the reversal trials. 
Two practice blocks (1 for each condition) were administered prior to the experiment 
and consisted of one initial acquisition stage and one reversal stage (the task 
proceeded to the reversal stage after 20 correct trials during acquisition). The 
practice block terminated after the participant reached 20 correct trials in the 
reversal stage or if the maximum of 80 trials was completed. All but one subject 
reached learning criterion in both stages of both practice blocks, indicating that 
they understood the task. Only one subject from age-group 3 failed to reach 
criterion in the acquisition stage of one of the practice blocks, but did understand 
the task as revealed by adequate performance on the second practice block and by 
the total number of completed reversal stages in the experimental blocks (20) (See 
Table 2 for the average number of reversals across the groups). 
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Data analysis
Adequate reversal learning on this task depended on two separate forms of learning. 
First, it required participants to learn Pavlovian associations between stimuli and 
their rewarding or punishing outcomes. An unexpected reward constituted a 
positive Pavlovian prediction error, because it indicated that the stimulus was better 
than expected. Conversely, an unexpected punishment constituted a negative 
Pavlovian prediction error, because it indicated that the stimulus was worse than 
expected. Second, the task also required participants to learn from instrumental 
prediction errors. In instrumental terms, an unexpected reward constituted a 
negative rather than a positive prediction error, because the actual outcome of the 
response (unexpected reward) did not match the predicted outcome (punishment). 
Similarly, an unexpected punishment also constituted a negative instrumental 
prediction error. Accordingly, the ability to learn from instrumental prediction 
errors could be quantified in terms of the valence- independent reversal score, and 
the ability to learn from Pavlovian prediction errors could be quantified in terms of 
the valence-dependent, reward signed reversal score. This enabled us to assess both 
valence-dependent (reward signed) and valence-independent (unsigned) reversal 
learning. Valence-dependent, reward signed reversal scores were calculated by 
subtracting the proportion of correct responses after unexpected punishment from 
the proportion of correct responses after unexpected reward. Conversely, valence-in-
dependent reversal scores were calculated by averaging the proportion of correct 
responses on reward and punishment based reversals. In addition, we also measured 
performance on the non-reversal trials, which were all trials that did not require 
stimulus-outcome updating (i.e. all trials except reversal trials).  
All trials in the acquisition stage (before the first reversal) were excluded from 
analysis. In total, there were six different trial-types: three for the unexpected 
reward condition and three for the unexpected punishment condition. These three 
trial-types per condition were (i) reversal (i.e. trials that followed an unexpected 
outcome), (ii) non-reversal reward (i.e. trials that required reward prediction, but no 
stimulus-outcome updating) and (iii) non-reversal punishment (i.e. trials that 
required punishment-prediction, but no stimulus-outcome updating). Proportions 
of correct responses were arcsine transformed (2 × arcsine(√x)) as is appropriate 
when the variance is proportional to the mean (Howell, 1997). Transformed 
proportions of correct responses and total numbers of reversals were analyzed using 
repeated measures ANOVAs (SPSS 16.0 for Windows, 2007) with the within-subject 
factor valence (2 levels: unexpected reward and unexpected punishment) and 
trial-type (3 levels: reversal, non-reversal reward and non-reversal punishment), and 
with the between-subject factor group (4 age groups). Significant valence-dependent 
and valence-independent effects (as revealed by significant valence × trial-type × 
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group and trial-type × group interactions) were further investigated with one-way 
ANOVAs to assess whether these measures changed linearly with age (as revealed by 
a linear trend), or showed a peak over age-groups (as revealed by a quadratic trend). 
Significant trends revealed by these analyses were assessed further with Pearson 
correlational analyses between age and reversal learning scores. 
IQ (as measured with the Standard Progressive Matrices (Bauma et al., 1998; Raven 
et al., 1998) increased linearly with age-group (F
(3, 54)
 = 8.61, p = .005). Thus, we 
included IQ as a covariate in the repeated measures ANOVA as well as in the 
(partial) correlation analyses. To further investigate any effects of IQ, participants 
were divided in 4 groups based on their IQ scores using a quartile split; IQ-group 1 
with 12 participants with IQ scores between 97 and 109, IQ-group 2 with 16 
participants with IQ scores between 112 and 119, IQ-group 3 with 11 participants 
with IQ scores between 121 and 123 and IQ-group 4 with 19 participants with IQ 
scores between 124 and 136. The frequency distribution of the IQ scores did not 
allow us to form 4 bins containing exactly equal numbers of participants. For 
example there were 6 participants (10.3 % of all participants) with the median (121) 
IQ score, cutting across the 50% boundary.  One-way ANOVA with IQ-group as a 
between-subject factor was used to assess linear and quadratic effects of IQ.
Supplementary analyses were conducted to investigate whether the effects on the 
reversal trials, which all required response alternation, could reflect effects on the 
adoption of a win-stay, lose-shift strategy. In particular, this supplementary 
analysis was aimed at excluding the possibility that the observed age-effect on 
valence-dependent reversal reflected age-induced overcoming of an, in this case, 
maladaptive win-stay, lose-shift strategy. To this end, we calculated the proportion 
of correct predictions on non-reversal reward trials and non-reversal punishment 
trials after a correctly predicted reward outcome (win-stay and win-shift, 
respectively), and the proportion of correct predictions on non-reversal reward 
trials and non-reversal punishment trials after a correctly predicted punishment 
outcome (lose-shift and lose-stay respectively), averaged over the two blocks. 
Age-related strategy effects on trials following reward and punishment were 
tested separately with repeated measures ANOVA with the factors strategy (2 levels: 
stay, shift) and current outcome (2 levels: reward, punishment) as within-subjects 
factors and group as the between-subjects factor. 
Greenhouse-Geisser corrections were applied when the sphericity assumption was 
violated. Levene’s test was used to assess homogeneity of variance and Games-Howell 
correction was applied for post hoc testing when homogeneity of variances was 
violated. 
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Results
Demographics
Three participants were excluded based on poor performance: Two participants 
(one from age-group 1 and one from age-group 2) did not reach learning criterion 
in the acquisition stage in at least one of the two conditions, and one participant 
from age-group 2 performed 2 of the 4 experimental blocks at chance level (50%). 
After exclusion of these 3 participants there were 13 participants in age-group 1 
(6 male), 14 participants in age-group 2 (6 male), 15 participants in age-group 3 
(5 male) and 16 participants in age-group 4 (5 male). Demographics of the included 
participants are listed in Table 1. Education of the parents was not recorded in the 
youngest age-group. In the other three age-groups, education level of the parents 
did not differ between the groups (F
(2) 
= 1.52). There was a significant effect of group 
on IQ (F
(3,54) 
= 3.96, p = .04). IQ measures increased linearly with age-group (F
(3,54)
 = 
8.61, p = .005), although post hoc comparisons revealed a significant difference 
only between the youngest and oldest group (T
(27)
 = 2.840, p  = .03). In separate 
analyses we assessed whether there were any effects of gender, outcome-response 
mapping (i.e. whether reward and punishment was mapped to the left or right 
hand; counterbalanced across participants), or order of valence block (counter-
Figure 2   Overall accuracy (proportion of correct trials; y-axis) for the four different 
age-groups (x-axis).
Overall accuracy was lower for the youngest (11-12 yrs) age-group compared with the three 
older age-groups. Error-bars represent the standard error of the mean. **  = significant difference 
at p<.005.
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balanced across participants). Repeated measures ANOVA with the factors valence 
(2 levels) and trial-type (3 levels) as within-subjects factors and mapping, order or 
gender as between-subjects factors did not reveal any effects of these latter factors. 
In addition, no effects of gender, mapping or order were found with repeated 
measures ANOVA on the reversal trials only with the factors valence (2 levels) as a 
within-subjects factor and mapping, order or gender as between-subjects factors. 
  
Reversal learning
The average proportions of correct predictions across all trials for the four 
age-groups are shown in Figure 2. The number of trials per age- group for each of 
the six trial-types is shown in Table 2. Accuracy per age-group for each of the six 
trial-types is shown in Table 3. 
Overall performance irrespective of reversal and valence 
Participants performed increasingly well with age, with overall performance 
reaching asymptote at adolescence. Repeated measures ANOVA with valence (2 
levels) and trial-type (3 levels) as between-subjects factor, group as within-subjects 
factor, and IQ as a covariate revealed a main effect of group on accuracy across all 
trials (F
(3)
= 16.6, p<.001). One-way ANOVA of accuracy scores averaged across 
trial-types revealed a significant linear trend (F
(3,54)
 = 17.83, p <.001) as well as a 
significant quadratic trend (F
(3,54)
 = 6.254, p = .015). Post hoc comparisons revealed 
a significant increase in overall accuracy between age groups 1 and 2 (T
(25)
 = 3.234, 
p = .005), a marginal increase in overall accuracy between groups 2 and 3 (T
(27)
 = 
2.84, p = .056), while accuracy was similar in age-groups 3 and 4 (T
(29)
 = - 0.16). 
Overall accuracy increased until maximum accuracy (0.89 ±0.1) in age-group 3. 
Correlation analysis revealed a relationship between overall accuracy and IQ (r = 
.374, p
two-tailed
 = .004), but partial correlations between age and overall accuracy, 
when controlled for IQ, were still significant (r = .589, p
two-tailed
 <.001). 
The effect of age-group on overall accuracy was paralleled by an effect of age-group 
on the total number of completed reversals (F 
(3,54)
 = 7.609, p < .001). Importantly, 
this overall effect was not accompanied by a valence-dependent effect on the total 
number of completed reversals: Repeated measures ANOVA on the total number of 
completed reversals with the within-subjects factor valence (2 levels), the be-
tween-subjects factor group (4 levels) and IQ as a covariate did not reveal any 
differences between the total number or reward reversal and punishment 
reversals, or an effect of age on this difference (main effect of valence: F
(1,53)
 = .204, 
interaction effect valence × group: F
(3,53)
 = .63). This enabled us to assess age effects 
on valence-dependent accuracy scores in a manner that was not confounded by 
differences in the total number of trials included in the analyses. 
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Valence-dependent effects of age on reversal learning
Inspection of the valence-dependent reversal scores (Figure 3a and 3b) revealed a 
linear relationship with age, so that participants performed increasingly well 
with age on reward reversals relative to punishment reversals. This finding was 
confirmed by repeated measures ANOVA of the mean proportions of correct 
responses, with IQ as covariate, which revealed a significant 3-way interaction 
between valence, trial-type and group (F
(6,106)
 = 2.554, p = .040). Breakdown of this 
3-way interaction by trial-type confirmed that the valence-dependent effect was 
significant for the reversal trials (valence × group: F
 (3,53)
 = 3.176, p = .031) and not for 
the non-reversal trials (valence × group: F
(3,53)
= 0.44; valence × group × trial-type (2): 
F
(3,53)
 = 2.339). Further analysis with one-way ANOVA of the valence-dependent 
reversal scores (proportion correct reward reversals minus proportion correct 
punishment reversals) revealed a significant linear trend (F
(3,54)
 = 3.71, p = .005), 
such that the balance between reward and punishment reversal learning shifted 
from better punishment reversal learning in the youngest age group to better 
reward reversal learning in the oldest age group. Post-hoc comparisons revealed a 
significant difference between age group 1 and age group 4 (T
(27)
 = 2.92, p = .022). 
There was no support for a peak in valence-dependent reversal learning as there 
was no significant quadratic trend (F
(3,53)
 = 1.42). 
The observed linear age-related changes in valence-dependent reversal learning 
cannot be explained by differences in IQ between the groups. First, partial 
correlation analyses revealed a significant association between age and valence- 
dependent reversal scores after controlling for IQ (r = .359, p
two-tailed
 = .006). Second, 
repeated measures ANOVA of the reversal scores with the within-subjects factor 
valence and the between-subjects factor IQ-group did not reveal any significant 
effects of IQ-group (valence*IQ-group: F
(1,54)
 = 2.46), and one-way ANOVA of the 
 valence-dependent reversal scores also did not reveal any linear or quadratic trend 
effects of IQ (linear: F
(3,54)
 = 2.25; quadratic: F
(3,54)
 = 0.16). Third, correlation analysis 
did not reveal any significant correlation between IQ and valence-dependent 
reversal scores (r = .15). 
Differential developmental trajectories of reward and punishment 
reversal 
Inspection of the reversal scores for each valence condition separately revealed 
that the linear shift with age towards better reward relative to punishment reversal 
was due to differential developmental trajectories of reward and punishment 
reversal learning (Figure 4). 
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On the one hand, follow-up repeated measures ANOVAs (with IQ as a covariate) of 
data from each valence condition separately revealed significant 2-way interactions 
between age-group and trial-type (3) for both the reward (F
(6,106)
 = 5.23, p = .001) and 
the punishment condition (F
(6,106)
 = 3.4, p = .013). These 2-way interactions reflected 
differences between age-effects on the reversal trials and age-effects on the 
non-reversal trials. Specifically, as discussed below (see next section), there was an 
Figure 3   Age-related effects on valence-dependent and valance-independent reversal 
learning.
a) Valence-dependent effects of age on reversal learning. Relative reversal learning scores 
(y-axis) for the four different age-groups (x-axis) are calculated as the proportion correct 
reward reversal trials minus the proportion correct punishment reversal trials. b) Significant 
linear trend between relative reversal scores and age (F
(3,54) 
= 3.71, p = .005). c)  Valence-inde-
pendent effect of age on reversal and non-reversal performance. Accuracy scores on reversal 
and non-reversal trials (y-axis) for the four different age-groups (x-axis) are calculated as the 
average proportion of correct predictions on both reward and punishment trials. d) 
Significant quadratic trend between relative reversal scores and age (F
(3,54) 
= 19.45, p <.001). 
Error-bars represent the standard error of the mean. Symbols represent individual data 
points. ** = significant difference at p<.005, * = significant difference at p<.05.
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inverted U-shaped relationship between age and reversal scores (but not 
non-reversal scores), for both the reward and punishment conditions: Adolescents 
performed better than adults on these reversal (relative to non-reversal) trials, 
irrespective of valence. 
However, in addition to this valence-independent effect, there was also a valence- 
dependent effect: The degree to which adolescents performed better than adults 
on reversal (relative to non-reversal) trials differed as a function of valence (as 
Figure 4   Age-related effects for the reward and punishment conditions separately.
a) Accuracy on the reversal, non-reversal reward and non-reversal punishment trials in 
the reward condition (y-axis) for the four different age-groups (x-axis). b) Linear and 
quadratic trend between accuracy on reward reversal trials and age (linear: F
(3,54) 
= 16.05, 
p < .001, quadratic: F
(3,54) 
= 9.73, p < .003). c) Accuracy on the reversal, non-reversal reward 
and non-reversal punishment trials in the punishment condition (y-axis) for the four 
different age-groups (x-axis). d) Quadratic trend between accuracy on punishment-reversal 
trials and age (F
(3,54)
 = 18.4, p < .001). Error-bars represent the standard error of the mean. 
Symbols represent individual data points. ** = significant difference at p<.005, * = significant 
difference at p<.05.
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confirmed by the 3-way interaction, see previous section). The nature of this 
difference was revealed by one-way ANOVAs of reward reversal scores and 
punishment reversal scores separately. The ANOVA of reward reversal scores 
showed both a significant linear (F
(3,54)
 = 16.05, p <.001) and a significant quadratic 
trend (F
(3,54)
 = 9.73, p = 003), while ANOVA of punishment-reversal scores revealed 
only a significant quadratic trend (quadratic: F
(3,54)
 = 18.36, p <.001, linear:  F
(3,54)
 = 
0.61). Post hoc tests showed that reward reversal increased near to maximum 
performance between age-group1 and 2 (T
(25)
 = 4.79, p <.001), while remaining 
stable between age-groups 2 and 3 (groups 2-3: T
(27)
 = 0.17; groups 1-3: T
(26)
 = 4.35, p 
< .001) and between age-groups 3 and 4 (groups 3-4: T
(29)
 = 0.03; groups 1-4: T
(27)
 = 
4.57, p <.001). Punishment reversal, on the other hand, showed a peak in 
performance across age-groups. There was a significant increase in performance 
between age-groups 1 and 2 (T
(25)
 = 3.48 , p = 0.005), no difference between 
age-groups 2 and 3 (groups 2-3: T
(27)
 = .31; groups 1-3: T
(26)
 = 3.28, p = .011), and a 
performance decrease between age-groups 3 and 4 (groups 3-4: T
(29)
 =-2.53 , p = .086; 
groups 2-4: T
(28)
 = -2.76, p = .045; groups 1-4: T
(27)
 = .88). 
Valence-independent effects of age on reversal learning
Inspection of the valence-independent reversal scores (Figure 3c and 3d) revealed 
a nonlinear, inverted-U shaped relationship with age, so that participants 
performed best during adolescence, but poorly during childhood as well as early 
adulthood. This finding was confirmed by the omnibus ANOVA, which revealed a 
significant 2-way interaction between group and trial-type (F
(6,106)
 = 5.456, p = .001), 
irrespective of valence, as well as by significant group × trial type interactions for 
each valence condition separately (see above). Breakdown of this omnibus 2-way 
interaction by trial-type revealed significant simple main effects of age-group 
both on the reversal trials (irrespective of valence) (F
(3,53)
 = 8.15, p < .001) and on the 
non-reversal trials (F
(3,53)
 = 11.325, P < .001). 
The 2-way group × trial-type interaction was due to the finding that the relationship 
between age and reversal scores was inverted-U shaped, while that between age and 
non-reversal scores was linear (Figure 3c). This was revealed by one-way ANOVAs on 
the reversal and the non-reversal scores (independent of valence), with age-group 
as a between-subjects factor. The ANOVA of reversal scores showed both linear, and 
a non-linear effects of age-group (linear: F
(3,54)
 = 7.91, p = .007, quadratic: F
(3,54)
 = 
19.45, p <.001), while the ANOVA of both non-reversal trial-types revealed only 
linear, but no non-linear effects of age (linear: F
(3,54)
 = 40.84, p <.001, quadratic: F
(3,54)
 
= 3.93). Post hoc tests revealed that valence-independent reversal scores peaked 
during adolescence. Reversal scores were higher in age-groups 2 and 3 compared 
with age-groups 1 (groups 1-2: T
(25)
 = -4.863, p = .018, groups 1-3: T
(26)
 = -4.398, p 
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=.009), and decreased again in adults (groups 1-4: T
(27)
 = -3.131). By contrast, accuracy 
on non-reversal trials did not show such a decrease. Non-reversal scores increased 
until age-group 3 (groups 1-2:  T
(25)
 = 2.83, p= .049, groups 2-3:  T
(27)
 = -3.03, p = .029) 
and did not differ between age-groups 3 and 4 (groups 3-4: T
(29)
 = -0.26, groups 1-4: 
T
(27) 
= -5.51, p <.001). 
Supplementary analyses
Both the reward and punishment reversal trials required response alternation. 
Accordingly, it could be argued that the effects of age reflect effects on the tendency 
to alternate responses after punishment relative to reward, i.e., the application of 
a win-stay/lose-shift strategy. To asses this possibility, we analyzed the application 
of such a strategy on the non-reversal trials. This analysis indicated that age did 
not alter the degree to which participants alternated responding after punishment 
relative to reward. Thus there were no main effects of win-stay/lose-shift strategy 
or strategy * group interactions on the trials after reward (main effects of strategy: 
F
(3,54)
 = .06, strategy * group: F
(3,54)
 = .85) or on the trials after punishment (main 
effects of strategy: F
(3,54)
 = 2.24; strategy * group: F
(3,54)
 = .85). 
Summary
A non-linear, inverted-U shaped relationship was observed between age and va-
lence-independent reversal scores, so that participants performed better during 
adolescence than during both childhood as well as early adulthood. Thus, 
adolescents were more responsive to unexpected outcomes of their behaviour than 
were children or adults. However, this inverted-U shaped relationship was 
accompanied by linear shift with age in terms valence-dependent reversal scores, 
with adolescents performing at an intermediate level relative to children and 
adults. Specifically, the ability to reverse predictions based on unexpected reward 
relative to punishment improved linearly with age.
Discussion
The present study examined developmental differences in reward and punishment 
based reversal learning during adolescence in four different age groups between 
10 and 25 years old. A reversal learning task was employed to assess effects of 
unexpected reward and unexpected punishment on reversal learning, while 
requirements for behavioural adjustments were well-matched between the 
conditions. This enabled assessment of the valence-dependent effects on reversal 
learning, by comparing effects of unexpected reward with effects of unexpected 
punishment on the updating of stimulus-outcome predictions. Following current 
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theory (see introduction), we had predicted that adolescents would display aberrant 
reward relative to punishmentbased reversal learning compared with children 
and adults.
In contrast to this hypothesis, results revealed a linear shift from better punishment 
relative to reward based reversal learning during childhood to better reward 
relative to punishment-based reversal learning in young adulthood. Thus reward 
relative to punishment reversal score was not aberrant in adolescents, but rather 
intermediate relative to those of children and adults. This linear effect of age was 
remarkably robust and not mediated by non-specific factors such as IQ or other 
factors, such as the need for behavioural adjustment, which was matched between 
valence conditions. Moreover, it contrasted with the observation of a non-linear, 
inverted-U shaped relationship between age and valence-independent reversal 
learning. Thus the ability to shift responding following unexpected outcomes 
(irrespective of the valence of the outcome) was maximal in 13-17 year olds 
compared with 10-11 and 18-25 year olds. This age effect on valence-independent 
reversal learning could also not be accounted for by non-specific factors, such as 
motivation or arousal, because a similar inverted-U shaped pattern was not 
observed for the non-reversal trials, which improved linearly with age. Accordingly, 
this finding suggests that non-linear changes during adolescence might involve 
exaggerated tendency to shift responding based on negative performance feedback, 
instead of an imbalance between systems processing reward and punishment per 
se. Together, these data indicate the need to refine current models of overactive 
reward systems in adolescence. 
One way to refine these models is by recognizing the existence of multiple 
mechanisms underlying reward learning. In particular, distinctions have been 
made between Pavlovian and instrumental mechanisms of learning (Maia, 2009; 
Balleine and O’Doherty, 2010; Maia and Frank, 2011). Such ideas have been 
formalized in actor-critic-like architectures, where optimal action selection 
involves (i) the encoding and updating of Pavlovian predictions of future outcomes 
associated with specific stimuli or states in the environment (the critic) and (ii) the 
instrumental selection of actions that, given those stimuli or states, are associated 
with the highest reward outcomes (the actor) (Sutton and Barto, 1998; Maia, 2009; 
Balleine and O’Doherty, 2010). 
Adequate performance on the current paradigm depends on both learning 
mechanisms but their contributions are expressed in different manners. Critic-like 
Pavlovian learning depends on Pavlovian prediction errors, which are positive 
when the outcome associated with the highlighted stimulus is better than 
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expected (unexpected reward) and negative when the outcome associated with the 
highlighted stimulus is worse than expected (unexpected punishments). Actor-like 
instrumental learning, on the other hand, depends on instrumental prediction 
errors, which in the present task are negative for both unexpected outcomes given 
that the outcome associated with the response was worse than expected (i.e. an 
incorrect prediction). Accordingly, any valence-dependent reversal effect on this 
task must reflect modulation of critic-like Pavlovian learning mechanisms. By contrast, 
any valence-independent effect that extends across the reward and the punishment 
reversal conditions of this task might reflect modulation of actor-like instrumental 
learning mechanisms. Based on this framework, we hypothesize that the observed 
linear relationship between age and valence-dependent reversal learning reflects 
a linear developmental trajectory of Pavlovian learning mechanisms. Furthermore, 
based on the observation that adolescents exhibited aberrant valence-independent 
learning, we hypothesize that this linear developmental trajectory of Pavlovian 
learning might be accompanied by a non-linear, inverted-U shaped development 
trajectory of instrumental learning.
This hypothesis concurs with current evidence for distinct neuro-developmental 
trajectories of the different learning mechanisms involved in our task. Thus, it has 
been suggested that the critic implicates the limbic striatum, including the ventral 
striatum and its strong connections with the amygdala, whereas the actor 
implicates the dorsal striatum (Montague et al., 1996). This has been supported by 
several human imaging studies, showing prediction error signals during 
instrumental learning in both dorsal and ventral striatum and prediction error 
signals during Pavlovian learning only in the ventral striatum  (O’Doherty et al., 
2004; Tricomi et al., 2009; Valentin & O’Doherty, 2009).  More specifically, previous 
neuroimaging work with the present task has revealed neural responses in the 
ventral striatum for positive reward signed prediction errors, and in the amygdala 
for negative reward signed prediction errors while valence-independent responses 
were found in the dorsal striatum, dorsolateral prefrontal cortex and anterior 
cingulate cortex (Robinson et al., 2010a) . 
Critically, there is evidence that dopaminergic mechanisms in the dorsal and 
ventral striatum exhibit differential developmental trajectories. First, dopamine 
innervations of, and receptor density in, the dorsal striatum is maximal during 
adolescence, followed by back-pruning in late adolescence, while development 
trajectories of the ventral striatum (nucleus accumbens) develop more linearly and 
do not seem to show such declines after adolescence(Teicher et al., 1995; Doremus- 
Fitzwater et al., 2010; Kuhn et al., 2010; Wahlstrom et al., 2010). Furthermore, in the 
ventral striatum, D1 receptor density continues to increase until late adulthood, 
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while D2 receptor density remains stable between adolescence and adulthood 
(Teicher et al., 1995; Andersen & Teicher, 2000; Wahlstrom et al., 2010). This increase 
of D1 relative to D2 receptor density in the ventral striatum is particularly 
pertinent here, because valence-dependent reversal learning on our task has been 
shown to depend critically on striatal dopamine transmission: Subjects with low 
dopamine function exhibit better punishment- than reward reversal, while 
subjects with high dopamine function exhibit  better reward than  punishment 
reversal (Cools et al., 2006; Cools et al., 2009; Robinson et al., 2010b). Accumulating 
evidence from a combination of genetic neuroscience and computational 
modelling work indicates that these effects of dopamine on reward and punishment- 
learning are mediated by action at D1 and D2 receptors respectively (Frank et al., 
2007c; Frank and Hutchison, 2009). Thus the shift from better punishment-based 
reversal learning in children to better reward based reversal learning in adults 
might well reflect a combination of linear age-related increases in dopaminergic 
innervations of the striatum, and/or increases in the ratio of D1:D2 receptor 
density in the ventral striatum. 
Our hypothesis might account for previous neuroimaging findings showing 
age-related inverted-U shaped neural changes during instrumental learning  in 
the dorsal striatum (caudate nucleus), but not the ventral striatum (Cohen, et al., 
2010, Van Leijenhorst, et al., 2010a)  (but see (Galvan et al., 2006)). Interestingly, 
Cohen et al. (2010) reported that the location of prediction error-related neural 
responses shifted from the dorsal striatum in adolescents to the ventral striatum 
in adults, regions previously shown to reflect instrumental and Pavlovian 
prediction errors, respectively (O’Doherty et al., 2004). Taken together, the linear 
and non-linear patterns observed for valence-dependent and valence-independent 
reversal learning respectively fit well with the neurochemical developmental 
trajectories of dorsal striatum associated with instrumental learning mechanisms 
and of the ventral striatum associated with Pavlovian learning mechanisms. 
One important implementation of this study is that decision making problems 
and increased risk taking during adolescence do not necessarily reflect dispropor-
tionate sensitivity to rewards and/or a lack of behavioural control (Ernst and 
Fudge, 2009; Casey et al., 2010; Somerville et al., 2010b), but instead might reflect 
aberrant responsiveness to recent negative performance feedback. This study is 
one of the first to show enhanced feedback-based learning in adolescents, a finding 
that is perhaps not surprising, given the great number of high-impact transitions 
that adolescents undergo in this period. At the same time, it is also not difficult to 
imagine how aberrant responsiveness to recent negative performance feedback 
could lead to behaviour that is not optimal. In our noisy, stochastic environment, 
6Reward and punishment learning across adolescence
157
some feedback is misleading and should be ignored and adequate adaptation to 
this environment requires integration of more remote reinforcements, either in 
the future or in the past. Thus, behaviour is driven not only by recent, local 
reinforcement, but also by more remote reinforcements. In adolescents, this 
hypothesized aberrant focus on recent feedback at the expense of integration of 
more remote feedback might account for a broader range of decision making 
abnormalities in adolescence than an account that highlights reward oversensitivity, 
including paradoxical oversensitivity to immediate short-term feedback, e.g. 
from peers, at the expense of longer-term feedback from parents. Future work 
should investigate whether aberrant learning from immediately preceding 
negative feedback is indeed accompanied by reduced integration of more remote 
reinforcement either in the future or the past. These insights have considerable 
implications for current developmental models and might provide an interesting 
functional framework, within which to investigate developmental changes and 
impulsivity in adolescence or developmental disorders like attention deficit 
hyperactivity disorder (ADHD). Recent advances have already revealed interesting 
changes in ADHD patients compared with controls that are consistent with this 
framework. For example, ADHD is accompanied by reduced responses in the ventral 
striatum during reward predictive cues  (Scheres et al., 2007) and anatomical 
compression and expansion of the ventral and dorsal striatum respectively (Qiu et 
al., 2009; Sobel et al., 2010). Furthermore, insights relating decision making 
deficits during adolescence to dopamine functioning are pertinent given that 
various neuropsychiatric disorders that implicate dopamine, such as schizophrenia, 
have their onset in adolescence. 
Some limitations need to be noted. First, the present study infers developmental 
trends based on between-subjects differences and it cannot be excluded that 
differences between groups might relate to unknown differences between the 
individuals within the groups. One such difference might result from the fact that 
subjects were recruited from educational institutions which could have biased the 
selection for different age groups. Further, IQ-scores were relatively high and 
differed between the youngest and oldest group. Although the present study 
specifically showed that IQ was not related to measurements of interest, it might 
have induced confounds for comparison between age-groups. Also, the relatively 
high IQ-scores across all subjects might have limited the generalizability of the 
results to lower IQ groups. Longitudinal studies are needed to avoid these 
confounds and confirm that our findings reflect developmental changes.
In summary, the present results demonstrate distinct developmental trajectories 
of different forms of reward based learning. Accordingly they indicate that current 
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models of the development of reward systems need to be refined. We propose that 
this may be achieved by considering the hypothesis that increased risk-taking in 
adolescence might reflect an imbalance between the critic-like Pavlovian control 
system and the actor-like instrumental control system such that the instrumental 
system, associated with the dorsal striatum is overactive relative to the Pavlovian 
system, associated with the ventral striatum. This hypothesis accounts for the 
pattern of performance observed in the present study, but is also consistent with 
evidence about distinct neurodevelopmental trajectories of different dopamine- 
dependent learning mechanisms. Clearly our proposal is speculative and requires 
further study, in which functional neuroimaging and dopamine psychopharma-
cology should be combined with the use of behavioural assays that enable the 
separate assessment of Pavlovian and instrumental learning. 
6Reward and punishment learning across adolescence
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General discussion
This thesis investigated neuronal mechanisms underlying individual differences 
in dopaminergic drug effects on flexible updating of outcome predictions. An 
important aspect in this process is the computation of prediction errors, i.e. the 
difference between expected and actual outcomes, which are used to update the 
value of expected outcomes. Dopamine is known to signal these prediction errors 
(Montague et al., 1996; Schultz et al., 1997) and therefore plays an important role 
in this form of adaptive learning. Computational modelling work has suggested 
that these dopamine signals affect the learning from reward and punishment by 
modulating activity in, respectively, the direct and indirect pathway of the basal 
ganglia (Frank, 2005; Frank, 2011). This model suggests that phasic increases in 
striatal dopamine in response to unexpected rewards facilitate reward learning 
through D1-receptor stimulation in the direct ‘GO’ pathway, while phasic decreases 
in striatal dopamine in response to unexpected punishments facilitate punishment 
learning in the indirect ‘NOGO’ pathway of the basal ganglia. In addition, tonic 
dopamine levels are suggested to modulate the efficacy of these phasic signals 
such that high tonic dopamine levels shift the balance towards better reward 
relative to punishment learning, while low tonic dopamine levels shift the balance 
towards better punishment relative to reward learning. 
Although various behavioural studies have repeatedly established that dopaminergic 
medications shift the balance between reward and punishment learning (Frank et 
al., 2004; Cools et al., 2006; Frank et al., 2007a), evidence for a specific role of the 
striatum has been less clear. Previous neuroimaging work that investigated the 
effects of dopaminergic drugs on striatal BOLD during reward and/or punishment 
learning revealed inconsistent results. One reason for these inconsistencies may 
relate to the fact that these studies used various tasks that differentially measured 
the learning from reward and punishment and did not allow the direct comparison 
of reward and punishment learning. In this thesis I have investigated the effects of 
various dopaminergic drugs on reward and punishment learning by using the 
deterministic reversal learning task that allows the direct comparison of reward- 
and punishment learning, while controlling for instrumental action-selection 
processes. A second reason for inconsistent results may relate to findings suggesting 
that dopaminergic drug effects depend on baseline dopamine levels, with opposite 
effects in high and low dopamine subjects. In this thesis I have further investigated 
individual variability in dopaminergic drug response by stratifying drug effects 
with baseline working memory capacity, a measure that has been previously 
associated with individual dopamine synthesis capacity (Cools et al., 2008b; Landau 
et al., 2009). Finally, as most dopaminergic drugs are chemically non- specific, it 
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remains unclear whether effects were mediated through D2-receptor mechanisms 
or through other dopaminergic or e.g. noradrenergic mechanisms. In this thesis 
I have adopted a pharmacological co-administration design that allowed me to 
test whether dopaminergic drug effects were mediated through D2-receptor 
mechanisms.  
In chapter 2 and 4 I demonstrate that dopaminergic drug effects vary within 
individuals as a function of task demands, thus shifting the balance between 
reward and punishment learning and between individuals as a function of 
baseline working memory capacity, supporting the baseline-dependency of 
dopaminergic drug effects. In chapter 2, I established that dopamine shifts the 
balance between reward and punishment learning by modulating BOLD signal in 
the striatum during reward and punishment learning.  Furthermore, by combining 
neuroimaging with a pharmacological co-administration design it was possible to 
demonstrate that dopaminergic drug effects on striatal BOLD signal during 
reward and punishment learning were mediated by D2-receptor mechanisms 
(chapter 2 and 3). In chapter 3 and 5 I have explored other factors that may explain 
individual variability in drug response, including white matter integrity (chapter 
3) and the role of temporal dynamics in clinical long-term drug use in ADHD 
(chapter 5). Finally, in chapter 6 I investigated how reward and punishment 
learning changes across adolescence, a period in which the dopamine system and 
cortico-basal ganglia-thalamic-cortico circuits undergo major changes. In this 
chapter I will summarize and interpret the results from chapter 2-6 and discuss 
the implications and future perspectives. 
Effects of sulpiride and bromocriptine
Shifting the balance between reward and punishment learning through 
striatal dopamine
The computational model, described in the introduction of this thesis suggests 
that striatal dopamine shifts the balance between reward and punishment 
learning by shifting the balance between D1-receptor mediated GO pathway 
processing and D2-receptor mediated NOGO pathway processing (Frank, 2005; 
Frank, 2011).  In chapter 2 I have tested the hypothesis that dopamine shifts the 
balance between reward and punishment learning by modulating striatal BOLD 
during reward and punishment learning.  Previous work has demonstrated both 
valence-dependent and valence independent striatal BOLD signals during reward 
and punishment learning (Robinson et al., 2010a). Accordingly, one question was 
whether dopaminergic drugs would affect valence-dependent striatal BOLD signal 
(i.e. opposite drug effects on striatal BOLD during unexpected rewards and 
punishments) or valence-independent striatal BOLD signal (i.e. parallel drug 
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effects on striatal BOLD during reward and punishment). A second question was 
whether these drug effects were neurochemically specific, i.e. mediated by 
D2-receptor mechanisms. Finally, to further interpret the drug effects on striatal 
BOLD a third question was how the drug effects on striatal BOLD relate to drug 
effects on behavioural measures of reward and punishment learning. Twenty-two 
healthy subjects were tested in the fMRI scanner on the deterministic reversal learning 
task on four occasions; once after administration of placebo, once after administration 
of the D2-receptor agonist bromocriptine, once after the administration of the D2- 
receptor antagonist sulpiride and once after combined administration of bromo- 
criptine and sulpiride. In addition, drug effects were stratified by baseline working 
memory capacity to take into account individual differences in baseline dopamine 
levels. 
Results revealed opposite effects of bromocriptine and sulpiride on valence- 
independent striatal BOLD. Relative to bromocriptine and placebo, sulpiride 
induced parallel baseline-dependent changes on striatal BOLD signal during 
reward and punishment learning. These effects were dependent on baseline 
working memory capacity. While sulpiride increased striatal BOLD during 
unexpected rewards and punishments in high working memory subjects, it 
decreased striatal BOLD during unexpected rewards and punishments in low 
working memory subjects. These effects were found to be neurochemically specific, 
i.e. mediated by D2-receptor mechanisms. Thus, the effects of the D2 receptor 
antagonist sulpiride on striatal BOLD were abolished by co-administration with 
the D2 receptor agonist bromocriptine. Next I investigated how drug effects on 
valence-independent striatal BOLD related to behavioural measures on reward 
and punishment learning. If it reflected processing that is the same for both 
unexpected rewards and punishments (e.g.  a mismatch between expected and 
actual outcomes or saliency (Redgrave et al., 1999a; Zink et al., 2003a; Jensen et al., 
2007)), then parallel increases on striatal BOLD during both rewards and punishments 
would be accompanied by parallel increases on behavioural measures of reward 
and punishment learning. Alternatively, if it reflects co-representation of both 
positive and negative prediction errors in the striatum (Seymour et al., 2005; 
Menon et al., 2007; Seymour et al., 2007a; Delgado et al., 2009; Robinson et al., 
2010a), than parallel increases on striatal BOLD during both rewards and 
punishments will be accompanied by opposite effects on behavioural measures of 
reward and punishment learning. The results supported the latter interpretation. 
When assessing the direct correlation between sulpiride’s effects on striatal BOLD 
and sulpiride’s effect on behaviour, I found that sulpiride-induced increases on 
striatal BOLD during both rewards and punishments were associated with 
sulpiride- induced increases on reward versus punishment learning. These results 
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are particularly interesting in the light of recent insights, which suggest that 
striatal BOLD signal increases with increased dopamine release (Knutson and 
Gibbs, 2007; Schott et al., 2008; Düzel et al., 2009) and more specifically with 
post-synaptic D1-receptor signalling (Knutson and Gibbs, 2007). Accordingly, we 
argue that sulpiride-induced increases in striatal BOLD might reflect a shift 
towards the D1-receptor mediated GO pathway, improving reward versus 
punishment learning, while sulpiride-induced decreases in striatal BOLD might 
reflect a shift away from the D1-receptor mediated GO pathway, improving 
punishment relative to reward learning. Together these results support the 
computational model by Frank (2005) by demonstrating that sulpiride shifts the 
balance between reward and punishment learning, by modulating striatal BOLD 
during unexpected rewards and punishments (the baseline-dependency and 
direction of these effects are discussed below). 
The role of fronto-limbic-striatal interactions
In chapter 2 I demonstrated that dopaminergic modulation of striatal BOLD is 
associated with drug effects on reward and punishment-based reversal learning. 
However, reversal learning is well-known to depend not only on the striatum but 
also on the OFC and amygdala (Iversen and Mishkin, 1970; Jones and Mishkin, 
1972; Baxter et al., 2000; Stalnaker et al., 2007; Schoenbaum et al., 2009). Based on 
the known modulatory role of dopamine on glutamatergic projections between 
the OFC, striatum and amygdala it was hypothesized that dopaminergic drug 
effects on striatal BOLD signal depend on the anatomical connection strength of 
these ventral network projections. Accordingly, in chapter 3 I extended the results 
from chapter 2 with DTI measures with the purpose of investigating whether 
dopaminergic drug effects on striatal BOLD depended on white matter integrity in 
a wider fronto-limbic-striatal network. By using a fiber-based approach I was able 
to investigate the neuroanatomical specificity of the proposed white-matter 
dependent effects and test whether dopaminergic drug effect on striatal BOLD 
during reversal learning depend on the cognitive dorsal fronto-striatal circuit or 
on the motivational ventral fronto-limbic-striatal circuits. More specifically, I also 
tested whether drug effects depended on direct fronto-striatal or limbic striatal 
pathways or on an indirect pathway connecting the OFC with the amygdala. This 
latter pathway was interesting as experimental animal work demonstrated that 
an intact interaction between the OFC and amygdala is crucial for reversal learning 
tasks (Baxter et al., 2000; Stalnaker et al., 2007). Results indeed supported the 
latter. Larger bromocriptine- relative to sulpiride-induced increases on striatal 
BOLD signal were associated with higher FA values and lower MD values in the 
OFC-amygdala pathway and not with FA or MD values in any of the other pathways. 
FA and MD rely on several micro-structural properties, including the level of 
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myelineation, intact axonal membranes and fiber density (Beaulieu, 2002). 
Accordingly, these results suggest that dopaminergic drug effects on striatal BOLD 
are larger in subjects that have better communicational efficacy within the 
OFC-amygdala pathway. These results provide fundamental insights into the 
mechanisms of action of dopaminergic drug effects on reversal learning by 
confirming the role of a wider ventral fronto-limbic-striatal network in the 
deterministic reversal learning task and more specifically by highlighting the 
importance of indirect OFC-amygdala interactions in dopaminergic modulations 
of reversal-related striatal activities. 
These findings support current theories on the role of this indirect pathway in 
reversal learning. While originally the OFC has been suggested to regulate reversal 
learning by rapidly encoding new association and directly driving striatal output 
neurons (Thorpe et al., 1983), current theories highlight a more indirect role for 
the OFC in reversal learning. Instead of directly encoding new associations, it is 
suggested that the OFC indirectly contributes to prediction updating by providing 
information about expected outcomes which are then compared with actual 
outcomes in downstream areas such as the amygdala (Schoenbaum et al., 2009; 
Takahashi et al., 2011). Indeed, monkey work demonstrates that the interaction 
between OFC and amygdala is crucial for reversal learning performance in 
monkeys (Baxter et al., 2000; Stalnaker et al., 2007). 
By using a co-administration design, I was also able to demonstrate that these 
effects are mediated by D2-receptor stimulation. This neurochemical specificity is 
consistent with pharmacological animal work that has demonstrated differential 
roles for D1- and D2-receptor function in the interaction between OFC, amygdala 
and striatum. While D1-receptor stimulation was found to attenuate prefrontal 
inhibition of amygdala output neurons, D2-receptor stimulation was found 
to potentiate sensory-driven amygdala outputs to the striatum. Based on this 
experimental animal work, I would like to speculate that bromocriptine 
potentiated sensory-driven amygdala output excitability during reversal learning 
to a greater extent in subjects with high communicational efficacy within the 
OFC-amygdala pathway than in those with low communicational efficacy in this 
pathway. However, because DTI does not provide information about the direction 
in which information travels, we cannot definitively support this hypothesis with 
our data.  Nevertheless, the results from this thesis provide fundamental insight 
into the mechanisms of action of dopaminergic drugs by demonstrating that 
dopaminergic drug effects on striatal BOLD involve not only dopamine within the 
striatum but may also involve dopaminergic modulations of interactions within a 
wider ventral fronto-limbic-striatal circuit. Moreover, these findings may have 
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important clinical implications by suggesting that white matter integrity can 
help predict pharmacological treatments effects on brain function, ultimately 
contributing to individual tailoring of drug treatment strategies in psychiatry.
Effects of methylphenidate
Acute effects of methylphenidate in healthy adults
While bromocriptine and sulpiride stimulate and block the D2-receptor, respectively, 
methylphenidate blocks the dopamine transporter resulting in increased extra- 
cellular dopamine in the synaptic cleft. Methylphenidate (or Ritalin) is one of the 
most commonly prescribed psycho-stimulants for attention deficit hyperactivity 
disorder (ADHD), but is also gaining popularity in the healthy student population, 
because it is thought to enhance cognitive and academic performance. However, 
studies testing methylphenidate effects in healthy students have revealed 
inconsistent results (Smith and Farah, 2011), raising questions about its effects in 
the healthy population. As with D2-receptor agents, the effects of methylphenidate 
have also shown to depend on baseline performance (Mehta et al., 2000; Mehta et 
al., 2004a; Eagle et al., 2007; Finke et al., 2010). More specifically, it has been 
suggested that methylphenidate effects depend the level of dopamine synthesis 
and release (Volkow et al., 2002), such that DAT blockade leads to larger increases 
in extracellular dopamine in subjects with a high cell-activity and rate of dopamine 
release than in subjects with low cell-activity and rate of dopamine release (Hooks 
et al., 1992; Volkow et al., 2002). In chapter 4 I investigated the baseline-dependency 
of methylphenidate effects on reward and punishment learning in healthy adults. 
I tested nineteen healthy subjects after administration of placebo and methyl-
phenidate (Ritalin ©) on the deterministic reversal learning paradigm and 
stratified drug effect with baseline working memory capacity to take into account 
individual differences in baseline dopamine levels. Results revealed that the effect 
of methylphenidate paralleled those seen for the D2-receptor antagonist sulpiride. 
Thus, consistent with the cell-activity hypothesis, methylphenidate improved 
reward versus punishment learning in high working memory subjects, while it 
impaired reward versus punishment learning in low working memory subjects. 
At first sight, these findings might appear inconsistent with the inverted 
U-hypothesis (Arnsten, 2011) and recent work showing beneficial effects of MPH on 
in subjects who perform poorly at baseline (Eagle et al., 2007; Finke et al., 2010). 
However, it should be noted that our study did in fact also reveal improvement in 
performance in low span subjects, but only if performance is calculated in terms 
of punishment versus reward learning. Accordingly our results refine current 
suggestions on the cognitive enhancing effects of methylphenidate by demonstrating 
that methylphenidate can both enhance and impair functioning. More specifically, 
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our results show that the effects of methylphenidate varied within individuals as 
a function of task demands, with differential effects on reward and punishment 
learning. In addition, they show that effects of methylphenidate varied between 
individuals as a function of baseline working memory, with opposite effects in 
high- and low-working memory subjects. Taken together, cognitive enhancing 
effects of methylphenidate critically depend on the person who is taking it and the 
task that he or she is doing.  
Long term effects of methylphenidate in subjects with ADHD
While in chapter 2-4 I investigated acute effects of dopaminergic drugs in healthy 
subjects, subjects with ADHD use methylphenidate on a daily basis and for longer 
periods. In chapter 5 I investigated the effects of withdrawal of methylphenidate 
in adults with ADHD. The effects of such long-term methylphenidate use might 
differ from those of acute administration and therefore require different inter-
pretations. One theory proposes that methylphenidate exerts its therapeutic effects 
on executive inhibitory control by increasing prefrontal tonic dopamine levels and, on 
the longer term, normalizes abnormal reward processing by dampening down 
subcortical phasic dopamine signalling (Seeman and Madras, 1998; Robbins, 2002). 
Thus, while acute administration in healthy subjects may increase tonic dopamine 
levels, long-term use of methylphenidate might paradoxically decrease phasic 
signalling an ADHD subjects. This is further supported by  Volkow et al., (2012) 
who demonstrated an attenuation in striatal methylphenidate-induced dopamine 
release after one year of oral methylphenidate treatment in subjects with ADHD. 
In chapter 5 I explored this hypothesis by investigating withdrawal effects on 
reward and punishment learning in subjects with ADHD who had been using 
medication for at least 9 months. Subjects were tested both ON and OFF methylphe-
nidate and performance was compared with a group of age and IQ matched healthy 
controls. Based on animal work demonstrating that long-term dopaminergic drug 
effects depend on the within-day temporal dynamics of the drugs (Post, 1980; King 
et al., 1994; Samaha et al., 2008; Bédard et al., 2011), I also compared withdrawal 
effects in subjects using immediate release methylphenidate (Ritalin ®) and 
sustained release methylphenidate (Concerta ®) in a post-hoc analysis.  
Consistent with the proposed dampening of phasic dopamine signals, results 
revealed reduced reward versus punishment learning in subjects with ADHD  who 
were OFF medication relative to healthy control subjects, but only in those ADHD 
subjects who used sustained-release methylphenidate. A replacement with 
immediate release methylphenidate normalized reward learning to the level of 
healthy subjects. The differential withdrawal effects of sustained release and 
immediate release methylphenidate support the suggestion that the observed 
Chapter 7
170
reduction in reward processing in ADHD subjects may relate to long-term 
medication use. In addition, this post-hoc finding  also provide preliminary 
evidence for the hypothesis that differences in the pharmaco-dynamic properties 
of methylphenidate may result in different long-term drug effects. This hypothesis 
is further supported by insights from addiction research. Thus, it is suggested that 
repeated intermittent exposure to fast-acting drugs of abuse induces sensitization 
(Post, 1980; Jentsch and Taylor, 1999) and increases phasic dopamine release, while 
continuous treatment with dopaminergic drugs induces tolerance and leads to 
reduced phasic dopamine release (Post, 1980; Seeman and Madras, 1998; Robbins, 
2002). Most studies investigating effects of immediate and sustained release 
 methylphenidate have focused on the safety of these drugs with regard to the 
potential risk for substance abuse and concluded that the risk for abuse was lower 
in sustained than in immediate release methylphenidate (Kollins et al., 1998; 
Kollins, 2003; Spencer et al., 2006). However, it is currently unclear whether the 
hypothesized reductions in phasic dopamine release may also result in detrimental 
long-term drug effects. For example, preclinical animal work revealed that 
exposure of MPH during adolescence decreased reward sensitivity and induced 
depressive-like symptoms that persist into adulthood (Marco et al., 2011). It needs 
to be noted, though, that our design was not a priori optimized for addressing 
questions about medication subtypes and that results were revealed by a post-hoc 
analysis. Nevertheless, together with animal work suggesting possible negative 
long-term effects of sustained release methylphenidate, these results emphasize 
the need for larger and better controlled studies, including never-medicated 
subjects, to better investigate differential long-term effects of immediate and 
sustained release methylphenidate in ADHD. Such studies are especially relevant 
in the light of increased use of sustained release methylphenidate in the clinic and 
may further increase our understanding of its therapeutic effects.
The inverted U-shape hypothesis and D2-receptor functioning 
In chapter 2 and 4 I demonstrated that the effects of sulpiride and methylphenidate 
on reward versus punishment learning varied between subjects as a function of 
baseline working memory capacity. Supported by previous neurochemical PET 
work, demonstrating that working memory capacity is positively associated with 
dopamine synthesis capacity (Cools et al., 2008b; Landau et al., 2009), I propose 
that these effects reflect effects that depend on individual baseline dopamine 
levels. Such baseline dependent effects have often been interpreted in the light of 
an inverted U-shaped relationship between brain dopamine and cognitive 
function. In subjects with low baseline dopamine levels, drug-induced increases in 
dopamine improve cognitive function by optimizing dopamine functioning. 
Conversely, in subjects that already have optimized dopamine levels, drugs impair 
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cognitive function by overdosing dopamine functioning. The mechanisms underlying 
such an inverted-U shaped relationship has been described and empirically 
supported for prefrontal D1-receptor functioning (Arnsten, 1997; Zahrt et al., 
1997; Seamans and Yang, 2004) but has remained descriptive for striatal D2-receptor 
functioning. The results presented in the current thesis may therefore contribute 
to a better mechanistic understanding of baseline-dependency effects of D2-receptor 
agents.  
One way to better understand the baseline-dependent effects of D2-receptor agents 
is by taking into account the bi-modal effects of D2-receptor agents (see figure 4 of 
the introduction). While D1-receptors are only located on the post-synaptic side of 
the synapse, D2-receptors are located on both pre- and postsynaptic sides where 
they exert different effects. While stimulation of post-synaptic D2-receptors results 
in suppression of NOGO activity in the indirect pathway of the basal ganglia, 
stimulation of pre-synaptic D2-autoreceptors leads to inhibition of firing, synthesis 
and dopamine release (Stahl, 2013), and thus indirectly to less post-synaptic 
stimulation. Similarly, blockade of postsynaptic D2-receptors will result in less 
suppression of NOGO activity and blockade of pre-synaptic D2-autoreceptors will 
result in less inhibition of dopamine release, and thus indirectly to more 
post-synaptic stimulation. Accordingly, the effects of D2-receptor agents on reward 
and punishment learning will depend on the receptor site of action. Pre-synaptic 
autoreceptors are found  to be more sensitive than post-synaptic D2-receptors such 
that low doses of D2-receptor agents are more likely to act pre-synaptically (Skirboll 
et al., 1979; Brannan et al., 1993). Moreover, based on principles of homeostasis, it 
is likely that pre-synaptic autoreceptors are more sensitive in subjects that have 
high dopamine levels, compared with subjects that have insufficient dopamine 
levels. Based on this theorizing we propose that the baseline dependent effects of 
sulpiride in chapter 2 might reflect individual difference in pre- versus 
post-synaptic D2-receptor sensitivity, with high working memory subjects being 
particularly sensitive to pre-synaptic effects of sulpiride. In other words, 
D2-receptor blockade might have improved reward versus punishment learning in 
high working memory subjects because it blocked pre-synaptic down regulation of 
dopamine release, leading to a net increase of extracellular dopamine and thus 
postsynaptic D1-receptor stimulation.  
Although this seems to be a plausible explanation for the observed effects, it 
remains difficult to definitively interpret the direction of D2-receptor agents, 
because the determinants of pre- and post-synaptic actions are unknown. Unlike 
D2-receptors, the dopamine transporter (DAT) is only located on the pre-synaptic 
side, where it removes excessive dopamine from the synaptic cleft.  Thus, similar 
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to the blockade of D2-autoreceptors, DAT blockade with methylphenidate has a net 
effect of increasing extracellular dopamine and thereby post-synaptic receptor 
stimulation. Accordingly, comparing the results from chapter 2 with those seen in 
chapter 4 may provide support for the proposed pre-synaptic effects of sulpiride. 
Indeed, the effects of methylphenidate paralleled those seen for sulpiride, with 
larger improvements on reward versus punishment learning in high relative to 
low working memory subjects. Together with the proposed baseline-dependency 
effects of methylphenidate (Volkow et al., 2002) (see above), chapter 4 generally 
supported the suggested pre-synaptic nature of sulpiride effects in high working 
memory subjects. It needs to be noted though, that this conclusion is based on the 
assumption that DAT and D2-autoreceptor blockade after acute drug administration 
elicit a similar effect on dopamine release and extracellular dopamine. Although 
animal work has indeed demonstrated similar effects of D2-receptor blockade and 
DAT-blockade on striatal dopamine release (Zhang et al., 2009), possible differences 
and interactions between DAT and D2-autoceceptor mechanisms may complicate 
this assumption. For example it has been suggested that auto-receptors also 
regulate DAT uptake (Wu et al., 2002) and that the effects of DAT-blockade depend 
on D2-autoreceptor functioning (Bello et al., 2011). Such interactions may also 
underlie the observed methylphenidate-induced impairments in reward versus 
punishment learning in low working memory subjects from chapter 4, which is 
presumably associated with decreases in dopamine. However, as our behavioural 
results do not allow such mechanistic interpretations, further investigation is 
needed to elucidate the role of these additional mechanisms and interactions in 
baseline dependent effects of methylphenidate. 
As described in the introduction, baseline dependent effects have repeatedly been 
demonstrated for D2-receptor agonists (Kimberg et al., 1997; Gibbs and D’Esposito, 
2005b). In addition, the direction of effects also often depends on the type of tasks 
used (Cools et al., 2001; Mehta et al., 2001; Cools et al., 2009). Thus, D2-agonist may 
improve performance on one task, but in the same subjects also impair performance 
on another task. In the light of the inverted-U hypothesis, these paradoxical results 
have been assigned to either differential baseline dopamine levels in the 
underlying task-related structures (Cools et al., 2001), or to task specific inverted-U 
shaped curves that each require different optimal dopamine levels (Cools and 
D’Esposito, 2011). However, these explanations would suggest that increasing 
dopamine in subjects that already have high dopamine levels, would ultimately 
impair performance on all tasks. Instead, in the light of the computational model 
(Frank, 2005) and bi-modal effects of D2-receptor agents, our baseline dependent 
effects are more consistent with a linear relationship between striatal dopamine 
and reward versus punishment learning. Thus, increases in dopamine improve 
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reward learning at the cost of punishment learning, while decreases in dopamine 
improve punishment learning at the cost of reward learning. This insight extends 
the suggestion that the nature of the relationship between cognitive effects of 
dopaminergic drugs and baseline working memory critically depends on task 
demands by specifying that dopamine shifts the balance between reward and 
punishment learning. As such, previously found opposite effects of dopaminergic 
drugs on spatial working memory tasks and probabilistic reversal learning tasks 
(Mehta et al., 2001; Clatworthy et al., 2009) may depend on the extent to which 
these tasks load on reward and punishment learning. While probabilistic reversal 
learning loads highly on punishment learning (as reversals are always signalled by 
a punishment (see introduction)) the spatial working memory task may load more 
on reward learning as the task requires the remembering of locations that were 
previously rewarded. Indeed, by using neurochemical PET, Clatworthy (2009) 
demonstrated that larger drug-induced increases in striatal dopamine were 
accompanied by larger methylphenidate-induced improvements on a reward-based 
spatial working memory task and larger methylphenidate-induced impairments 
on a punishment-based probabilistic reversal learning task. It needs to be noted 
that the complex relationship between brain dopamine and cognitive functioning 
is not restricted to reward versus punishment learning, the striatum or to 
dopamine. Working memory performance and focused attention have been 
associated with dopamine functioning in the prefrontal cortex (Arnsten, 1997) 
and the balance between cognitive flexibility and cognitive stability is suggested 
to be mediated by dopamine receptor stimulation in both the striatum and 
prefrontal cortex or their interaction (van Schouwenburg et al., 2010a; van 
Schouwenburg et al., 2010b; Cools and D’Esposito, 2011; Fallon et al., in preparation). 
Extensive research has also demonstrated a critical role for other neurotransmitter 
systems, such as noradrenalin in cognitive functioning and similar inverted-U 
shaped models have been proposed for noradrenalin and cognitive task 
performance (Aston-Jones and Cohen, 2005; Berridge and Arnsten, 2012). 
Nevertheless, the investigation of the neurochemical specificity of drug effects on 
selective and isolated cognitive processes is important to ultimately understand 
the complex interactions between neurotransmitter systems and brain regions 
that orchestrate the broad spectrum of human behaviour. 
Refining developmental models of reward processing 
Chapter 2-5 have revealed that reward and punishment learning in adults may 
depend on various factors, including individual differences in baseline striatal 
dopamine levels and the white matter integrity of fronto-limbic-striatal networks. 
Adolescence is a period in which prefrontal and subcortical regions, as well as the 
dopamine system, undergo major changes. These changes have traditionally been 
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associated with aberrant reward processing in adolescents, but it remains unclear 
whether these changes are specific to reward learning.  Accordingly, in chapter 6 
I have investigated the development of reward and punishment learning across 
adolescence and linked the results to what we currently know about the changes 
in fronto-striatal and dopaminergic functioning during adolescence. Sixty-one 
subjects from four different age groups between 10 and 25 years old were tested 
on the deterministic reversal learning paradigm to assess the hypothesis of 
 disproportionate increased reward sensitivity in adolescents. By investigating 
both valence-dependent (i.e. the difference in performance between reward and 
punishment learning) and valence-independent (i.e. the average performance on 
reward and punishment learning) reversal learning I was able to test whether the 
hypothesized increases in reward learning during adolescence were specific to 
reward processing or whether they also extend the punishment processing in our 
task. Our results supported the latter. While valence-dependent reversal learning 
changed linearly across age with better punishment relative to reward learning in 
children and better reward relative to punishment learning in adults, valence- 
independent reversal learning showed a peak during adolescence with overall 
better reversal performance in adolescents than in children and adults. Thus 
adolescents did not demonstrate the expected increase in reward relative to 
punishment learning but, instead, showed better learning from both rewards and 
punishments. Together with the knowledge gained from chapter 2-4 on the 
underlying biological mechanisms of reward and punishment learning in the 
deterministic reversal learning task, these results indicate the need to refine 
current models of overactive reward systems in adolescence (Casey et al., 2010; 
Somerville and Casey, 2010). 
As already stated in the introduction, adaptive behaviour involves multiple 
sub-processes. First one needs to learn which stimuli lead to which outcome and 
correctly update these predictions when stimulus-outcome associations change 
(i.e. knowing which restaurant currently serves the best food). Second, one needs 
to make a behavioral decision based on these predictions (i.e. choosing to which 
restaurant to go). Accordingly, one way to refine these models is by recognizing 
multiple mechanisms of adaptive behaviour that can explain the distinct 
development of valence-based (Pavlovian) learning and action-based (instrumental) 
learning. One model that incorporates such a distinction between learning 
processes in the explanation of adaptive behavior is the actor-critic model (Sutton, 
1988). This model suggests that correct action selection depends on two 
computational modules. The critic learns to predict which states or stimuli are 
associated with reward and punishment outcomes and the actor determines 
which actions to select. Based on the anatomical organisation of fronto-basal 
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 ganglia-thalamic-fronto circuits (Alexander et al., 1990), these computational 
models were later associated with ventral and dorsal striatal circuits, respectively 
(Houk et al., 1995; Joel et al., 2002). Phasic dopamine signals in the ventral striatum 
are thought to drive accurate updating of Pavlovian stimulus-outcome predictions 
or state-values based on prediction errors that signal whether outcomes are better 
or worse than expected (i.e. the critic). Phasic dopamine signals in the dorsal 
striatum are thought to drive instrumental action-specific value representations, 
based on prediction errors that signal whether an action was correct or incorrect 
(Balleine and O’Doherty, 2010; Maia and Frank, 2011). In this thesis I argue that 
valence-dependent reversal learning reflects modulation of Pavlovian critic-like 
mechanisms in the ventral striatum, while valence-independent reversal learning 
reflects modulation of instrumental actor-like mechanisms in the dorsal striatum. 
This is supported by findings from this  thesis  demonstrating that valence-dependent 
reversal learning involves dopaminergic modulations of ventral striatal regions 
(chapter 2) (van der Schaaf et al., 2012) and that these dopaminergic modulations 
depend on white matter integrity of a ventral-fronto-limbic-striatal network rather 
than that of a dorsal fronto-striatal network (chapter 3) (van der Schaaf et al., 
2013). In addition, previous work, using the probabilistic selection task, has 
demonstrated that a linear increase with age in positive relative to negative 
learning rates was accompanied by increased ventral fronto-striatal functional 
connectivity (van den Bos et al., 2012). Based on previous work (Robinson et al., 
2010a; van den Bos et al., 2012) and the results presented in chapter 2 and 3 (van 
der Schaaf et al., 2012; van der Schaaf et al., 2013) we can now link the distinct 
development patterns observed for valence-dependent and valence-independent 
reversal learning to known developmental changes in these circuits. Critically, 
there is evidence for differential developmental trajectories for dopamine 
functioning in ventral and dorsal striatal circuits (Wahlstrom et al., 2010). While 
linear increases in dopamine innervations and receptor densities have been 
reported for ventral fronto-striatal circuits, early maturations and quadratic 
patterns have been reported for dorsal fronto-striatal circuits (Teicher et al., 1995; 
Naneix et al., 2012). Moreover, D1 receptor expression has shown to linearly 
increase relative to D2-receptor expression in the ventral striatum (Teicher et al., 
1995). These findings are particularly interesting with respect to the findings on 
valence-dependent reversal learning. Thus the observed linear increase in reward 
versus punishment learning between childhood and adulthood may well reflect a 
combination of age-related linear increases in dopaminergic innervations and 
increases in the ratio of D1:D2 receptor density in the ventral striatum. Conversely, 
the observed peak in valence-independent reversal learning during adolescence 
may reflect age-related quadratic changes in dopamine innervations and receptor 
expressions in dorsal fronto-striatal circuits. 
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One important implication is that increased risk taking and decision making 
problems during adolescence do not necessarily reflect increased reward sensitivity 
and reduced behavioural control as proposed by current developmental models 
(Casey et al., 2010; Somerville and Casey, 2010). Instead, they might reflect an 
imbalance between critic-like mechanisms in ventral fronto-limbic-striatal circuits 
and actor-like mechanisms in dorsal fronto-striatal circuits. Such an imbalance is 
consistent with recent animal work showing differential developmental trajectories 
for ventral and dorsal systems that implement instrumental action-outcome 
learning and Pavlovian stimulus-outcome learning (Naneix et al., 2012). However, 
they seem to contradict results from a recent study that demonstrated, by using an 
amphetamine challenge, selective reduction of dopamine transmission in dorsal 
but not ventral striatal regions in adolescent relative to adult rats (Matthews et al., 
2013). Future work should further investigate how these neurobiological changes 
in ventral and dorsal striatal circuits relate to changes in behaviour including 
pavlovian and instrumental processes. Nevertheless the results from chapter 6 as 
well as these recent experimental animal studies highlight the role of distinct 
developmental trajectories for dorsal and ventral fronto-striatal networks in 
adolescent behaviours. 
Considerations and future perspectives for psychiatry
In this thesis I have investigated various factors that were associated with individual 
differences in dopaminergic drug response. In two studies I have demonstrated that 
drug effects depended on baseline working memory capacity and in one study I 
demonstrated that dopaminergic drug effects depended on white matter integrity 
within the OFC-amygdala pathway. These findings raise the question whether we 
can use such measures to predict dopaminergic drug effects in psychiatry to e.g. 
improve individual tailoring of drug treatments. This option is specifically tempting 
for a measure such as working memory capacity which was, in the studies described 
in this thesis, assessed by a 5 minute digit span task. In addition, in the light of 
previously observed contrasting effects of dopaminergic drugs, it might be 
particularly important to take into account individual differences in baseline 
working memory to better compare differences in the directions of the drug effects 
between studies. For example, a recent study investigated the effects of sulpiride on 
the deterministic reversal learning paradigm in new group healthy (and older) 
subjects (Janssen et al., in preparation). Results revealed that sulpiride impaired 
reward relative to punishment learning consistently across all healthy subjects, but, 
consistent with the findings from chapter 2, assessment of their working memory 
capacity revealed that most participants were at the lower end of the working 
memory spectrum. It remains unclear whether such findings will also extend to 
clinical populations. The relationship between working memory capacity and drug 
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effects was not assessed in the ADHD study reported in chapter 5 and even if it was 
assessed, a relationship between working memory and drug effects could have been 
precluded by differences in dose as subjects were tested on their individualized 
optimal dose of methylphenidate.  Another reason that may reduce the predictive 
value of working memory in the clinic is that additional factors might play a role 
when drugs are used on a chronic basis. For example, experimental animal work 
and preliminary evidence from chapter 5 suggest that different drugs may have 
different long-term effects on phasic dopamine signalling and it is unclear whether 
baseline working memory capacity can predict such effects. Accordingly, additional 
work is needed to test whether working memory capacity can serve as a prediction 
factor for (long-term) drug effects in clinical patients groups. 
In chapter 3 I demonstrated that dopaminergic drug effects depend on white 
matter integrity of fronto-limbic pathways. The effects of D2-receptor stimulation 
were larger in subjects with high communicational efficacy in fronto-limbic 
pathways than in subjects with low communicational efficacy in these pathways. 
These results may suggest that we could use DTI measures to predict drug-treatment 
response in psychiatry. More specifically, I would like to hypothesize that 
dopaminergic drug treatments may be more beneficial in psychiatric patients that 
have intact fronto-limbic white matter pathways than in patients that have 
affected white matter microstructure of these pathways. Such a finding is 
particularly relevant for psychiatry, as many neuropsychiatric disorders have 
been associated with alterations in white matter microstructure (Mandl et al., 
2012). Accordingly, these results may provide insight into neurobiological 
mechanisms that may explain why some patients do respond to pharmacological 
treatment, while others do not. Some interesting neuroimaging work into that 
direction reveals a pattern by which higher medial prefrontal activity in response 
to emotional stimuli predicted better treatment response to pharmacological 
treatments, while lower activity in these regions predicted a better response to 
psychological treatments such as cognitive behavioral therapy (Roiser et al., 2012). 
Accordingly, it would be interesting to test whether such patterns can be explained 
by differential communicational efficacy in fronto-subcortical pathways. Such 
insights may not only increase our understanding of why some patients are 
unresponsive to pharmacological treatments, but may also increase our 
understanding of the mechanisms underlying psychological treatments. In other 
words, these insights may have major impact on individual tailoring of treatment 
in psychiatry for both pharmacological and psychological treatments.  
Taken together, the results from this thesis provide evidence that baseline working 
memory and white matter integrity are associated with dopaminergic drug effects 
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in healthy subjects. However, more research is needed to test whether these 
measures may serve as valuable prediction factors for long-term drug treatments 
in psychiatry. 
Conclusions 
The work in this thesis investigated the effects of various dopaminergic drugs on 
reward and punishment learning in healthy adults as well as in a group of ADHD 
subjects. The research in this thesis extends previous findings of opposite effects 
of dopaminergic drugs in several ways. First, they refine current suggestions of 
individual differences in dopaminergic drug response by demonstrating that 
dopaminergic drug effects vary within individuals as a function of task demands 
and between individuals as a function of baseline working memory capacity. 
Second, they increase the mechanistic understanding of dopaminergic drug 
effects by establishing that dopamine can shift the balance between reward and 
punishment learning through D2-receptor dependent modulation of neural 
activity in the striatum. However, the work in this thesis also emphasizes that 
dopaminergic drug effects are complex and that in addition to task demands and 
baseline dopamine levels, multiple other factors, including the white matter 
integrity of fronto-limbic-striatal pathways and possible changes due to long-term 
treatment regiments may play a role in the final outcome of drug administration. 
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In ons dagelijks leven zijn we constant bezig met het maken van de juiste keuzes. 
Bijvoorbeeld, je gaat met een vriend uit eten en je kunt kiezen tussen een Indiaas 
restaurant, waar je eerder hebt genoten van overheerlijke kruidige curries en een 
pizzatent waar de pizza’s veel te dik zijn naar jouw smaak. Op basis van deze eerdere 
ervaringen besluiten jullie naar de Indiër te gaan en verwachten jullie weer heerlijke 
kruidige curries te krijgen. Echter, de Indiër heeft sinds kort een nieuwe kok en het 
eten was lang niet zo lekker als je had verwacht. Teleurgesteld lopen jullie langs de 
pizzatent en door de ramen zien jullie dat deze tent ook een nieuwe kok heeft 
ingehuurd en nu heel mooie dunne knapperige pizza’s serveert! De volgende keer 
wordt het dus pizza. Het maken van de juiste keuzes en het aanpassen aan een steeds 
veranderende omgeving vereist de kennis van welk gedrag op dit moment beloond 
wordt en welk gedrag op dit moment gestraft wordt. In het voorbeeld hierboven 
kunnen we dit proces opsplitsen in drie stappen. Eerst moet je weten welk restaurant 
op dit moment lekker eten serveert en welk restaurant geen lekker eten serveert. 
Vervolgens moet je deze kennis kunnen aanpassen wanneer blijkt dat de kwaliteit 
van het eten in de restaurants is veranderd. Tot slot moet je deze kennis gebruiken 
om de te besluiten naar welk restaurant je zult gaan. 
Het onderzoek in dit proefschrift richt zich op het tweede proces. Hoe houd je, in 
een wereld waarin de kwaliteit van restaurants constant verandert, bij in welk 
restaurant op dit moment goed eten wordt geserveerd en in welk restaurant op dit 
moment slecht eten wordt geserveerd? Belangrijk in dit proces is dat je deze kennis 
aanpast aan de hand van onverwachte straffen (het eten was slechter dan verwacht) 
en onverwachte beloningen (het eten was beter dan verwacht). Het hersenstofje 
dopamine speelt een belangrijke rol bij het signaleren van deze onverwachte 
uitkomsten. We weten van eerder onderzoek met apen dat dopaminekernen in de 
hersenstam in een korte tijd veel dopamine afgeven wanneer een aap onverwacht 
een beloning krijgt en kort pauzeren in de dopamine afgifte wanneer een aap een 
beloning verwacht maar deze niet krijgt. In dit proefschrift heb ik de rol van dopamine 
in de hersenen van mensen onderzocht bij het aanpassen van verwachtingen aan de 
hand van onverwachte beloningen en onverwachte straffen. Dit heb ik onder 
andere gedaan door proefpersonen verschillende medicijnen te geven die het 
 dopaminesysteem beïnvloeden. Deze medicijnen noem ik vanaf nu dopaminerge 
medicijnen. Figuur 1 laat een overzicht zien van de medicijnen die in dit proef- 
schrift zijn gebruikt . Vervolgens heb ik de effecten van deze medicijnen gemeten 
op het gedrag en de hersenactiviteit door proefpersonen een computertaak te laten 
uitvoeren die meet hoe mensen hun verwachtingen aanpassen na onverwachte 
beloningen en onverwachte straffen. 
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Figuur 1   De werking van dopamine en dopaminerge medicijnen.
1) De werking van dopamine: Na een inkomend signaal in het pre-synaptische neuron wordt 
dopamine uit de blaasjes vrijgegeven in de synapsspleet. Hier kan dopamine verschillende 
receptoren stimuleren. Stimulatie van de D1-receptor met dopamine zorgt voor verhoging van 
activiteit in het directe ‘GO’ pad en het leren van beloningen. Stimulatie van de D2-receptor 
met dopamine zorgt voor verlaging van activiteit in het indirecte ‘NOGO’ pad en het leren van 
straffen. Dus, meer dopamine in de synaps spleet verschuift de balans naar beter leren van 
beloning en slechter leren van straf. De dopamine transporter en de autoreceptor reguleren 
het dopamine niveau in de synapsspleet. De dopamine transporter neemt het teveel aan 
dopamine weer op in het pre-synaptische neuron en stimulatie van de auto-receptor verlaagt 
de afgifte van dopamine. 2) De werking van methylphenidaat. Methylphenidaat blokkeert de 
dopamine transporter en voorkomt hiermee de heropname van het teveel aan dopamine uit 
de synapsspleet. Het gevolg is dat er meer dopamine in de synapsspleet blijft en de balans 
wordt verschoven naar beter leren van beloning dan van straf. De mate waarin methylphenidaat 
dopamine niveaus kan verhogen hangt af van de hoeveelheid dopamine die wordt vrijgegeven. 
3) De werking van bromocriptine en sulpiride. Bromocriptine is een D2-receptor agonist en 
stimuleert, net als dopamine, de D2-receptor en de autoreceptor. Sulpiride is een D2-receptor 
antagonist en blokkeert de D2- en auto-receptor en voorkomt daarmee dat dopamine deze 
receptoren stimuleert. Bromocriptine en sulpiride kunnen de balans tussen het leren van 
straf en beloning op twee manieren verschuiven. Ze kunnen de activiteit in het indirecte 
‘NOGO’ pad direct beïnvloeden via stimulatie of blokkade van de D2-receptor en ze kunnen de 
dopamine afgifte en daarmee de hoeveelheid dopamine in de synapsspleet beïnvloeden via 
auto-receptoren. Deze duale werking is een mogelijke verklaring voor de individuele 
verschillen in de effecten van bromocriptine en sulpiride.
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De computertaak die in dit proefschrift is gebruikt is de zogenaamde “reversal 
learning” taak. In deze taak leren proefpersonen dat het ene plaatje altijd gevolgd 
werd door een beloning (een blije groene smiley met +100 euro) en het andere 
plaatje altijd gevolgd werd door een straf (een boze rode smiley met -100 euro). 
Wanneer de proefpersoon een aantal keer achter elkaar de juiste voorspelling 
heeft gedaan wordt de situatie omgedraaid (de reversal). Het plaatje dat voorheen 
werd gevolgd door een beloning, wordt nu ineens gevolgd door een straf en het 
plaatje dat voorheen  werd gevolgd door een straf, wordt nu ineens gevolgd door 
een beloning. Vervolgens wordt gemeten hoe goed de proefpersoon zijn voor-
spellingen aanpaste aan de nieuwe situatie in reactie op de onverwachte beloning 
en onverwachte straf. Met deze taak kon ik zowel veranderingen in de balans 
tussen leren van straf en beloning onderzoeken (uitkomst-afhankelijk leren), als 
ook de verandering in het leren van onverwachte uitkomsten, ongeachte of het een 
straf of beloning was (uitkomst-onafhankelijk leren) .
Figuur 2   De relatie tussen dopamine niveau en prestatie op een taak.
a) Schematisch weergave van de omgekeerde U-hypothese. Deze hypothese suggereert dat 
een middelmatig dopamine niveau samen gaat met de beste prestaties op een taak (B) en dat 
te weinig (A) of teveel (C) dopamine zorgt voor slechtere prestaties op deze taak. Verhogen 
van het dopamine niveau kan daarom de prestatie op een taak verbeteren in proefpersonen 
die een laag dopamine niveau hebben (AB), maar kan de prestatie verslechteren in proef- 
personen die al een optimaal dopamine niveau hebben (BC). b) Schematische weergave 
van de verschuiving in de balans tussen het leren van straf en beloning. De resultaten uit dit 
proefschrift (hoofdstuk 2, 4 en 6) toonden aan dat dopamine niet alleen de prestatie op één 
taak beïnvloedt, maar dat dopamine de balans tussen twee verschillende taken verschuift 
zoals die tussen het leren van beloning en het leren van straf.
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Individuele verschillen
Eerdere onderzoeken hebben laten zien dat er veel individuele verschillen zijn in 
zijn in de reactie op dopaminerge medicijnen. De prestatie op een bepaalde taak 
kan bij de één door het medicijn verbeterd worden terwijl het bij de ander juist 
verslechtert. Sommige onderzoekers verklaren deze bevindingen met de omgekeerde 
U-hypothese (figuur 2a). Deze hypothese suggereert dat een middelmatig dopamine 
niveau samen gaat met de beste prestaties op de taak en dat te veel of te weinig 
dopamine zorgt voor slechtere prestaties op de taak. Een praktisch voorbeeld 
Figuur 3   Overzicht van hersennetwerken.
De basale ganglia, een verzameling kernen in het midden van het brein (de grijze bol), 
communiceren met de hersenschors, de gekleurde blokken. Deze communicatie wordt 
beïnvloed door dopamine vanuit kernen in de hersenstam, hier aangegeven met rode 
pijltjes. Er zijn 3 belangrijke netwerken. De verbindingen tussen de orbito-fontale cortex, 
amygdala, hippocampus en basale ganglia vormen het motivationele netwerk, en is 
betrokken bij het leren en aanpassen van verwachtingen (groen). De verbindingen tussen de 
dorsolaterale prefrontale cortex en de basale ganglia vormen het cognitieve netwerk en is 
belangrijk voor het onthouden en verwerken van informatie (blauw). De verbindingen 
tussen de motor cortex en de basale ganglia vormen het motor netwerk en zijn belangrijk 
voor de selectie en uitvoering van bewegingen. Afkortingen: PFC = prefrontale cortex, DA = 
dopamine.
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hiervan is het drinken van koffie. Eén kop koffie kan je helpen beter te focussen op 
je werk, maar wanneer je daarna nog meer koffie drinkt, wordt je onrustig en krijg 
je weer moeite met focussen. Binnen het kader van dit onderzoek zou je kunnen 
zeggen dat de effecten van dopamine verhoging afhankelijk zullen zijn van het 
niveau waarop de proefpersoon al zat. Van eerder onderzoek is bekend dat de score 
op een werkgeheugentaak samenhangt met het dopamine niveau in het brein. In 
dit proefschrift heb ik daarom onderzocht of de effecten van dopaminerge 
medicijnen samenhangen met de score op een werkgeheugentaak. 
De effecten van bromocriptine en sulpiride
De basale ganglia zijn kernen die zich in het midden van het brein bevinden en in 
verschillende netwerken communiceren met de buitenste schors van de hersenen(-
figuur 3). De basale ganglia spelen een belangrijke rol in het leren van staf en 
beloning. De kernen binnen het netwerk van basale ganglia communiceren met 
elkaar via twee belangrijke paden, het directe ‘GO’ pad dat geassocieerd is met het 
leren van beloning en het indirecte ‘NOGO’ pad dat geassocieerd is met het leren 
van straf. Volgens het model van Michael Frank reguleert dopamine de balans 
tussen het leren van straf en beloning door de balans tussen deze twee paden in de 
basale ganglia te beïnvloeden. In hoofdstuk 2 heb ik dit model getest door te 
onderzoeken of dopaminerge medicijnen een effect hebben op de hersenactiviteit 
tijdens onverwachte straffen en beloningen en of dit effect samenhangt met de 
balans tussen het leren van straf en beloning. Tweeëntwintig proefpersonen 
kregen twee verschillende medicijnen, Bromocriptine en Sulpiride, waarvan 
bekend is dat ze tegenovergestelde effecten op het dopaminesysteem hebben 
(figuur 1). De resultaten toonden aan dat deze twee medicijnen inderdaad 
omgekeerde effecten op de hersens activiteit in de basale ganglia hadden tijdens 
onverwachte straffen en beloningen. Bovendien hing dit effect samen met een 
verandering in de balans tussen het leren van de straf en beloning. Een toename 
in hersenactiviteit hing samen met een verbetering in het leren van beloning en 
een verslechtering in het leren van staf. Deze resultaten ondersteunen daarmee 
het model van Michael Frank door aan te tonen dat dopamine de balans tussen 
straf en beloning reguleert door de activiteit in de basale ganglia te beïnvloeden. 
Echter, de basale ganglia staan niet op zichzelf en communiceren ook met de 
hersenschors via verschillende netwerken. In hoofdstuk 3 heb ik de rol van deze 
netwerken verder onderzocht. 
Hersengebieden communiceren met elkaar via witte stof banen, een soort 
snelwegen in het brein waarover informatie kan worden verzonden van het ene 
gebied naar het andere gebied. Deze witte stof banen verbinden de basale ganglia 
en de hersenschors met elkaar en vormen zo verschillende netwerken. We kunnen 
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grofweg drie verschillende netwerken onderscheiden. Ieder netwerk is gespeciali-
seerd in het uitoefenen van een verzameling functies zoals het verwerken van 
beloningen en straffen (motivationele netwerk), het onthouden en verwerken van 
informatie (cognitieve netwerk)en het initiëren van acties (motorische  netwerk) 
(figuur 3). Gebaseerd op de kennis dat dopamine de communicatie binnen deze 
netwerken beïnvloedt wilde ik de hypothese testen of de effecten van dopaminerge 
medicijnen afhangen van de kwaliteit van witte stof banen. Ik wilde in het 
bijzonder onderzoeken of de effecten van dopaminerge medicijnen afhankelijk 
zijn van witte stof banen in het motivationele netwerk of dat de effecten afhankelijk 
zijn van witte stof banen in het cognitieve/motor netwerk. Daarom heb ik in 
hoofdstuk 3 de resultaten van hoofdstuk 2 verder uitgebreid met Diffusie Tensor 
Imaging, een techniek die de kwaliteit van witte stof banen meet. Hieruit bleek dat 
de tegenovergestelde effecten van sulpiride en bromocriptine op de hersenactivite-
it in de basale ganglia afhankelijk zijn van bepaalde verbindingen in het 
motivationele netwerk en niet van de verbindingen in het cognitieve/motor 
netwerk. Deze resultaten geven meer fundamenteel inzicht in de onderliggende 
mechanismen van het leren en aanpassen van verwachtingen en ondersteunen 
een huidige theorie waarin gesuggereerd wordt dat de communicatie binnen het 
motivationele netwerk een essentiële rol speelt in de vergelijking tussen verwachte 
en ervaren uitkomsten. 
De effecten van methylphenidaat
In hoofdstuk 4 en 5 heb ik onderzoek gedaan naar de effecten van methylphenidaat, 
beter bekend onder de merknaam Ritalin (figuur 1). Dit medicijn wordt gebruikt 
voor de behandeling van Attention Deficit Hyperactivity Disorder (ADHD) en helpt 
mensen met ADHD beter te focussen, bijvoorbeeld op school of tijdens het studeren. 
Ook steeds meer gezonde mensen gaan Ritalin gebruiken om beter te kunnen 
studeren. Echter, onderzoek met methylphenidaat bij gezonde volwassenen levert 
gemengde resultaten. Dit is misschien te verklaren met behulp van de omgekeerde 
U-relatie tussen de prestaties op een taak en het dopamine niveau, die ik eerder heb 
beschreven in deze samenvatting. Het is dus de vraag of het medicijn dezelfde effecten 
heeft bij gezonde studenten, als bij mensen met ADHD bij wie het dopaminesysteem 
verstoord is. Een tweede mogelijke reden voor gemengde bevindingen is dat 
 methyl phenidaat mogelijk niet alleen maar prestaties verbetert, maar ook de 
prestatie op bepaalde taken verslechtert. In hoofdstuk 2 zagen we al dat 
dopaminerge medicijnen de balans tussen het leren van straf en beloning 
verschuift. In hoofdstuk 4 heb ik daarom 19 gezonde studenten getest op de 
reversal learning taak nadat ze Ritalin hadden ingenomen en nadat ze een placebo 
hadden gekregen. Een placebo ziet er hetzelfde uit als de echte pil, maar bevat een 
niet werkende stof. De resultaten toonden aan dat methylphenidaat, net als de 
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medicijnen in hoofdstuk 2, de balans tussen het leren van straf en beloning 
verschuift en dat deze effecten samenhingen met de score op een werkgeheugen-
taak, waarvan eerder is aangetoond dat de score samenhangt met het dopamine 
niveau in het brein. Deze resultaten gaven nieuwe inzichten met betrekking tot de 
omgekeerde U-hypothese. Ze toonden aan dat methylphenidaat niet alleen 
prestaties verbetert, maar dat methylphenidaat een balans verschuift en prestaties 
verbetert op de ene taak, ten koste van prestaties op de andere taak (figuur 2b). 
Daarnaast toonden de resultaten aan dat de effecten afhankelijk zijn van het 
dopamine niveau in iemands brein. Het is dus niet vanzelfsprekend dat methyl-
phenidaat iemand zal helpen bij het studeren, de effecten zijn afhankelijk van de 
persoon die het neemt en de taak die hij uitvoert. 
In hoofdstuk 5 heb ik gekeken naar de effecten van langdurig gebruik van meth-
ylphenidaat in mensen met ADHD. ADHD is een stoornis die gekenmerkt wordt 
door hyperactiviteit en problemen met de aandacht, maar ook door veranderingen 
in het beloningssysteem. Deze symptomen worden vaak geassocieerd met 
abnormale dopamine functie in de basale ganglia en prefrontale cortex. Er zijn 
verschillende soorten medicijnen met methylphenidaat voor ADHD. Ritalin en 
Concerta zijn de bekendste. Ritalin geeft de methylphenidaat snel af, werkt kort en 
moet 3 keer per dag ingenomen worden. Concerta geeft langzaam methylpheni-
daat af, werkt langer en hoeft daarom maar 1 keer per dag ingenomen te worden. 
De klinische effecten van deze medicijnen worden vaak toegeschreven aan hun 
verhogende effect op de rust-dopamine niveaus in het brein. Echter, een theorie 
voorspelt dat langdurig gebruik van methylfenidaat op den duur ook leidt tot een 
daling van de korte dopamine pieken die zo belangrijk zijn voor het leren van 
beloningen. Doordat methylphenidaat ook de rust-niveaus verhoogd, blijft dit 
effect onopgemerkt. De theorie voorspelt dus dat mensen met ADHD die zich 
onthouden van hun medicijnen veel slechter leren van beloningen (hun ‘belonings-
signaal’ is immers verlaagd) dan wanneer ze getest worden nadat ze hun medicijnen 
hebben ingenomen. Om deze hypothese te testen heb ik de reversal learning taak 
afgenomen bij 23 proefpersonen met ADHD en 26 proefpersonen zonder ADHD. 
De personen met ADHD slikten minstens 9 maanden medicijnen en werden getest 
na een dag onthouding van hun medicatie en na normale inname van hun 
medicatie. Dieronderzoek heeft aangetoond dat de lange termijn effecten van 
dopaminerge medicijnen sterk afhangen de snelheid van afgifte van het medicijn. 
Daarom heb ik ook gekeken naar de verschillen tussen Ritalin en Concerta 
gebruikers. Over de gehele ADHD groep vond ik geen betekenisvolle effecten. 
Echter, wanneer ik de personen die normaal gesproken Ritalin gebruikten, 
vergeleek met de personen die normaal gesproken Concerta gebruikten, ontdekte 
ik dat alleen de Concerta groep na onthouding veel slechter leerden van beloning 
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dan de Ritalin groep en deelnemers zonder ADHD. Deze resultaten waren 
opvallend en gaven aanleiding tot een nieuwe hypothese, namelijk dat de lange 
termijn effecten van methylphenidaat afhangen van de temporele dynamiek van 
het medicijn. Deze hypothese sluit aan bij resultaten uit verslavingsonderzoek dat 
heeft aangetoond dat een zeer snel werkende drug veel verslavender is dan een 
langzaam werkende drug. Hoewel er veel onderzoek is gedaan naar de eventuele 
verslavende werking van Ritalin of Concerta is er minder bekend over mogelijk 
negatieve effecten van langzaam werkende medicijnen zoals Concerta, zoals een 
verminderde beloningsgevoeligheid. Het onderzoek in mijn proefschrift was te 
beperkt om hier definitieve conclusies uit te trekken, maar geeft wel aanleiding 
voor een nieuw en speciaal hiervoor opgezet onderzoek waarin deze hypothese 
beter getest kan worden. 
Straf en beloning tijdens de adolescentie
In hoofdstuk 2 tot en met 5 heb ik laten zien dat verschillende factoren invloed 
kunnen hebben op het leren van staf en beloning in volwassenen. De resultaten 
gaven meer inzicht in de rol van het dopaminesysteem en de verbindingen in het 
motivationele netwerk tijdens het uitvoeren van de reversal learning taak. Tijdens 
de adolescentie ondergaan deze systemen grote veranderingen. Adolescentie is een 
periode die gekarakteriseerd wordt door verhoogde impulsiviteit en risicovol 
gedrag, wat vaak geassocieerd wordt met een verhoogde beloningsgevoeligheid. 
Echter, ondanks eerder onderzoek is het nog altijd onduidelijk of adolescenten 
specifiek gevoeliger zijn voor beloningen (en minder gevoelig voor straffen) of dat 
ze gevoelig zijn voor zowel beloningen als straffen. Om deze vraag te beantwoorden 
heb ik in hoofdstuk 6 de reversal learning taak afgenomen bij 61 proefpersonen 
tussen 10 en 25 jaar oud. Hierbij heb ik zowel de leeftijdsgerelateerde verandering 
in de balans tussen het leren van straf en het leren van beloning (uitkomst- 
afhankelijk leren) onderzocht als de leeftijdsgerelateerde verandering in het leren 
van beide uitkomsten samen (uitkomst-onafhankelijk leren). De resultaten lieten 
niet de voorspelde specifieke verhoging in beloningsgevoeligheid zien, maar 
toonden aan dat adolescenten, vergeleken met kinderen en volwassenen, beter 
waren in het leren van zowel straffen als beloningen (uitkomst-onafhankelijk 
leren). De balans tussen leren van straf en leren van beloning verschoof geleidelijk 
met leeftijd. Kinderen waren beter in het leren van straf dan van beloning, terwijl 
volwassenen beter waren in het leren van beloning dan van straf. Deze resultaten 
benadrukken dat de bestaande adolescentie modellen bijgeschaafd moeten 
worden. Dus in plaats van een specifieke verhoging in de beloningsgevoeligheid is 
er bij adolescenten sprake van een verstoord evenwicht tussen uitkomst- afhankelijk 
leren en uitkomst-onafhankelijk leren. In hoofdstuk 6 beargumenteer ik dat deze 
bevindingen samenhangen met verschillen in de ontwikkeling van het motivationele 
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netwerk dat belangrijk is voor het leren en aanpassen van de associatie tussen een 
stimulus en de uitkomst (e.g. het restaurant en het eten) en het cognitieve/motor 
netwerk dat belangrijk is voor het maken van de juiste keuze (het restaurant 
binnen stappen). Het verhoogde risicovolle gedrag tijdens adolescentie is dus mogelijk 
gerelateerd aan een verstoorde balans tussen deze twee netwerken waarbij actie 
de overhand krijgt boven kennis. 
Conclusies
Om de juiste keuzes te maken in het belangrijk dat we onze verwachtingen 
aanpassen aan de hand van onverwachte straffen en beloningen. In dit proefschrift 
heb ik onderzocht hoe medicijnen die het dopaminesysteem beïnvloeden het leren 
van straf en beloning veranderen. De resultaten toonden aan dat het niet vanzelf-
sprekend is dat een pilletje ons functioneren alleen maar verbetert. De effecten 
van een medicijn zijn afhankelijk van de persoon die het inneemt en de taak die 
hij uitvoert. In dit proefschrift heb ik dit aangetoond door te laten zien dat 1) 
dopaminerge medicijnen de balans tussen het leren van straf en beloning 
verschuiven en 2) dat deze effecten variëren naar gelang de score op een 
werkgeheugen taak. Een pilletje kan dus het leren van beloning verbeteren, ten 
kosten van het leren van straf, of andersom. Ook toon ik aan dat effecten van 
medicijnen op activiteit in de basale ganglia samenhangt met de verschuiving in 
de balans tussen het leren van straf en beloning, wat de rol van dopamine in deze 
hersenkernen tijdens dit proces benadrukt. Samen dragen deze resultaten bij aan 
ons begrip van individuele verschillen in de effecten van dopaminerge medicijnen.
Echter, het werk in dit proefschrift benadrukt ook de complexiteit van de effecten 
van dopaminerge medicijnen en laat zien dat ook andere factoren, zoals de 
kwaliteit van witte stof banen en lange termijn effecten van medicijnen, invloed 
kunnen hebben op de precieze werking van een medicijn. Het beter begrijpen van 
deze effecten is belangrijk voor het gebruik van deze medicijnen, zowel in de 
gezonde populatie als in de psychiatrie. Kunnen we metingen zoals werkgeheugen 
en witte stof banen gebruiken om de effecten van medicijnen in klinische groepen 
beter te voorspellen? Kunnen we ons intellect verbeteren door het juiste pilletje 
voor de juiste taak te nemen? Toekomstig onderzoek zal dat hopelijk uitwijzen.
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